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ABSTRACT 
Stagonospora nodorum is a necrotrophic fungal pathogen of wheat and related 
grasses. It is the causal agent of Stagonospora nodorum blotch of wheat, a major 
disease causing upwards of 100 million dollars (AU$) damage in yield loss per 
annum.  
Stagonospora nodorum is a member of the Dothideomycete class of filamentous 
ascomycetes. Within this class are numerous plant pathogens that rely on 
secondary metabolite (SM) phytotoxins of the polyketide class as pathogenicity 
and/or virulence factors. While the production of proteinaceous host specific 
toxins has been studied extensively in S. nodorum, the role of secondary 
metabolites in the pathogenic lifecycle of this fungus is completely unexplored.  
In this study a combination of bioinformatics, molecular biology and analytical 
chemistry techniques are used to investigate polyketide synthesis in S. nodorum. 
In silico analysis of polyketide synthase (PKS) gene and protein sequences was 
used to catalogue and classify the PKS repertoire of S. nodorum, assign putative 
functions to PKS genes based on homology, identify PKS gene clusters and 
elucidate the phylogenetic history of PKSs in S. nodorum. Transcriptomics 
techniques were used to identify genes active during important stages of the 
pathogenic lifecycle as candidates for targeted gene deletion experiments. The 
role these genes play in host colonisation and disease progression was analysed 
using knockout mutagenesis and in vitro and in planta characterisation of mutant 
strains. Secondary metabolite extraction and LC-MS analysis techniques were 
evaluated to identify key compounds produced by the wild type fungus that were 
differentially abundant in the knockout mutants. 
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With this approach, a highly conserved alternative melanisation pathway gene 
cluster involving the putative DHN-melanin synthase MEL1, a putative 
oxidoreductase and a putative transcription factor has been identified. Further 
findings highlighted a rapid evolution and plasticity of PKS genes in S. nodorum. 
Knockout mutants for the SMS1, PKS1 and PKS3 polyketide synthase genes 
have been generated and were tested for defects in pathogenicity, metabolism 
and sporulation. No significant differences to the wild type were detected, 
indicating a menial role for these genes during pathogenesis. An SPE based 
method for isolating SM from culture filtrate was developed and used to identify 
compounds produced by S. nodorum in liquid culture, as well as two putative 
polyketide products absent in cultures of the SMS1 knockout mutant putatively 
linked to a cryptic mycotoxin pathway.  
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1 General Introduction 
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1.1 Wheat production and impact of disease 
Wheat (Triticum spp) is one of the oldest cultivated crops, with a history dating 
back to the Neolithic (Zohary and Hopf, 2000). It is one of the most important 
cereals in agriculture, with an annual production of nearly 700 million tonnes (MT) 
worldwide in 2009. Australia is the 9th largest producer of wheat in the world (per 
tonnes produced), with a production volume of 21.4 MT in 2009 (Food and 
Agriculture Organisation of the United Nations, 
www.fao.org/docrep/011/ai482e/ai482e03.htm). More than 60% of the total 
production is exported, making it the most important export crop in Australia and 
a significant source of revenue (Australian Bureau of Statistics, 
http://www.abs.gov.au).  
Wheat production in Australia is threatened by a range of diseases mainly 
caused by fungi, bacteria, viruses and nematodes. Average annual losses to 
pathogens are estimated at almost 20% of the value of production, or 913 million 
Australian dollars (AU$). Necrotrophic fungi have the highest impact, accounting 
for 322 million AU$. They are especially prevalent in Western Australia, the 
largest Australian wheat growing region (Table 1-1) (Murray, 2009).  
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Figure 1-1 Wheat growing regions of Australia  
(Australian Bureau of Statistics, http://www.abs gov.au, 2012)  
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Table 1-1 Impact of fungal wheat pathogens in Australia 
Potential and present average annual yield losses (% per year) caused by fungal wheat 
pathogens in Grains Research and Development Corporation regions of Australia, 
adapted from (Murray, 2009). S. nodorum is highlighted in bold font 
Pathogen 
Northern Southern Western 
Potential Present Potential Present Potential Present 
Necrotrophic leaf fungi 
Cochliobolus sativus 0 0 0 0 0 0 
Drechslera wirreganensis 0 0 0 0 0 0 
Mycosphaerella graminicola 0 0 0.9 0.1 0 0 
P avenaria f. sp. triticea 0 0 0 0 0 0 
P. nodorum 0 0 0 0 12.9 6 
Pyrenophora semeniperda 0 0 0 0 0 0 
P. tritici-repentis 19 4.3 3.9 1 12.9 6 
       
Biotrophic leaf fungi 
Blumeria graminis f. sp. tritici 0.9 0.2 0.1 0 0.4 0.1 
Puccinia graminis f. sp. tritici 39.6 0.4 4 0 2.2 0.3 
P. triticina 11 0.8 3.6 0.1 1.4 0.2 
P. striiformis 44.3 5.3 25.5 2.8 3.7 1.1 
Sclerophthora macrospora 0 0 0 0 0 0 
Urocystis agropyri 2.4 0 1.7 0 0.6 0 
       
Root and crown fungi 
C. sativus 3.2 0.8 4 1.2 0 0 
Fusarium culmorum 1.1 0.3 0.4 0.1 0 0 
F. pseudograminearum 22.2 4.4 10.5 1.8 1.5 0.3 
S. graminis var. tritici 0 0 3.6 0.4 1.4 0.2 
Pythium spp. 0.1 0.1 1 0.4 0.4 0.1 
Rhizoctonia solani 0 0 4.1 2 4.5 1.1 
Tapesia yallundae 0 0 0.2 0 0 0 
Wojnowicia graminis 0 0 0 0 0 0 
       
Inflorescence fungi 
Claviceps purpurea 0 0 0.5 0 0 0 
Fusarium graminearum 0.2 0.1 0 0 0 0 
Tilletia laevis, T. caries 0.2 0 2.8 0 0.6 0 
Ustilago tritici 1.8 0 1.3 0 0 0 
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1.2 Fungal pathogens  
Fungi affect human nutrition in several ways. Firstly, fungal fruiting bodies serve 
as food directly. Mushrooms like Agaricus, Boletus, Morchella, Lentinula and 
Tuber spp. are common examples of edible fungi that are farmed or manually 
collected in their natural habitat (Boa et al., 2004). Secondly, fungi are used in 
the production and processing of foodstuffs. The oldest confirmed examples are 
brewing of beer by Sumerians as early as 7000 BC. and leavening of bread by 
the Egyptians around 4000 BC (Demain, 1981), the fermentation of rice and soy 
beans for the production of sake, miso and soy sauce using the ―Koji‖ fungus 
Aspergillus oryzae (Demain, 2008), or the production of citric acid by 
fermentation with the fungus Aspergillus niger and Candida yeasts (Grewal and 
Kalra, 1995). Lysed yeasts cells (yeast extract) are marketed as flavour 
enhancers and as a source of B-vitamins. Mycorrhizal fungi, especially 
arbuscular mycorrhiza (AM), are a key beneficial factor in agriculture (Evelin et 
al., 2009).  
Not all fungi, however, are welcomed in agriculture. More than 10.000 fungal 
species act as parasites on plants and animals, both domesticated and wild-living 
(Agrios, 2005). Pathogenic fungi cause annual losses in excess of 200 billion 
$US in agriculture, more than any other group of microorganisms (Birren et al., 
2002). Fungal plant pathogens were commonly classified into three categories 
according to their nutritional strategies: biotrophic fungi (biotrophs) that rely on 
living plant tissue to survive, necrotrophic fungi (necrotrophs) that derive their 
nutrition from dying plant tissue and hemibiotrophs, which have a biotrophic 
phase followed by necrotrophic growth (Perfect and Green, 2001; Oliver and 
Ipcho, 2004). These divisions, however, are somewhat arbitrary and disputed, 
and indeed a number of fungi have been classified into two or even all three 
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groups by different authors. Research in recent years has brought a better 
understanding of the molecular mechanisms of fungal pathogenesis and has 
thereby opened up new principles for classifying fungal pathogens (Oliver and 
Ipcho, 2004).  
One useful criterion is the presence/absence of haustoria. Haustoria are formed 
by the plasma membranes of the host and the pathogen and serve as structures 
for nutrient acquisition for the fungus but also modulation of host metabolism and 
suppression of host defence (Mendgen and Hahn, 2002; Dodds, 2009). The 
inducible plant defence consists of a two-stage system (Jones and Dangl, 2006). 
The first stage is initiated by recognition of pathogen-associated molecular 
patterns (PAMPs), conserved microbe-specific features like flagellin (bacteria) or 
chitin and ergosterol (fungi). PAMP recognition is mediated through receptor-like 
kinases associated with the plant cell surface. Binding of the relevant molecules 
activates MAP Kinase (MAPK) signalling cascades, which induce defence genes 
for a primary immune response (Chisholm, 2006). Some pathogenic fungi 
(biotrophs and hemibiotrophs) have evolved effector proteins that can suppress 
this process and avoid the so-called PAMP-triggered Immunity (PTI). Some of 
these effector proteins, however, are recognized by a second stage of plant 
defence. This system involves intracellular proteins which are the products of 
plant resistance (R) genes. R proteins directly or indirectly recognize the products 
of fungal avirulence genes (Avr) and initiate defence responses, a process 
referred to as effector triggered immunity (ETI) (Ellis, 2007). ETI responses of the 
plant are mediated by salicylic acid (SA)-dependent pathways, leading to 
activation of pathogenesis-related (PR) genes. The defence mechanisms involve 
oxidative burst and a form of programmed cell death also known as 
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hypersensitive reaction (HR) (Hammond-Kosack and Parker, 2003; Glazebrook, 
2005). 
While the interaction of biotrophs with (resistant non-host) plants is governed by a 
gene-for-gene relationship, interaction of some necrotrophs and (susceptible 
host) plants is governed by an inverse gene-for-gene reaction. Here, the product 
of a fungal virulence gene, e.g. a host specific toxin (HST), interacts with the 
product of a plant sensitivity gene, resulting in cell death and susceptibility of the 
plant (Friesen et al., 2008a; Horbach et al., 2011). These HTSs can be small 
secreted proteins or secondary metabolites, significant examples of the latter are 
discussed in 1.5. Necrotrophs have also been shown to actively elicit plant 
defence reactions targeted at biotrophs, like oxidative bursts and HR (Horbach et 
al., 2011). The interaction of Cochliobolus victoriae and Victoria oats is an 
example for an R gene conferring resistance to a biotroph causing susceptibility 
to a necrotroph (Meehan, 1947; Lorang et al., 2010) (see 1.5.4). Resistance to 
necrotrophs is mediated through jasmonate and ethylene-dependent pathways 
(Jones and Dangl, 2006). These pathways act in antagonism to SA mediated 
pathways and also govern responses towards mechanical wounding and 
herbivore-induced damage (Glazebrook, 2005; Chisholm, 2006).  
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1.3 Stagonospora nodorum  
Stagonospora (syn. Septoria) nodorum (Berk.) Castell. & Germano [teleomorph: 
Phaeosphaeria (syn. Leptosphaeria) nodorum (Müll.) Hedjar.] is a filamentous 
fungus belonging to the Dothideomycetes class of ascomycetes (Cunfer, 1999; 
Goodwin, 2004; Hane et al., 2007), see Figure 1-2. Like many other members of 
this group, it is a non-haustorial, necrotrophic pathogen of wheat and other cereal 
crops (Solomon, 2006b; Solomon et al., 2006c). In wheat, the disease caused is 
called stagonospora nodorum blotch (SNB), characterised by chlorosis and tip 
burn of the leaf, followed by necrotic lesions and tissue collapse at the affected 
areas, as well as discoloration of the head, known as glume blotch (Solomon, 
2006b). Stagonospora nodorum is distributed worldwide and is an major 
pathogen in important wheat growing regions (Wiese, 1987). In Australia, 
average annual losses due to SNB sum up to 108 million AU$, making it the third 
most important pathogen of wheat. It is especially prevalent in the wheat growing 
regions of Western Australia (Figure 1-4), where it is the most important 
pathogen along with Pyrenophora tritici-repentis, causing yield losses of up to 9% 
per year (p.a.), and a destructive potential of nearly 20% (Murray, 2009).  
The pathogenic life cycle (Figure 1-3, A) of S. nodorum begins with a spore 
germinating on the host leaf surface. A germ tube is formed, and within 12 h of 
germination, fungal hyphae penetrate the leaf via stomata or directly through the 
cuticle without obvious differentiation (Solomon et al., 2006c). Inside the host, S. 
nodorum grows in the intercellular space and produces proteinaceous host-
specific toxins (HSTs) to actively kill the host tissue (Liu, 2004; Friesen et al., 
2007; Friesen et al., 2009). Infected leaves undergo tissue necrosis (Figure 1-3, 
B) within one week after inoculation (Solomon et al., 2006c). The fungus then 
forms pycnidia in the leaf (Figure 1-3, C), in which asexual conidiospores are 
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generated (Solomon, 2006b). Rain-splash dispersed conidia are the main 
inoculum for secondary infection and propagation of S. nodorum during the 
growing season (Shah, 2001). At the end of the season, the fungus produces 
sexual ascospores which are transmitted over great distances by air and, along 
with infected seeds, serve as the primary inocula for the following season (Shah, 
2000; Bathgate, 2001). 
Several genetic factors required for successful host colonisation and disease 
propagation have been identified. S. nodorum produces several proteinaceous 
HSTs that cause tissue necrosis in susceptible plants. Lack of one or more HSTs 
of the fungus or sensitivity genes in the host result in variably reduced disease 
(Liu et al., 2006; Friesen et al., 2007; Friesen et al., 2008b; Friesen et al., 2009; 
Liu et al., 2009). Of the toxins identified to date, SnToxA is the most potent and 
best understood (Friesen et al., 2006). SnToxA is a 13.2kDa protein secreted by 
S. nodorum during in planta growth. It is imported into mesenchymal cells where 
it interacts with a target protein in the chloroplast of wheat lines carrying the Tsn1 
susceptibility locus, causing necrosis in a light dependent manner (Manning and 
Ciuffetti, 2005; Manning et al., 2007; Manning et al., 2009). ToxA was first 
described in the related fungus Pyrenophora tritici-repentis (PTR), yet genetic 
evidence suggests that the ToxA gene was acquired by PTR by lateral 
(horizontal, interspecific) gene transfer around 1940, with S. nodorum as the 
donor (Friesen et al., 2006). 
The significance of cellular signalling has been shown for numerous pathogenic 
fungi (Liu and Dean, 1997; Takano et al., 2000; Xu, 2000; Leberer et al., 2001; 
Urban et al., 2003; Yu and Keller, 2005; Cousin et al., 2006; Doehlemann et al., 
2006; Zhao et al., 2007). In S. nodorum, a role in pathogenesis has been 
demonstrated for G-protein (Solomon et al., 2004), MAP kinase (Solomon et al., 
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2005) and Ca2+-Calmodulin dependent protein kinase signalling (Solomon et al., 
2006a) as well as the SnStuA transcription factor (IpCho, 2010). Apart from being 
apathogenic or reduced in virulence, several mutants impaired in these pathways 
also fail to conidiate. Sporulation and pathogenicity were also significantly 
reduced in mutants impaired in trehalose metabolism (Lowe, 2009), while 
disruption of mannitol metabolism did not affect pathogenicity, but resulted in 
complete loss of sporulation in planta (Solomon, 2006a). As the fungus requires 
several cycles of asexual sporulation, disruption of the required pathways is likely 
to affect SNB propagation in the field (Shah and Bergstrom, 2002).  
Crop protection measures targeted on S. nodorum include selection of cultivars 
resistant to the major toxins and application of fungicides (Solomon, 2006b; 
Waters, 2011). While Stagonospora nodorum has long been recognized as a 
significant plant pathogen, there is now evidence that it is also a producer of 
mycotoxins (Tan et al., 2009). The recently sequenced genome revealed a 
number of significant homologs to genes involved in the production of mycotoxins 
in other fungi, including 6-methylsalicylic acid (6-MSA), fumonisin, cercosporin 
and sterigmatocystin (Hane et al., 2007).  
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Figure 1-2 Phylogenetic background of S. nodorum  
Each species name is preceded by a unique AFTOL ID number (Assembling the Fungal Tree 
of Life, www.aftol.org). The tree is a 50% majority rule consensus tree of 45,000 trees 
obtained by Bayesian inference. All nodes had posterior probabilities of 100% except where 
numbers are shown above nodes. Similarly, all nodes had maximum likelihood bootstraps 
above 80% except where numbers are shown below nodes. Asterisks indicate nodes that 
were not resolved in >50% of bootstrap trees (Hane et al., 2007)  
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Figure 1-4 Estimated losses in wheat yield due to Stagonospora nodorum 
Colours indicate given percentage of yield loss per respective area (Brennan, 1998)  
A B 
C 
Figure 1-3 Pathogenic life cycle of Stagonospora nodorum  
A: infectious cycling on the plant and required structures (Sommerhalder, 2011);  
B: macroscopic symptoms on wheat; C: maturing pycnidia (Solomon et al., 2006c) 
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1.4 Secondary metabolism in fungi 
The interaction between the kingdoms of fungi and humans (or vertebrates in 
general) is not limited to primary metabolism. In addition to their impact on human 
nutrition described previously, fungi can affect humans and their livestock‘s 
health on different levels via the production of secondary metabolites.  
The definition of primary and secondary metabolism has evolved with the 
progress of molecular biology and biochemistry. The concept was first introduced 
in the late 19th century (Sachs, 1882; Kossel, 1891) and gained wider recognition 
during the 1950s, especially in the context of phytochemicals or sekundäre 
Pflanzenstoffe (secondary plant compounds) (Lemmermann, 1950). Originally, 
the definition of secondary metabolites was based on the fact that they were only 
present in certain cells or tissues or at certain time points during growth 
(Lemmermann 1950; Fraenkel 1959; Maggon, Gupta et al. 1977). Interestingly, at 
that time, proteins and nucleic acids were regarded metabolites as well, and 
already their chemical diversity and possible ecological role(s) were highlighted 
(Fraenkel, 1959; Maggon et al., 1977). Today, there are still numerous definitions 
in the literature. A very detailed discussion of the definitions of secondary 
metabolites and metabolism can be found in Bennet and Bentley (1989). A 
general consensus in the literature is that secondary metabolites are small 
molecular weight compounds, that are dispensable for vegetative growth, but 
may serve an important ecological role for the producing organism in its natural 
habitat, (Demain and Fang 2000; Bok and Keller 2004; Fox and Howlett 2008; 
Shwab and Keller 2008). ―Small molecular weight organic compound‖ serves to 
distinguish (secondary) metabolites from high molecular weight (usually >2000 
amu) polymeric macromolecules such as proteins, nucleic acids and polymeric 
carbohydrates. They may be synthesised from precursors derived from the 
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primary metabolism (e.g. sugars and acetate units) (Hill, 2006) but can also 
contain unusual or unique compounds (e.g. non-proteinogenic amino acids) 
(Demain and Fang, 2000). This definition however is still rather vague and 
arbitrary. 
1.4.1 Polyketide Synthesis in Fungi 
Common substance classes of fungal secondary metabolites comprise 
polyketides, non-ribosomal peptides, alkaloids and terpenes (Keller et al., 2005). 
Of those, the polyketides are the most diverse and abundant group, with a 
research history dating back over one hundred years (Keller et al., 2005). 
In the late 19th century, John Norman Collie first postulated that certain naturally 
occurring organic compounds were synthesised by polymerisation of acetate 
units (Collie and Myers, 1893; Collie, 1907). His theory received little resonance 
until the 1940s and 50s, when Rittenberg, Little and Bloch used isotopically 
labelled acetate to demonstrate that fatty acids and steroids were ultimately 
derived from this common primary metabolite (Rittenberg and Bloch, 1945; Little 
and Bloch, 1950). Building on this work, Birch demonstrated that this was also 
the case for a simple polyketide, 6-methylsalicylic acid (6-MSA) (Figure 1-8, 1) 
and that 6-MSA itself is transformed to the mycotoxin patulin in Penicillium 
patulum (Birch et al., 1955). Polyketide and fatty acid synthases work by a 
common iterative ―programmed assembly-line‖ mechanism (Figure 1-5), which is 
also found in nonribosomal peptide synthetases (Majerus and Vagelos, 1967; 
Fischbach and Walsh, 2006; Cox et al., 2009). CoA-bound acyl precursors 
(acetate, malonate and others) are coupled to the respective enzymes as thio-
esters. In the case of fatty acid synthesis, a starter acetate unit on a ketosynthase 
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(KS) is condensed to an extender malonate (C2) unit on an acyl carrier protein 
(ACP) under release of CO2 (Majerus et al., 1964). The intermediate remains 
bound to the ACP and undergoes sequential reduction (of the β-keto-group), 
dehydration, and reduction by a Ketoreductase (KR), Dehydrogenase (DH) and 
Enoylreductase (ER), respectively. This way, the nascent product is elongated by 
one fully reduced carbon unit each time this cycle is repeated (Majerus et al., 
1964; Staunton and Weissman, 2001).  
Polyketide synthases can lack KRs, DHs and ERs or skip them during specific 
iterations according to their programming, allowing for partially and non-reduced 
products like 6-MSA (Figure 1-6). They are classified as highly reducing (HR) 
PKS, partially reducing (PR) PKS and as nonreducing (NR) PKS, based on the 
extent of reducing reactions (Cox et al., 2009). PKS can also have additional 
domains not found in FAS like Cyclases (Cyc), Methyl Transferases (MT) or 
Reductases (R). Unlike bacterial (type II) PKS, all the domains of a fungal 
(eukaryotic type I) PKS are on the same polypeptide chain (Fischbach and 
Walsh, 2006). The newly synthesised PK skeleton can be altered by so-called 
tailoring enzymes like oxidases/reductases, transferases and cyclases, which are 
often found clustered with the respective PKS, pathway-specific regulators and 
other accessory proteins required for correct formation of the specific PK product 
(Kennedy et al., 1999; Osbourn, 2010).  
 1
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Figure 1-5  The common mechanism of polyketide and fatty acid synthesis 
Starting from malonyl CoA (top centre), the nascent polyketide or fatty acid undergoes carboxylation and subsequent reducing reactions catalysed by the 
domains indicated. Polyketide synthases can lack one or more reducing domain, or skip them during specific iterations, giving rise to partially or non-reduced 
products. MAT: malonyl-acetyl transferase (more commonly named acetyl transferase AT); ACP: acyl carrier protein; KS: ketosynthase; KR: ketoreductase; 
DH: dehydratase; ER: enoyl-reductase TE: thioesterase. Adapted from Staunton (2001) 
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Figure 1-6 mechanism of 6-MSA synthesis 
Reducing reactions are only carried out during specific iterations, giving rise to the partly 
reduced polyketide 6-MSA. Adapted from Staunton (2001).  
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1.4.2 Ecological role of fungal secondary metabolites 
It was long believed that secondary metabolites might simply serve to dispose of 
accumulating primary metabolites (Maggon et al., 1977), but a growing body of 
evidence, indicative of crucial ecological roles, has made this theory obsolete 
(Thomas, 2007). In the kingdom of fungi, secondary metabolites serve numerous 
purposes: pigments such as melanin provide protection of mycelia and spores 
against various environmental factors and may also act as virulence factors 
(Calvo et al., 2002; Langfelder et al., 2003). Siderophore chelators facilitate the 
uptake of micronutrients (Miethke and Marahiel, 2007). Some SM act as 
hormones, e.g. to initiate sexual reproduction (Wolf and Mirocha, 1977; Champe 
et al., 1987). Bioactive compounds may be used more passively as feed 
deterrents (Rohlfs et al., 2007), to promote symbiosis and mutualisms or, as 
antibiotics and toxins, to actively weaken or even kill other organisms such as 
hosts or competitors (Fleming, 1929; Graniti, 1972; Gilchrist, 1997; Bhatnagar et 
al., 2002; Rohlfs et al., 2007; Liao and Chung, 2008; Logrieco et al., 2009; 
Möbius and Hertweck, 2009; Horbach et al., 2011). Some fungal secondary 
metabolites are only produced under certain environmental circumstances, while 
others are physiologically and functionally linked to certain stages in the 
organism‘s life cycle. The regulation of fungal secondary metabolism is therefore 
a highly complex matter and despite a lot of dedicated research not fully 
understood (Demain, 1996; Demain and Fang, 2000; Bok and Keller, 2004; 
Brodhagen and Keller, 2006; Howlett, 2006; Fox and Howlett, 2008). 
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1.4.3 Significant fungal secondary metabolites in history 
1.4.3.1 Claviceps alkaloids 
There are fungi and their secondary metabolites that occur repeatedly throughout 
large parts of history, unidentified as such for most of the time, which started as 
significant threats to human and animal health but lead to the development of 
various valuable pharmaceuticals. One such example are the compounds 
produced by the ergot fungus Claviceps purpurea and related species. The 
biology and biochemistry of Claviceps purpurea as well as the aetiology of ergot 
poisoning (ergotism or Saint Anthony‘s Fire) have been reviewed 
comprehensively (van Dongen and de Groot, 1995; Wiesemüller, 2005; Schardl 
et al., 2006; Krska and Crews, 2008; Shwab and Keller, 2008; Lorenz et al., 
2009; Avalos and Estrada, 2011; Strauss and Reyes-Dominguez, 2011). The first 
reports of Claviceps infection of grains and its health effects (though not the 
connection of the two) date back to as early as the times of the Assyrians 
(600BC) and Parsees (400BC). Later, plagues of ergot poisoning became 
especially devastating in Europe, where rye was the prevalent grain for most of 
history (Lee, 2009a). The first recorded ergot epidemic in Europe was in the 
Rhine valley in 857AD, but it was not until 1596 that the connection of ergotism 
and the consumption of Claviceps infested rye was made by German physician 
Wendelin Thesius (Schuman, 2003). Interestingly, twelve years earlier, German 
botanist Adam Lonitzer had already described the sclerotia of ergot and their use 
in inducing labour in women in his Kräuterbuch (book of herbs) (Lee, 2009a). 
One major active compound produced by Claviceps purpurea, the ergot alkaloid 
ergotamine, was first isolated by Arthur Stoll at Sandoz Chemicals, Basel 
(Switzerland) in 1918. Ergotamine acts as vasoconstrictor via an antagonistic 
effect on serotonergic and α-adrenergic receptors of the extracranial arteries, but 
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it may also elicit contractions of the uterus and stimulate vomiting (Dollery, 1991). 
It was used as an analgesic for the treatment of migraines and remained the 
standard treatment until the introduction of the non-steroidal anti-inflammatory 
drug ibuprofen in the 1960s (Lee, 2009b).  
In 1938, Albert Hofmann, a colleague of Stoll‘s at Sandoz, inadvertently 
discovered the psychotropic properties of the derivative of another C. purpurea 
natural product: Lysergic Acid Diethylamide (LSD). When Hofmann experienced 
a state of intoxication in his laboratory, he concluded that this must be an effect of 
the LSD he has been working on at that time. He decided to undertake a series 
of self-experiments, during which he would ingest what he believed to be a 
minute amount of 250µg, but what is now known to be 5 times the threshold 
dose. He and Stoll published the results in 1947, along with an account of the 
hallucinations Hoffmann experienced during what is now regarded as the first 
―acid trip‖ (Dyck, 2005). Retrospectively, LSD did not fulfil the hopes placed in it 
as a therapeutic substance, but it ultimately led to the synthesis of bromocriptine 
and other valuable pharmaceuticals (Lee, 2010). Furthermore, it became one of 
the most important substances (ab)used in the 1960s youth- and drug cultures 
(Dyck 2005; Dyck 2007)(Lee, 2010). 
Over time, Claviceps secondary metabolites and their derivatives also helped to 
inspire countless artists, from 15/16th century European painters Hieronymus 
Bosch and Mathis Gothard Grünewald (Donadio, 1985; van Dongen and de 
Groot, 1995) to 20th century popular music ensemble The Beatles. Although band 
member John Lennon initially denied claims that the lyrics and first letters of the 
song Lucy in the Sky with Diamonds were a direct reference to LSD and its 
consumption, fellow member Sir Paul McCartney later admitted that it served as 
an inspiration in writing the song (bbc.co.uk, 2004). If this song was to be seen as 
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the description of a ―good trip‖, Bosch‘s triptych ―The Temptation of Saint 
Anthony‖ and Grünewald‘s painting of St. Anthony being harassed by demons on 
the Isenheim altar (Figure 1-7) would best be understood as representation of a 
―bad trip‖ along with other symptoms of ergotism (Dixon, 1984; van Dongen and 
de Groot, 1995). There is even evidence that certain cases of ―bewitchment‖ 
might have been a result of ergot poisoning (Caporael, 1976; Matossian, 1982).  
Outbreaks of ergotism occurred regularly in Europe but decreased in number due 
to the monitoring of grains in developed countries. Still, it remains a threat to 
human health especially in developing countries, as recent outbreaks of ergotism 
in India and Ethiopia demonstrate (Demeke et al., 1979; Krska and Crews, 2008).  
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Figure 1-7 Ergotism in European arts of the 16
th
 century 
A section of the Isenheim Altar (1512-1516) by Mathis Gothard Grünewald, depicting 
Saint Anthony being tormented by demons. A figure in the bottom left corner shows the 
ulcers and discolorations of the skin symptomatic of the gangrenous form of ergotism.  
(http://commons.wikimedia.org/wiki/File:Mathis_Gothart_Grünewald_015.jpg) 
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1.4.3.2 Aflatoxins and related mycotoxins 
Ergotism is just one example of a mycotoxicosis, or poisoning by toxic fungal 
secondary metabolites called mycotoxins. Generally, any small molecular weight 
compound of fungal origin that is toxic in low concentrations to humans and/or 
vertebrate animals can be considered a mycotoxin, with a bias towards those 
compounds regularly found as contaminants in food and feed and excluding the 
causal agents of mushroom poisoning (Bennett, 1987; Bennett and Klich, 2003). 
Many of these compounds also show varying levels of toxicity to other organisms 
like invertebrates, plants, bacteria and other fungi (Bennett, 1987). The term 
mycotoxin was coined in the course of the investigation of another food-borne 
illness that sparked interest and research in this class of fungal secondary 
metabolites in the mid-20th century. 
In 1960, over one hundred thousand turkeys and other farm birds died of an 
unknown disease, named Turkey-X disease and characterised by acute liver 
failure, to which at first no causal agent was to be found. It was noted, however, 
that the symptoms resembled those of alkaloid poisoning, but no evidence of 
either natural (alkaloids, other plant toxins) or artificial (solvents, pesticides) 
toxins could be found (Lancaster et al., 1961). The disease was later identified in 
other animals as well, such as cattle, pigs and sheep. Also, the outbreak of the 
disease seemed to follow the use of specific batches of Brazilian groundnut meal 
in the feed, which were found to be contaminated with the mould Aspergillus 
flavus (Sargeant et al., 1961). The groundnut meal was examined more closely, 
and two distinct toxic compounds of fungal origin were identified. They were 
designated Aflatoxin B (Figure 1-8, 2) and G due to their characteristic 
fluorescence under UV (blue and green) (Nesbitt et al., 1962). More compounds 
followed, and today there are more than twenty Aflatoxins as well as their 
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metabolites and precursors described (Heathcote, 1978). It was shown very early 
that most of those compounds are not just acutely toxic, but also carcinogenic 
(Lancaster et al., 1961; Ames, 1983), so much so that the Aflatoxins are counted 
among the most potent naturally occurring mutagens (Squire, 1981; Ames, 
1983). The primary target organ is the liver, with other organs affected according 
to the route of exposition (Coulombe R.A, 1994). Chemically, Aflatoxins are 
difuranocoumarin derivatives synthesised via polyketide pathways (Lee et al., 
1976). In vertebrates, they are converted by p450 enzymes to an active epoxy-
form that is capable of binding DNA and proteins (Eaton and Groopman, 1994). 
The Aflatoxin biosynthetic pathways are highly complex and require an array of 
sequential fatty acid and polyketide synthases and so-called tailoring enzymes, 
involving precursors and intermediates, that are, like sterigmatocystin, potent 
mycotoxins in their own right (Mahanti, 1996; Bennett, 1997; Payne and Brown, 
1998; Hicks et al., 2002). Mycotoxins will continue to pose a serious threat to 
human health, because mycotoxin contamination of foodstuffs is already 
prevalent worldwide (Gocho, 1987; Dalcero, 1997; Li et al., 2001; Li, 2002; 
MacDonald, 2004; Miller, 2008; Muthomi, 2008) and likely exacerbated by a 
changing world climate (Paterson, 2010; Magan et al., 2011). 
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1.4.3.3 The history of fungal pharmacy 
Not all fungal secondary metabolites have such a detrimental impact on human 
health as the mycotoxins. Another functional class, the antibiotics, have 
contributed significantly to the increase in life expectancy in the last century 
(Demain, 2009).  
The oldest known instant of a fungus used for medicinal purposes dates back to 
the Neolithic. The glacial mummy known as ―Ötzi the Iceman‖, or the ―Man from 
Hausalbjoch‖ carried pieces of Piptoporus betulinus fruiting body on a leather 
thong when discovered in 1991 (Peintner et al., 1998). This fungus has been 
shown to produce anti-inflammatory and antibiotic secondary metabolites, 
supporting theories suggesting a medicinal use rather than tinder (Schlegel, 
2000; Wangun, 2004). Reports of mouldy bread and other foodstuffs being 
applied topically in wound treatment date back at least to ancient Chinese and 
Egyptian times and continue to appear in folk medicine until the early 20th century 
(Milton, 1989; Sipos et al., 2004). The first report of microbial antagonism caused 
by a fungus was in 1874 by William Roberts, who found that contamination with 
Penicillium glaucum suppressed growth of bacterial cultures (Friday, 1974). The 
early 20th century then saw the development of the first chemotherapeutics, 
Arsphenamine (Salvarsan, 1910) and Prontosil (a sulphonamide, 1932), but since 
these compounds are fully synthetic, they are not antibiotics in a strict sense 
(Madigan et al., 2000; Bentley and Bennett, 2003; Wilson et al., 2010). It was 
therefore a chance finding in 1928, that led to the development of the first true 
antibiotic of microbial (fungal) origin (Henderson, 1997). 
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1.4.3.4 The discovery of Penicillin 
Alexander Fleming, while at St. Mary‘s Hospital in London, described a halo of 
inhibited bacterial growth around a colony of a then not further defined 
Penicillium sp. contaminant on a plate of Staphylococcus sp. Unlike in previous 
instances (Friday, 1974), Fleming attributed the inhibition not to a limiting effect of 
the fungus in terms of resources (nutrients, oxygen), but to formation of a 
bacteriolytic substance by the fungus (Fleming, 1929). He found liquid cultures of 
this specific Penicillium strain to be active as well, but not cultures of other fungi 
including other Penicilli. He tested culture broth filtrate, for which he coined the 
term penicillin, against various bacteria, and found that almost exclusively Gram-
positive bacteria were affected, while the Gram-negative strains were mostly 
insensitive. Also, he noted that penicillin did not affect growth of the original 
Penicillium strain or cause toxic symptoms on animals, including humans, even 
when administered in high doses. In the same article, he described how penicillin 
was used to help isolate (insensitive) Bacillus influenzae (now Haemophilus 
influenzae) from human sputum in a strong background of (sensitive) 
Pneumococci and Streptococci, and noted possible uses of penicillin as an 
antiseptic and for microbiological research.  
It was later shown that the active component of Fleming‘s crude penicillin, the 
substance now referred to as penicillin G (Figure 1-8, 3), interferes with bacterial 
cell was synthesis by covalently binding to the active site of bacterial 
transpeptidases, the enzymes responsible for cross-linking of the nascent 
peptidoglycan layer (Madigan et al., 2000; Koch, 2003). This also explains the 
inefficiency of penicillin against Gram-negative bacteria, which have an extra lipid 
membrane protecting their peptidoglycan, fungi, which synthesise their cell walls 
mainly from glucosamine, and animals, which lack cell walls overall.  
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A decade after Fleming‘s original experiments, Chain, Florey and colleagues 
would pick up the work on penicillin, concentrating on its use as a 
chemotherapeutic agent against systemic bacterial infections (Chain, Florey et al. 
1940). By that time, the Second World War had brought a dramatic demand for 
antibacterial wound treatment (and treatment for venereal diseases), and efforts 
were made to increase production by improving purification techniques and 
isolating overproducing strains (Chain et al., 1940; Rob, 1990; Bentley, 2009).  
1.4.3.5 Present day fungal pharmaceuticals 
More than half a century after the discovery of penicillin, numerous valuable 
pharmaceuticals in clinical use are fungal secondary metabolites or their 
derivatives. Despite the fact that today about two thirds of all (antibacterial) 
antibiotics are originally derived from actinomycetes (Demain, 2008), antibacterial 
agents like the aforementioned penicillins and related ß-lactams are remarkable 
not just for being the first ―true‖ antibiotics, but even more for sparking recognition 
of microbial secondary metabolites as a valuable and ample source for novel 
pharmaceuticals.  
Today, there are numerous fungal secondary metabolites that have been 
developed for a wide range of therapeutic uses. The Echinocandines and their 
semi-synthetic derivatives have been developed since the 1970s and are used 
against Candida, Aspergillus and Pneumocystis infections (Nyfelder and Keller 
1974; Denning 2003; Zaas and Alexander 2005; Turner, Drew et al. 2006). There 
are also antiviral and antitumor compounds currently being developed from 
fungal secondary metabolites or their derivatives. Many of these compounds act 
on unusual targets and show unexpected and novel activities like 
antiangiogenesis (Zhang et al., 1999; Serwe et al., 2009; Ahmed et al., 2010) or 
insulin mimesis (Zhang et al., 2006), opening up new fields and potential 
28 
 
treatment options for a range of critical diseases (Misiek and Hoffmeister, 2007). 
A group of inhibitors of mammalian enzymes even turned out to become the most 
commercially successful small molecule pharmaceuticals (Demain 2008; Marinelli 
2009). In 1976, Brown and colleagues described a Penicillium derived antifungal 
agent, compactin (Brown et al., 1976), a precursor of the more active derivative 
Lovastatin (Figure 1-8, 4) later isolated from Monascus and Aspergillus cultures 
(Endo et al., 1976). It was shown that these compounds were potent inhibitors of 
HMG-CoA reductase, the major regulative and rate-limiting enzyme in 
mammalian cholesterol synthesis (Endo, 1979; Alberts et al., 1980). Elevated 
blood cholesterol levels are regarded a key factor in cardiovascular diseases, one 
of the major causes of death in the western societies, and therefore it is not 
surprising that lovastatin and derivatives have a market volume in the 15 billion 
dollar (US) range (Demain, 2008).  
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(1) ℗ 
(4)℗  (3)  
(2) ℗  
Figure 1-8 Molecular structures 1-4 
6-Methylsalicylic acid (6-MSA) (1), Aflatoxin (2), Penicillin G (3), 
Lovastatin (4) 
℗=Polyketide, =Pharmaceutical, =Mycotoxin 
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1.5 Secondary metabolites in pathogenesis 
Elucidating the purpose secondary metabolites serve for their producers has 
been a constant topic in secondary metabolite research. Some pathogenic fungi 
invest a significant amount of resources into secondary metabolite production, 
indicating a crucial role during pathogenesis. They employ SMs to facilitate 
invasion of the host, and/or to kill host cells during in planta growth and 
proliferation. As described earlier, the functions of SMs may often be ambiguous. 
In the following paragraphs, there will be examples of phytotoxins that are also 
significant mycotoxins. More often than not, the classification into these generic 
and somewhat arbitrary and artificial groups simply depends on whether the 
describing scientists see themselves as phytopathologists or toxicologists. Here, 
compounds will be discussed that may or may not cause mycotoxicoses in 
humans and animals, but that act as pathogenicity or virulence factors for the 
producing plant pathogenic fungi. 
1.5.1 Appressoria function 
The rice pathogen Magnaporthe grisea is a model organism for penetrating host 
plant leafs by means of brute force. Germinating Magnaporthe spores form 
structures called appressoria, in which enormous osmotic pressures are 
generated. Melanin is incorporated into the cell wall of the appressoria, where it is 
oxidatively cross-linked and serves as a chemical barrier to allow accumulation of 
compatible solutes and water for turgor generation as well as a mechanical 
barrier to resist the building pressure (Howard and Ferrari, 1989). The pressure is 
instrumental in penetration of the host cuticle by the penetration peg, and 
melanin deficient mutants are unable to penetrate intact leaf surfaces, but can 
still infect the plant if the leaf is wounded artificially (Howard and Valent, 1996).  
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1.5.2 Photosensitizers 
A widespread strategy of plant pathogens relies on light-activated 
photosensitizing agents containing perylenequinone backbones. The best 
understood compound of this class of aromatic polyketides is cercosporin (Figure 
1-9, 6), produced by certain Cercospora spp. Other examples are the 
elsinochromes produced by Elsinoe spp, altertoxin (Figure 1-9, 7) and alteichin 
by Alternaria sp and cladochrome and claphostin by Cladosporium spp (Daub 
and Ehrenshaft, 2000; Daub et al., 2005). Cercosporin was first isolated in the 
1950s as a red pigment from Cercospora kikuchii (Kuyama and Tamura 1957), 
but its role in pathogenesis was not recognized until the 1970s, when its structure 
had been elucidated (Lousberg et al., 1971; Yamazaki and Ogawa, 1972). 
Cercosporin acts as a photosensitiser by generating activated oxygen species in 
two ways. Absorption of photons first results in an excited electron triplet state of 
the molecule itself. Energy is then transferred to oxygen, either via transfer of the 
excited electron, producing radical oxygen species like superoxide (O2ꜙ) and 
hydrogen peroxide (H2O2), or, more efficiently, via direct energy transfer, 
producing toxic and reactive singlet oxygen (1O2). The ROS generated damages 
plant cell membranes by lipid oxidation, and can also contribute to programmed 
cell death by triggering apoptosis (Daub, 1982; Daub and Hangarter, 1983). 
These effects are by no means limited to plant cells, and cercosporin has been 
shown to exert photosensitizing activity under influence of light and oxygen in 
animals, bacteria (Foote, 1976; Dickman et al., 2001), Oomycetes and other fungi 
(Yamazaki et al., 1975). Perylenequinone-producing organisms protect 
themselves from the ROS generated in several ways. Firstly, cercosporin is 
actively excreted from cells of C. kikuchii via Cfp, a transporter protein of the 
major facilitator superfamily (MFS) (Daub et al., 2005) (Callahan et al., 1999). 
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Secondly, a role for pyridoxine (Vitamin B6) as a quencher of superoxide and 
singlet oxygen has been demonstrated (Jenns et al., 1995; Ehrenshaft et al., 
1999). Furthermore, resistant fungi seem to be able to transiently detoxify 
cercosporin reductively, however this mechanism is still poorly understood (Daub 
et al., 1992). A possible contribution of degradative enzymes, transporter proteins 
and oxidative stress-related genes under the influence of the transcription factor 
CRG1 (Cercosporin Resistance Gene 1) is being investigated (Chung et al., 
2003; Daub et al., 2005). 
1.5.3 Targeting membrane function and energy generation 
Some fungi produce phytotoxic compounds that compromise plant cell wall 
integrity in a direct manner. Cercospora beticola produces beticolins (Figure 1-9 
5,) or yellow toxins, polycyclic polyketides that self-assemble into pore-forming 
multimeres. The beticolins effectively form ion-channels in the host cell 
membranes, leading to membrane depolarization, inhibition of H+-transport and 
loss of solutes (Goudet et al., 1998; Goudet et al., 2000). 
Another strategy targeted at host membrane integrity is inhibition of enzymes 
involved in fatty acid synthesis and ceramide metabolism. Cyperin (Figure 1-9, 8) 
is a simple diphenylether phytotoxin produced by Preussia, Phoma and 
Ascochyta spp (Weber and Gloer, 1988; Stierle et al., 1991; Venkatasubbaiah et 
al., 1992). It is structurally related to the protoporphyrinogen inhibitor class of 
commercial herbicides, but has a different mode-of-action. Cyperin inhibits the 
enoyl reductase domain of type II FAS in a fashion similar to that of the 
structurally related FAS inhibitor triclosan (Dayan et al., 2008). Important 
examples of ceramide metabolism inhibitors are the closely related polyketide 
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sphingosine analogues AAL-toxin (Figure 1-9 9), produced by Alternaria alternata 
and the fumonisins (Figure 1-9, 10) by Fusarium spp (Williams et al., 2007). 
Ceramides are important for membrane and lipoprotein structure but also have a 
crucial role in plants and animals as second messengers in numerous cell 
signalling processes including apoptosis (Merrill Jr et al., 1993; Merrill Jr et al., 
2001). It is therefore not surprising that fumonisins and AAL-toxin are also potent 
mycotoxins that cause disease in humans and animals in a similar way to their 
action as phytotoxins, involving the complex sphinganine signalling pathways 
(Gilchrist, 1997; Bennett and Klich, 2003) and disturbed membrane functions by 
altered fluidity and glycosylphosphatidylinositol- (GPI-) anchored protein function 
(Fischer et al., 2004; Borner et al., 2005; Gutiérrez-Nájera et al., 2005). In maize, 
it was shown that only fumonisin-producing strains of F. verticillioides will cause 
the full extent of disease symptoms on seedlings, and that treatment with purified 
fumonisin alone is sufficient to elicit the same symptoms (Williams et al., 2007). 
In Arabidopsis, Fumonisin B1 induced programmed cell death has been shown to 
depend at least in part on ethylene, jasmonate and salicylate mediated signalling 
pathways (Asai et al., 2000) and the depletion of extracellular ATP (Chivasa et 
al., 2005).  
Disruption of membrane function can also affect energy generation. The highly 
virulent race T of Cochliobolus heterostrophus produces T-toxin (Figure 1-9, 11), 
a family of linear, partially reduced C35 - C49 polyketides (Baker et al., 2006). T-
toxin moved into the focus of research when an epidemic of Southern Corn leaf 
blight caused by C. heterostrophus race T decimated cornfields in the USA in the 
late1960s. The molecular target of T-toxin is the mitochondrial membrane protein 
URF13, which is encoded by the mitochondrial gene T-urf13, responsible for 
male pollen sterility (Forde et al., 1978). The URF13 protein consist of one 
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hydrophobic (helix I) and two amphipathic α-helices (II, III) (Korth et al., 1991; 
Levings Iii and Siedow, 1992). Binding of T-toxin causes conformational changes 
in the quaternary structure of URF13 tetramers, rearranging the amphipathic 
helices II and III to have their hydrophilic portions form a pore in the inner 
mitochondrial membranes (Rhoads, Levings et al. 1995). The results are 
mitochondrial swelling, calcium and nutrient leakage, impaired respiration and 
ultimately death of affected cells (Rhoads et al., 1995). Other phytotoxins are 
targeted at energy-generating enzymes directly. Tentoxin (Figure 1-10, 12, p38), 
a cyclic nonribosomal peptide synthesised by a number of Alternaria spp, has 
been shown to block ATP synthase/ATPase function in chloroplasts of 
susceptible plants by arresting ADP/ATP exchange at inhibitory concentrations 
(Meiss et al., 2008). ATPases are also the target of fusicoccin (Figure 1-10, 13), a 
glycosylated terpene produced by Fusarium amygdali. Fusicoccin stabilises the 
interaction of the plasma membrane H+-ATPases of stomatal cells with its 14-3-3 
protein activator, forcing the stomata open and causing the plant to wilt (Marre, 
1979; Sze et al., 1999).  
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Figure 1-9 Molecular Structures 5-11 
beticolin 5, cercosporin 6, altertoxin 7, cyperin 8, AAL-toxin 9, fumonisin B1 10, T-toxin 
11; ℗=polyketide, =recognised as mycotoxin or for universal toxicity 
9 ℗  
10 ℗  
11 ℗ 
6 ℗  7 ℗  
8 ℗ 
5 ℗ 
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1.5.4 Subverting the plant defence 
A major strategy employed by necrotrophic fungi is activating the plant‘s own 
apoptotic pathways. The pro-apoptotic action of the fumonisins has already been 
discussed above (see 1.5.3). Other mycotoxins/phytotoxins with pronounced pro-
apoptotic effects are the trichothecenes T2-toxin (Figure 1-10, 14), HT2-toxin and 
diacetoxyscirpenol (DAS) (type A trichothecenes) and nivalenol (NIV), 
deoxynivalenol (DON, Figure 1-10, 15) (type B trichothecenes). The 
trichothecenes are non-volatile sesquiterpenes produced by Fusarium spp, the 
causal agent of Fusarium head blight on various cereals and ear rot of maize 
(Maier et al., 2006; Nishiuchi et al., 2006). As mycotoxins, trichothecenes have 
long been known to inhibit translational initiation and elongation by interacting 
with the peptidyl transferase active site of 60s ribosomal subunits (McLaughlin, 
1977). Their phytotoxic effect and influence on pathogen virulence depends 
largely on the host plant, but also on the individual trichothecene (Maier et al., 
2006). In Arabidopsis, type A trichotecenes induce MAPK pathways that 
participate in plant defence responses, resulting in callose deposition, H2O2 
production, SA accumulation, tissue chlorosis and lesion formation through 
programmed cell death (PCD) (Nishiuchi et al., 2006). DON, a type B 
trichothecene, inhibited protein translation but did not activate these defence 
pathways. It is, however, a virulence factor in disease progression in wheat spike 
(Bai et al., 2002). It is therefore hypothesized that F. graminearum uses type A 
and B trichothecenes for distinct roles during pathogenesis (Nishiuchi et al., 
2006). 
Another PCD eliciting phytotoxin was the first host specific toxin (HST) to be 
reported. In 1946, Meehan and Murphy described a new species of 
5 ℗ 
6 ℗  
7 ℗ 
8  
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Helminthosporium (now Cochliobolus) victoriae, that causes blight disease in the 
crown rust resistant Victoria varieties of oats (Meehan, 1946). They demonstrated 
that C. victoriae excreted phytotoxic secondary metabolites that elicited the same 
symptoms as the infection, but only on the susceptible Victoria oats (Meehan, 
1947). Later, it was shown that the major phytotoxic compound, victorin C (Figure 
1-10, 16), was a cyclic peptide comprised of five unusual amino acids (Macko et 
al., 1985; Wolpert et al., 1985). The genetic basis for victorin sensitivity and C. 
victoria susceptibility is the dominant Vb gene, which is also known as the Pc2 
gene that confers rust resistance (Lorang et al., 2010). A presumed Vb ortholog, 
LOV (locus orchestrating victorin effects), has been identified in Arabidopsis. 
LOV1 is a member of the coiled-coil nucleotide binding site leucine-rich repeats 
(CC-NBS-LRR) resistance gene family, known to participate in plant resistance 
(Lorang et al., 2004; Lorang et al., 2007). In plants carrying the susceptibility 
allele, victorin elicits a combination of resistance and hypersensitivity reactions, 
culminating in programmed cell death. The cellular target of victorin is the 
mitochondria (Wolpert et al., 1994b), although there are indications for an 
alternative/additional receptor on the cell surface (Tada et al., 2005). Import of 
victorin into the mitochondria is mediated by a mitochondrial permeability 
transition, leading to mitochondrial swelling and membrane depolarization (Curtis 
and Wolpert, 2004). The molecular target of victorin is the 100kDa P-protein 
component of the glycine decarboxylase complex located in the mitochondrial 
matrix (Wolpert et al., 1994a) that plays a vital role in the photorespiration of C3 
plants (Douce et al., 2001). Binding of P protein ultimately inhibits 
photorespiration, causes RUBISCO cleavage and elicits a hypersensitive 
reaction, including DNA laddering and heterochromatin condensation, which are 
the tell-tale signs of apoptosis (Navarre and Wolpert, 1999; Tada et al., 2005). 
Further symptoms resemble classical plant defence mechanisms like callose 
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deposition, lipid peroxidation, K+-efflux, respiratory burst and phytoalexin 
synthesis (Tada et al., 2005). 
  
12  
14  
15   
13  
16  
Figure 1-10 Molecular structures 12-13 
tentoxin 12, fusicoccin 13, T2-toxin 14, DON 15, victorin 16 
=recognised as mycotoxin 
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1.6 Summary and project aims 
There are economically important plant pathogens among the 
Dothideomycetes that use secondary metabolites as pathogenicity or 
virulence factors to cause significant diseases among important crop plants. 
Some of these were among the first examples of HSTs in the literature. 
Stagonospora nodorum is a model Dothideomycete and a significant 
pathogen of wheat throughout the world. The ability of this fungus to produce 
the mycotoxin alternariol has been demonstrated previously. The biosynthetic 
origin of this mycotoxin, however, remains unclear, as does the further 
mycotoxigenic potential of S. nodorum. The goal of this project is to initiate a 
comprehensive study of secondary metabolism in S. nodorum, using a 
combination of ‗omics techniques to shed light on various aspects of this 
intriguing pathogen. This involved  
 In silico analysis of S. nodorum PKS genes to identify possible 
candidates for targeted gene disruption experiments as well as to 
investigate the phylogenetic background and evolutionary history of 
these genes in the Dothideomycetes 
 Transcriptome analysis to identify PKS genes active during important 
stages of the infectious life cycle of S. nodorum 
 targeted disruption of these genes to create SM-impaired knockout 
mutants 
 plant-based assays to investigate the ability of the mutants to cause 
disease on the host in comparison to the wild type fungus  
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 Method development for cultivating S. nodorum under SM-inducing 
conditions, extracting and enriching SM from cultures and for liquid 
chromatography – mass spectrometry analysis of extracts. 
 metabolomics profiling and identification of the secondary metabolites 
produced by S. nodorum in comparison to the Knockout mutants by 
LC-MS.   
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2 General Materials and Methods 
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2.1 Reagents 
Unless noted otherwise, all chemical reagents were of Analytical Reagent grade, 
obtained from Merck or Sigma. Water was of mQ Grade (Millipore, Australia) 
2.2 General solutions and media additions 
100× Trace solution   
50  g/l KCl 
50  g/l  MgSO4 × 7H2O 
1  g/l  ZnSO4 × 7H2O 
1  g/l  FeSO4 × 7H2O 
0.25  g/l CuSO4 × 7H2O 
Stored at 4℃  
Complete Supplement (CS) 
20  g/l bacto-casamino acids, 
20  g/l bacto-peptone 
20  g/l bacto-yeast extract 
3  g/l  adenine 
20  mg/l p-aminobenzoic acid 
20  mg/l thiamine 
2  mg/l biotin 
2  mg/l  nicotinic acid 
2  mg/l  pyridoxine 
Solution was filter sterilised (0. 2 μm syringe filter, 
Milipore) and stored at 4℃ prior to use 
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Phleomycin stock  
250  mg/l  phleomycin (Invitrogen, Australia) 
stored at -20℃ prior to use, working concentration 
50 mg/l 
Centrifuged V8 juice 
Campbell‘s V8 Juice, centrifuged at 5000 × g for 10 
min 
Supernatant was decanted and stored at -20 ℃ 
prior to use 
2.3 Media 
Unless noted otherwise, all media were prepared using mQ H2O, adjusted to pH 
6.0 with NaOH and/or HCl and autoclaved at 121℃, 15psi for 16 min. For solid 
media, 15 g/l Agar (Difco, ―Grade A‖) were added prior to autoclaving.  
Minimal Medium 
4.5  g/l Glucose 
2  g/l NaNO3 
1  g/l K2HO4 
10 ml/l 100× Trace solution 
YMG Medium 
10  g/l malt extract (difco) 
4  g/l  yeast extract (difco) 
4  g/l glucose 
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CYA 
32  g/l Czapek-Dox agar 
5  g/l  Yeast Extract 
1  g/l K2HPO4 
CzV8CS 
45.5  g/l Czapek-Dox liquid broth 
200  ml/l centrifuged V8 juice (see 2.2) 
5  ml/l  Complete Supplement (CS) were 
added after autoclaving. 
V8PDA/V8PDB 
10  g/l PDB (liquid culture)/PDA (solid 
substrate) (Difco) 
3  g/l CaCO3 (liquid culture only) 
150  ml/l Campbell‘s V8 juice 
 
Benzimidazole agar 
10  g/l Agar 
75  mg/l Benzimidazole 
ad 1l tap water 
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2.4 S. nodorum strain and culturing conditions 
Stagonospora nodorum strain SN15 was obtained from Department of Agriculture 
and Food Western Australia (DAFWA). Unless noted otherwise, all strains were 
grown on V8PDA plates at 20℃ under a 12h dark/near-UV light regime. Liquid 
cultures were 100ml of media in 250ml Erlenmeyer flasks grown at 20℃ in the 
dark and shaken at 145rpm. Flasks were inoculated with 105 Spores. 
2.5 Isolation of fungal spores 
Pycnidiospores were harvested from V8PDA plates by flooding the plate with 5-
10 ml sterile H2O. Release of spores was aided by gentle scraping with a 1 ml 
pipette tip. The spore suspension was then filtered through a sterile 5 ml syringe 
partially filled with sterile glass wool to remove any carryover mycelia. The filtrate 
was centrifuged for 5 min at 5000 × g and the supernatant removed. The pelleted 
spores were resuspended in 1 ml sterile mQ H2O and counted on a Neubauer 
Improved haemocytometer. 
2.6 Storage of fungal strains 
All strains were stored at -80℃ as spores in sterile 20% (w/v) glycerol. 
2.7 Wheat Cultivars and Growth Conditions 
Wheat (Triticum aestivum cv. Calingiri) was routinely grown in 10 cm (diameter( 
planting pots with a 2-3cm base layer of perlite and main fill of vermiculite (The 
Perlite and Vermiculite Factory, Australia). For Whole Plant Sprays (WPS), 
twelve seeds per pot were planted, twenty for Detached Leaf Assays (DLA). 
Plants and were grown for eleven days at 20℃ under a 12h light/dark regime 
prior to manipulation.  
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DLAs were prepared as described by Benedikz (1981). Sections of 11d old wheat 
leaves had ~2cm of the distal end removed and a ~5cm portion was placed on 
benzimidazole agar (see 2.3) with the ends submerged in the agar, adaxial side 
up. DLAs were incubated at 25 ℃ in a 12h light/dark cycle. 
2.8 Primer sequences 
Primers were diluted to a 100μM stock solution in sterile mQ H2O. Primer names 
and sequences are listed in Table 2. Bold text refers to sequences that are 
complementary to the primers used to amplify the phleomycin cassette (pan8) 
2.9 Isolation of fungal genomic DNA  
Fungal mycelia were harvested in 1.5 ml reaction tubes and snap-frozen in liquid 
nitrogen. Genomic DNA was extracted using a Retsch MM301 ball mill and 
Qiagen BioSprint according to the manufacturer‘s instructions.  
2.10 Nucleic acid synthesis  
Unless stated otherwise, DNA was synthesised by Polymerase Chain Reaction 
(PCR) using TAKARA ExTaq™ polymerase (Takara Bio Inc, Japan) with the 
proprietary buffer (10 ×) and dNTP solution according to the manufacturer‟s 
instructions. Each reaction consisted of variable amounts of template DNA, 0.1 μl 
(1 Unit) polymerase, 2.0 μl buffer, 1.6 μl dNTP solution, 0.5 μl each f/r primer 
(see 2.8) and sterile mQ H2O to 20 μl. Reactions were carried out in an 
Eppendorf Mastercycler ep thermocycler. The standard program was 35-40 
cycles of an initial hold at 95℃ (denaturation) for two min in the first cycle and 1 
minute for each following cycle, 55-60℃ for one minute (annealing), 72℃ for one 
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minute per kb expected amplicon (synthesis). The last cycle ended with a final 
extension of 5-10 min at 13 72℃ 
 
Table 2-1 List of names and sequences of PCR primers used in this study  
Primer Name Primer Sequence 
pan8f AGACGGCGTAACCAAAAGTCACA 
pan8r TTCTGGGTAAACGACTCATAGGAGA 
ActinpPCRf AGTCGAAGCGTGGTATCCT 
ActinqPCRr ACTTGGGGTTGATGGGAG 
PhleoqPCRf ACTTCATCGCAGCTTGACTAAC 
PhleoqPCRr TGATGAACAGGGTCACGTC 
  
00477KO5f CGGCCTCTGATCTTTCAGT 
00477KO5r TGTGACTTTTGGTTACGCCGTCTGTAGCCTTTGGAGATGGTCTT 
00477KO3f TCTCCTATGAGTCGTTTACCCAGAACATGGGCGTTGAAGACAT 
00477KO3r CGACGCACATCAACTAGATCT 
00477RTf GCTGCAGAGCAAAGGAATAA 
00477RTr TGCAGGTGCACTCTGATCT 
00477ScrF CGTATTTAATCGCAGCACAC 
00477ScrR ATCCAGGAGATGTTGCTGA 
  
05791KO5' CACACGCTGTTGACTAACTTTC 
05791KO5 TGTGACTTTTGGTTACGCCGTCTCTTAACGGAGCCAACATACAG 
05791KO3' TCTCCTATGAGTCGTTTACCCAGAACGATCGATATCGGCTATCTC 
05791KO3' GCGCATAGGCACGTTAAT 
05791RTf GACCTCGTCGTGCAAGTATC 
05719RTr GTGGGATAAGTCTCACGTAGGAT 
05791ScrF GTCATCTTCATTGGCATCC 
05791ScrR TCGTTGTAGGGGCTGTATT 
  
11272KO5' CTTCCAGTTCTTCACCACTTACC 
11272KO5 TGTGACTTTTGGTTACGCCGTCTTTAGAATGGTGACCCCAGC 
11272KO3' TCTCCTATGAGTCGTTTACCCAGAAGATGAGAAGGACTTCATTCGC 
11272KO3' AAGTGCGTGAGAGCAAACAT 
11272RTf CGACGAACCATGACAGAAG 
11272RTr TCTTCTGTTTATCCGGCGT 
11272ScrF TACGCCTGAAGAAAGTTGG 
11272ScrR GTCGTTGTAGGGGCTGTAT 
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2.11 Gel electrophoresis  
DNA synthesised by PCR was visualised and purified using 1% (m/v) Agarose 
(BioRad) gels in TAE buffer (40mM Tris base, 20mM Acetic acid , 1mM Na2EDTA 
(pH8.5)) containing 1ppm SybrSafe gel stain (Invitrogen) in a horizontal gel tank 
(BioRad). DNA was mixed with 6 × loading dye (Promega) before loading. For 
band size estimates, lanes containing 1kb ladder DNA marker (Promega) were 
included. Gels were run in TAE buffer at a constant 70-120V and visualised on a 
BioRad Geldoc 1000 imager.  
For purifications, the appropriate bands were excised from the gel and the DNA 
purified using a QIAquick Gel Extraction kit according to the manufacturer‘s 
protocol.  
2.12 Determination of nucleic acid concentration 
DNA and RNA concentrations were determined using a NanoDrop 1000 
spectrophotometer. 
2.13 Statistical analysis – JMP® 
Statistical significance of results (p<0.05) was determined with Tukey-Kramer 
HSD analysis (JMP 8.0.2, SAS institute).  
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3 In silico analysis of Polyketide 
Synthases in Stagonospora 
nodorum 
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3.1 Introduction 
Fungi have long been used as a source of bioactive small molecules or 
secondary metabolites. Many of these compounds have been developed into 
valuable pharmaceuticals, e.g. antibiotics and anticancer therapeutics (Newman, 
2007). While molecular and analytical techniques for studying small molecules 
and drug discovery have advanced significantly in recent years, there are still 
countless secondary metabolism-related genes that have not yet been 
functionally characterised, not least because they are dormant under standard 
laboratory conditions (Hertweck, 2009).  
Whole genome sequencing and in silico analysis of fungal genes and genomes 
has emerged as a valuable tool for identifying novel secondary metabolite genes 
and gene clusters, particularly those involved in polyketide synthesis (Dean et al., 
2005; Kämper et al., 2006; Bergmann et al., 2007; Hane et al., 2007; Bushley 
and Turgeon, 2010; Brakhage and Schroeckh, 2011). PKS are large multidomain 
enzymes that synthesise their products in an ―assembly-line‖ manner (Fischbach 
and Walsh, 2006). Product size (i.e. the number of iterations), structure (e.g. 
cyclisation patterns) and degree of reduction and/or methylation are hard-wired 
into the structure and hence the sequence of the polyketide synthase (Yadav et 
al., 2009). In silico analysis of PKS genes and their particular domains can 
therefore serve as a tool for assigning putative functions to fungal polyketide 
synthases.  
The vast chemical diversity of fungal secondary metabolites is also the product of 
additional reactions that occur after synthesis of the backbone structure produced 
by a PKS or NRPS. The genes involved in these reactions are almost always 
found in clusters around those for synthesis of the backbone structure. Gene 
clustering is a hallmark of secondary metabolite genes in fungi (Zhang et al., 
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2004). Furthermore, it has been shown that those clusters can be transferred as 
a whole between organisms via HGT (Schmitt and Lumbsch, 2009; Slot and 
Rokas, 2011). 
In this section, putative functions are assigned to S. nodorum PKS based on 
functionally characterised orthologs in other fungi. In silico analysis of the 
phylogenetic relationship of S. nodorum PKS and their orthologs in other fungi is 
used to elucidate the evolutionary history of the PKS family in this fungus, their 
inheritance and phylogenetic background.  
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3.2 Materials and methods 
3.2.1 Orthologs of S. nodorum PKSs in other organisms 
Stagonospora nodorum SN15 polyketide synthase protein sequences were 
retrieved from the Joint Genome Initiative (http://genome.jgi-psf.org/Stano2) and 
used as blastp queries against the NCBI non-redundant protein sequence 
databases (Altschul, 1990). Domain organisation and KS, AT and ACP domain 
sequences were retrieved using the NCBI protein database and Conserved 
Domain Database (CDD). Individual KS (ketosynthase) domain sequences were 
used as blastp queries against the NCBI non-redundant protein sequence 
databases (Altschul, 1990). The KS, AT and ACP sequences, domain 
organisation and functional annotations (where applicable) of the five best hits 
(by score) were retrieved, as well as those of the best hit for the Dothideomycete 
organisms Cochliobolus heterostrophus, Leptosphaeria maculans, 
Mycosphaerella graminicola, Pyrenophora teres f. teres and P. tritici-repentis. 
Those KS and AT domains were then blasted back against S. nodorum to test for 
reciprocal best hits (RBH). Clades were inferred based on homology and domain 
organisation according to Kroken (2003). 
3.2.2 Phylogenetic analysis of S. nodorum PKSs 
The KS sequence of each S. nodorum PKS, its top ten blast hits and one 
Ustilago maydis PKS (outgroup, NCBI acc. UM06418) were aligned in Geneious 
5.5 (Drummond AJ, Ashton B, Buxton S, Cheung M, Cooper A, Heled J, Kearse 
M, Moir R, Stones-Havas S, Sturrock S, Thierer T, Wilson A (2011) available 
from http://www.geneious.com) using ClustalW algorithm in standard settings 
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(BLOSUM, gap open cost 10, gap extension cost 0.1). Phylogenetic trees for 
each alignment were constructed using the Geneious Tree Builder algorithm by 
neighbour joining with Jukes-Cantor gene distance model and resampling using 
10,000 replicates with minimum 50% bootstrap support.  
For SNOG_11981, orthologs were included from the non-dothideomycete 
organisms Botryotinia fuckeliana (=Botrytis cinerea) and Sclerotinia sclerotiorum 
(Leotiomycetes), Magnaporthe oryzae and Neurospora crassa (Sordariomycetes) 
and the Eurotiomycete Aspergillus fumigatus.  
3.2.3 Analysis of secondary metabolite gene clusters 
Putative gene clusters containing the identified S. nodorum polyketide synthases 
were predicted using the SMURF (Khaldi et al., 2010) online tool on the J. Craig 
Venter Institute website (http://www.jcvi.org/smurf/index.php). The protein 
sequences of clustered genes were used as blastp query against informative 
(functionally annotated) top hit organisms. The best hits were retrieved and used 
as queries against S. nodorum to test for reciprocal hits. Colinearity of clusters 
was analysed by aligning whole genome sequences in Mauve 2.3 (Darling et al., 
2010). 
The cercosporin synthesis cluster described by Chen and co-workers (Chen et 
al., 2007) was used as tblastn query against S. nodorum. 
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3.3 Results 
3.3.1 Polyketide Synthases in S. nodorum and putative orthologs 
Analysis of S. nodorum gene sequences from JGI and NCBI has revealed a total 
of 20 polyketide synthases and one PKS-NRPS hybrid, listed in Table 3-1. Two 
further genes SNOG_06676 and 09490, were shown to possess an incomplete 
sets of domains, with missing domains located in a neighbouring gene 
(SNOG_06677 and 09491). Where applicable, domains in those neighbouring 
genes were included in the analysis. No expression data exist on any of the 
disputed genes.  
To assign putative functions to the polyketide synthases in S. nodorum, 
functionally characterised orthologs in other ascomycetes were retrieved based 
on sequence homology. The ketosynthase domains of the known S. nodorum 
PKSs were used as blastp queries against the NCBI non-redundant protein 
database as described in 3.2.1. Table 3-2 contains results for S. nodorum genes 
with informative blast hits, the complete analysis is shown in Appendix I. 
Generally, homology as determined by blast scores was higher to non-
Dothideomycetes than to the more closely related Dothideomycetes. Orthologs of 
the five selected Dothideomycetes never solely made up the top five hits, and 
only for SNOG_11981 were all top 10 hits within Dothideomycetes.  
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The three top hits for SNOG_00477 are ATEG_06275 from Aspergillus terreus, 
ACLA_093660 from Aspergillus clavatus and Bnpks from Byssochlamys nivea. 
All three genes are annotated as 6-methylsalicylic acid synthases, but only Bnpks 
is functionally characterised. All domains tested of the three genes have 
SNOG_00477 as top blast hit in S. nodorum. The blast scores for the respective 
KS domains range between 70 to 74% of that of the SNOG_00477 KS. All three 
top hits have an additional DH domain between their AT and KR domains that is 
not present in SNOG_00477. Another functionally annotated homolog is 
otapksPN, responsible for ochratoxin synthesis in P. nordicum. The blast score 
for the KS sequcene is about 66% of that of the SNOG_00477 KS. Only a partial 
sequence containing KS and AT has been provided in GenBank. 
Two top hits for SNOG_08614 have been annotated as CTB1 cercosporin-related 
polyketide synthases in Mycosphaerella coffeicola and Cercospora nicotianae. 
Only the C. nicotianae CTB1 has been functionally characterised. All domains 
tested of the two genes have SNOG_08614 as top blast hit in S. nodorum. Their 
KS scores are 76% of that of the S. nodorum gene. The two genes have an 
additional ACP domain not present in SNOG_08614.  
SNOG_11981 is highly conserved among ascomycetes with homologs annotated 
as melanin synthases. All top ten blast hits are within the Dothideomycetes. 
Three functionally characterised homologs are ArPKS1 from Ascochyta rabiei, 
PKS1 from Bipolaris oryzae and PKS18 from C. heterostrophus. With the 
exception of the homolog in Pyrenophora teres-teres (PTT), all genes have 
variations in their domain organisation, but high blast scores for their respective 
KS domain of up to 94% of that of SNOG_11981. 
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Table 3-1 Polyketide Synthase genes in S. nodorum 
Gene number, proposed gene name, scaffold accession, scaffold coordinates (gene 
start/stop) and additional information is given for all S. nodorum PKS genes. 
gene number name NCBI Accession Scaffold Nr Strand 
SNOG_00308 NPH1 EAT91803 1 + 
SNOG_00477 SMS1 EAT91972 1 - 
SNOG_02561 PKS4 EAT89292 4 - 
SNOG_04868 PKS5 EAT87259 7 + 
SNOG_05791 PKS1 EAT86855 8 - 
SNOG_06676 PKS6 EAT86507 9 + 
SNOG_06682 PKS7 EAT86513 9 - 
SNOG_07020 PKS8 EAT85671 10 + 
SNOG_07866 PKS2 EAT85332 11 + 
SNOG_08274 PKS9 EAT84550 12 - 
SNOG_08614 PKS10 EAT83782 13 + 
SNOG_09490 PKS11 EAT82755 15 + 
SNOG_09623 PKS12 EAT82888 15 + 
SNOG_09932 PKS13 EAT82267 16 + 
SNOG_11066 PKS14 EAT81565 18 + 
SNOG_11076 PKS15 EAT81575 18 + 
SNOG_11272 PKS3 EAT80980 19 - 
SNOG_11981 MEL1 EAT80393 21 - 
SNOG_12897 PKS16 EAT79697 24 - 
SNOG_13032 PKS17 EAT79359 25 - 
SNOG_14927 PKS18 EAT77779 34 + 
SNOG_15829 PKS19 EAT76667 41 - 
SNOG_15965 PKS20 EAT76544 42 + 
 
 
Table 3-2 Orthologs of selected S. nodorum PKSs (following pages) 
Orthologs of S. nodorum PKS were retrieved using the KS sequence as blastp query 
against the NCBI NR protein database. For each S. nodorum PKS and putative ortholog, 
gene name, gene number, accession (NCBI Protein database), and blast score are given. 
Clades for S. nodorum PKSs were determined based on the system proposed by Kroken 
(2003). For the putative orthologs, organism, function (evidence level: 1: functionally 
characterised by KO or heterologous expression, 2: RBH to a level 1 gene/protein, 3: 
homology) and reciprocal blast hit in S. nodorum for KS, AT and ACP domain are given. 
Dothideomycetes are highlighted blue, matching domain organisation are highlighted 
yellow and reciprocal hits for KS, AT or ACP domains are highlighted green 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_00477 SMS1 XP_001791162.1 KS-AT-KR-ACP fungal 6-MSAS 817 
 
putative orthologs       
gene number/name blast hit organism NCBI acc (protein) inferred function (evidence level) 
ATEG_06275 Aspergillus terreus NIH2624 XP_001215453.1 6-methylsalicylic acid synthase (3) 
ACLA_093660 Aspergillus clavatus NRRL 1 XP_001273093.1 6-methylsalicylic acid synthase (3) 
Bnpks Byssochlamys nivea AAK48943.1 6-methylsalicylic acid synthase (1) 
AFLA_114820 Aspergillus flavus NRRL3357 XP_002385535.1 - 
otapksPN Penicillium nordicum AAP33839.2 ochratoxin A polyketide synthase (1) 
PKS25 Cochliobolus heterostrophus AAR90279.1 - 
PTRG_09108 Pyrenophora tritici-repentis Pt-1C-BFP XP_001939440.1 lovastatin nonaketide synthase (3) 
PTT_17304 Pyrenophora teres f. teres 0-1 XP_003304655.1 - 
PKS6 Mycosphaerella graminicola IPO323 EGP90777.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)         
gene number/name domain organisation score KS (% of SNOG) KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
ATEG_06275 KS-AT-DH-KR-ACP 608 (74.4%) SNOG_00477 SNOG_00477 SNOG_00477 
ACLA_093660 KS-AT-DH-KR-ACP 578 (70.7%) SNOG_00477 SNOG_00477 SNOG_00477 
Bnpks KS-AT-DH-KR-ACP 574 (70.3%) SNOG_00477 SNOG_00477 SNOG_00477 
AFLA_114820 KS-AT-KR-ACP 553 (67.7%) SNOG_00477 SNOG_00477 SNOG_00477 
otapksPN KS-AT 536 (65.6%) SNOG_00477 SNOG_00477 #N/A 
PKS25 KS-AT-KR-ACP 475 (58.1%) SNOG_00477 SNOG_00477 SNOG_11981 
PTRG_09108 KS-AT-MT-ER-KR-ACP 296 (36.2%) SNOG_04868 SNOG_12897 SNOG_05791 
PTT_17304 KS-AT-DH-MT-ER-KR-ACP 295 (36.1%) SNOG_07866 SNOG_12897 SNOG_05791 
PKS6 KS-AT-DH-MT-ER-KR-ACP 294 (36%) SNOG_07866 SNOG_12897 SNOG_05791 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 294 (36%) SNOG_07866 SNOG_07866 SNOG_05791 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_08614 PKS10 XP_001798923.1 KS-AT-ACP-TE non-reducing clade II 911 
 
putative orthologs       
gene numbe/name blast hit organism NCBI acc (protein) inferred function 
CTB1 Mycosphaerella coffeicola ADO14690.1 cercosporin polyketide synthase(3) 
CTB1 Cercospora nicotianae AAT69682.1 cercosporin biosynthesis(1) 
GLRG_08620 Glomerella graminicola M1.001 EFQ33691.1 - 
pks3 Gibberella fujikuroi CAC88775.1 - 
SS1G_05681 Sclerotinia sclerotiorum 1980 XP_001592760.1 - 
PTT_20106 Pyrenophora teres f. teres 0-1 XP_003306836.1 - 
LEMA_P081920.1 Leptosphaeria maculans CBX98953.1 - 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (2) 
PKS18 Cochliobolus heterostrophus AAR90272.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
 
putative orthologs (continued)          
gene number/name domain organisation score KS (% of SNOG) KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
CTB1 KS-AT-ACP-ACP-TE 695 (76.3%) SNOG_08614 SNOG_08614 SNOG_08614 
CTB1 KS-AT-ACP-ACP-TE 694 (76.2%) SNOG_08614 SNOG_08614 SNOG_08614 
GLRG_08620 AT-KS-AT-ACP-TE 679 (74.5%) SNOG_08614 SNOG_08614 SNOG_08614 
pks3 KS-AT 596 (65.4%) SNOG_08614 SNOG_09932 #N/A 
SS1G_05681 KS-AT-TE 605 (66.4%) SNOG_09932 SNOG_09932 #N/A 
PTT_20106 KS-AT-ACP-TE 584 (64.1%) SNOG_09932 SNOG_11981 SNOG_08614 
LEMA_P081920.1 KS-AT-ACP-TE 530 (58.2%) SNOG_09932 SNOG_09932 SNOG_08614 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 511 (56.1%) SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 508 (55.8%) SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  505 (55.4%) SNOG_11981 SNOG_11981 SNOG_11981 
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Snog# name domain organisation NCBI acc (protein) inferred clade blast score KS 
SNOG_11981 MEL1 KS-AT-ACP-ACP-TE XP_001802212.1 non-reducing clade II 869 
 
putative orthologs       
gene number/name blast hit organism NCBI acc (protein) inferred function 
ArPKS1 Ascochyta rabiei ACS74449.1 1,3,6,8-tetrahydroxynaphthalene polyketide synthase (1) 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (2) 
PTT_09773 Pyrenophora teres f. teres 0-1 XP_003298917.1 - 
PKS18 Cochliobolus heterostrophus AAR90272.1 THN melanin synthesis (1) 
PKS1 Bipolaris oryzae BAD22832.1 polyketide synthase required for melanin biosynthesis (1) 
N/A Setosphaeria turcica AEE68981.1 related to pathogenicity and melanin production (3) 
ALM1 Alternaria alternata BAK64048.1 conidial pigment polyketide synthase (3) 
LEMA_P098490.1 Leptosphaeria maculans CBX98440.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
EfPKS1 Elsinoe fawcettii ABU63483.1 elsinochrome phytotoxin production (1) 
 
putative orthologs (continued)           
gene number/name domain organisation score KS (% of SNOG) KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
ArPKS1 KS-AT 817 (94%) SNOG_11981 SNOG_11981 #N/A 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 827 (95.2%) SNOG_11981 SNOG_11981 SNOG_11981 
PTT_09773 KS-AT-ACP-ACP-TE 827 (95.2%) SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 824 (94.8%) SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 AT-KS-AT-ACP-ACP-TE 825 (94.9%) SNOG_11981 SNOG_11981 SNOG_11981 
N/A KS-AT-AT-ACP-ACP-TE 823 (94.7%) SNOG_11981 SNOG_11981 SNOG_11981 
ALM1 KS-AT-AT-ACP-ACP-TE 820 (94.4%) SNOG_11981 SNOG_11981 SNOG_11981 
LEMA_P098490.1 AT-KS-AT-ACP-ACP-TE 818 (94.1%) SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  771 (88.7%) SNOG_11981 SNOG_11981 SNOG_11981 
EfPKS1 KS-AT-AT-ACP-ACP-TE 770 (88.6%) SNOG_11981 SNOG_11981 SNOG_11981 
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3.3.2 Phylogeny of S. nodorum PKSs and their orthologs 
Phylogenetic trees for the 23 putative S. nodorum PKSs were constructed in 
Geneious 5.5 from ClustalW alignments with their respective homologs. For 
reasons of brevity, only the trees for SMS1, PKS10 and MEL1 are shown here. 
Trees for all PKSs can be found in Appendix II.  
SMS1 (SNOG_00477, Figure 3-1, red) is within a clade containing putative 6-
MSASs and other PKSs from A. clavatus, A. terreus, A. flavus, P. nordicum and 
B. nivea. With the exception of C. heterostrophus PKS25, all Dothideomycete 
homologs are contained in a different clade. The tree is incongruent (i.e. location 
of species within clades do not match) with the species tree depicted in Figure 
1-2.  
PKS10 (SNOG_08614, Figure 3-2, red) is within a clade containing cercosporin 
synthesis genes of the Dothideomycetes Cercospora nicotianae and M. coffeicola 
and a PKS gene of the Sordariomycete G. graminicola. A second clade contains 
the Sordariomycete Gibberella fujikori, the Leotiomycete Sclerotinia sclerotiorum 
and the Dothideomycetes P. teres f. teres and L. maculans. The tree is 
incongruent with the species tree depicted in Figure 1-2. 
The tree for MEL1 (SNOG_11981, Figure 3-3, red) is the only tree that is 
congruent with the species tree depicted in Figure 1-2. MEL1 is contained within 
a clade also containing all Dothideomycete homologs. The homologs in 
Leotiomycetes, Sordariomycetes and Eurotiomycetes all form distinct clades. The 
distribution of the species within the Dothideomycete clades is also highly similar 
to the distribution in Figure 1-2.  
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Figure 3-1 Phylogenetic tree based on SNOG_00477 and putative orthologs 
Tree was generated in Geneious 5.5 as described in 3.2.2. Please refer to 
section 3.3.2 for details 
 
Figure 3-2 Phylogenetic tree based on SNOG_08614 and putative orthologs 
Tree was generated in Geneious 5.5 as described in 3.2.2 Please refer to section 
3.3.2 for details 
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Figure 3-3 Phylogenetic tree based on SNOG_11981 and putative orthologs 
Tree was generated in Geneious 5.5 as described in 3.2.2 Please refer to section 
3.3.2 for details 
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3.3.3 Gene cluster analysis  
Gene clusters were predicted with the Secondary Metabolite Unknown Region Finder 
(SMURF) (Khaldi et al., 2010) and used as blastp queries against informative top hits 
for the respective PKS.  
For SMS1 (Table 3-3), the top hit was Aspergillus terreus. Eleven genes from the 
putative SMS1 cluster had blastp hits in A. terreus, including putative transcription 
factors, p450 oxidoreductase-like enzymes and permeases. 
For PKS10 (Table 3-4), sequence data was available for the C. nicotianae cercosporin 
gene cluster (Chen et al., 2007). Four homologs, three of them reciprocal blast hits to 
genes contained in the Cercospora cercosporin cluster were found in the putative 
PKS10 cluster. They encode a transcription factor, a methyltransferase and a MFS 
transporter protein. 
For MEL1, Two out of nine putative cluster genes had homologs in C. heterostrophus, 
a transcription factor and an oxidoreductase.  
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Table 3-3 blastp analysis of the putative SMS1 gene cluster 
S. nodorum 
Snog# 
 A. terreus  
acc. Nr (protein) gene number 
 
annotated function 
 
reciprocal 
SNOG_00466  XP_001213009.1 ATEG_03831 Transcription factor TRUE 
SNOG_00467  XP_001213461.1 ATEG_04283 contains AA permease domain TRUE 
SNOG_00468      
SNOG_00469      
SNOG_00470      
SNOG_00471      
SNOG_00472  XP_001218177.1 ATEG_09555 60S ribosomal protein L23 TRUE 
SNOG_00473      
SNOG_00474      
SNOG_00475  XP_001217215.1 ATEG_08629 Gamma-aminobutyrate permease and related  FALSE 
SNOG_00476  XP_001217215.1 ATEG_08629 Gamma-aminobutyrate permease and related  FALSE 
SNOG_00477  backbone PKS SMS1 
SNOG_00478      
SNOG_00479  XP_001217258.1 ATEG_08672 peptidase  FALSE 
SNOG_00480  XP_001218197.1 ATEG_09575 contains two effector domains of the CAP family of transcription factors and two 
Amn1 (Antagonist of mitotic exit network protein 1) domains 
TRUE 
SNOG_00481      
SNOG_00482      
SNOG_00483      
SNOG_00484  XP_001218137.1 ATEG_09515 contains helicase domains TRUE 
SNOG_00485  XP_001218138.1 ATEG_09516 RNase PH TRUE 
SNOG_00486  XP_001209999.1 ATEG_07313 contains p450 and AA permease domain TRUE 
SNOG_00487      
SNOG_00488  XP_001218455.1 ATEG_09833 contains MFS domain TRUE 
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Table 3-4 blastp analysis of the putative PKS10 gene cluster 
S. nodorum Cercospora nicotianae 
Snog# acc. Nr (protein) gene name annotated function reciprocal 
SNOG_08609 ABK64185.1 CTB8 zinc finger transcription factor TRUE 
SNOG_08610 ABK64180.1 CTB2 O-methyltransferase TRUE 
SNOG_08611 ACD42873.1 ATR1 MFS transporter (Amnuaykanjanasin and Daub, 2009) FALSE 
SNOG_08612 ABC79591.2 CTB3 cercosporin toxin biosynthesis protein TRUE 
SNOG_08613 - 
SNOG_08614 backbone PKS10 
 
Table 3-5 blastp analysis of the putative MEL1 gene cluster 
S. nodorum Cochliobolus heterostrophus 
Snog# acc. Nr (protein) gene name annotated function reciprocal 
SNOG_11990 BAA24225.1 Brn1 THN melanin reductase TRUE 
SNOG_11989 - 
SNOG_11988 - 
SNOG_11987 ABI81496.1 Cmr1 Transcription factor TRUE 
SNOG_11986 - 
SNOG_11985 - 
SNOG_11984 - 
SNOG_11983 - 
SNOG_11982 - 
SNOG_11981 backbone PKS MEL1 
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Table 3-6 tblastn analysis of the C. nicotianae cercosporin gene cluster 
The cercosporin polyketide synthesis cluster of C. nicotianae (Chen et al., 2007) was 
used as tblastn query against S. nodorum. Genes are listed in the order of their position 
in the C. nicotianae cluster. Genes contained within the predicted S. nodorum PKS10 
cluster are highlighted in bold font. 
C. nicotianae  predicted function (Chen et al., 2007) S. nodorum 
ORF12 Truncated transcription factor SNOG_08609 
ORF11 Truncated transcription factor SNOG_08609 
CTB8 Zinc finger transcription factor SNOG_08609 
CTB7 FAD/FMN-dependent oxidoreductase SNOG_06495 
CTB5 Oxygen, FAD/FMN-dependent oxidoreductase SNOG_08608 
CTB3 O-methyltransferase/ FAD-dependent monooxygenase SNOG_08612 
CTB1 backbone PKS SNOG_08614 
CTB2 O-methyltransferase SNOG_08610 
CTB4 Major Facilitator Superfamily (MFS) Transporter SNOG_05808 
CTB6 NADPH-dependent oxidoreductase SNOG_11921 
ORF9 Conserved eukaryotic protein of unknown function SNOG_15208 
ORF10 Hypothetical protein SNOG_00587 
 
 
 
 
 
Figure 3-4 Collinear melanin synthesis clusters in S. nodorum and C. heterstrophus 
The melanin synthesis cluster in C. heterostrophus (green, top) is collinear with a putative 
melanin synthesis cluster in S. nodorum (blue, bottom). Red bar: 1 kb 
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3.4 Discussion 
3.4.1 Polyketide synthases in S. nodorum  
Stagonospora nodorum has 20 polyketide synthase genes and one 
(SNOG_00308, NPH1) polyketide synthase-nonribosomal peptide synthase 
hybrid. In comparison, the related Dothideomycete Cochliobolus heterostrophus 
has 25 PKS (Turgeon and Baker, 2007). This is in line with the findings of Kroken 
(2003), Khaldi (2010) and colleagues, that pathogenic Pezizomycotina have large 
numbers of PKS genes (Table 3-7). Whether this is due to an evolutionary 
advantage or a lack of sequenced saprobes is yet to be elucidated. In two cases 
the minimum required domains KS, AT and ACP were split over two adjacent 
genes. No expression data exist on these genes (Ipcho, 2012), therefore a mis-
annotation cannot be excluded. However, it is possible that these genes have 
been rendered unfunctional by mutation through the introduction of stop codons 
as a form of adaptation by the fungus to evade recognition by the host by 
processes similar to those that lead to hypervirulence in Magnaporthe ACE1 
mutants (Böhnert et al., 2004).  
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Table 3-7 Number of putative PKS genes in different fungi 
Pathogenic Pezizomycotina have a high number of putative PKS genes 
Organism number of putative PKS genes 
S. nodorum (pathogen, Pezizomycotina) 20 (+1 NRPS-PKS) 
C. heterostrophus (pathogen, 
Pezizomycotina) 
25 (Kroken et al., 2003) 
M. grisea (pathogen, Pezizomycotina) 23 (Dean, 2005) 
P. teres (pathogen, Pezizomycotina) 18 (Ellwood et al., 2010) 
B. cinerea (pathogen, Pezizomycotina) 
S. sclerotiorum (pathogen, Pezizomycotina) 
16 (Amselem et al., 2011) 
F. graminearum (pathogen, Pezizomycotina) 15 (Gaffoor et al., 2005) 
L. maculans (pathogen, Pezizomycotina) 14 (Rouxel, 2011) 
N. crassa (saprobe, Pezizomycotina) 7 (Galagan, 2003) 
S. pombe (saprobe, Taphrinomycotina) 0 (Wood, 2002) 
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3.4.2 Assigning functions based on homology 
Only in three out of 23 cases were putative functions assigned to the putative 
PKSs. These are the putative 6-MSAS SNOG_00477 (SMS1), a putative 
cercosporin synthase SNOG_08614 (PKS10) and a putative melanin synthase 
SNOG_11981 (MEL1). On further examination, only the evidence for MEL1 was 
sufficient enough for a functional annotation: 
For SMS1, three top blast hits with reciprocal hits in SMS1 were annotated as 6-
MSASs. One of them, Byssochlamys nivea Bnpks (AAK48943.1) has been 
functionally characterised (Puel et al., 2007). All three genes are RBH to SMS1 
for their KS, AT and ACP domain, but the sequence similarity and coverage for 
the KS domain as represented by the blast score were considered insufficient for 
a functional annotation based on homology. Most importantly, SMS1 lacks the 
DH domain responsible for the step that gives rise to the double bond in the 
nascent PKS chain during 6-MSA synthesis (Figure 1-6). 
The top two hits of PKS10 are annotated as CTB1, which has been functionally 
characterised as cercosporin synthase for Cercospora nicotianae (Choquer et al., 
2005). Both orthologs are RBHs to PKS10 for all domains tested, but, as for 
SMS1, the blast scores were considered insufficient for a functional annotation 
based on homology. 
MEL1 is highly conserved not just among Dothideomycetes, but also 
Pezizomycotina. All orthologs tested are RBHs to MEL1 for their KS, AT and ACP 
domains. Their function as melanin synthases has been demonstrated for A. 
rabiei (Akamatsu et al., 2010) and C. heterostrophus (Eliahu et al., 2007). High 
KS domain blast scores of up to 95% of that of the S. nodorum homolog indicate 
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high sequence similarity and coverage, providing conclusive evidence for 
assigning a putative function based on sequence homology.  
3.4.3 Phylogenetic relationship and evolutionary history 
The phylogenetic tree for MEL1 is the only tree that very closely resembles 
Figure 1-2, which was constructed from ITS sequences (Hane et al., 2007). This 
is the only obvious case of a gene that is likely to be simply and vertically 
inherited. It also indicates that melanin synthesis is an ancient, well conserved 
feature of the fungi concerned. All remaining trees are incongruent, and those 
PKS gene homologues from other Dothideomycetes grouping in different clades 
to S. nodorum are also not reciprocal best hits, indicating that they are not 
orthologs. Therefore, at least part of the PKS repertoire of S. nodorum might be 
attributed to duplication, deletion and/ or horizontal gene transfer (HGT) events. 
To postulate HGT between two organisms, however, incongruent phylogenetic 
trees alone are not considered sufficient evidence (Oliver and Solomon, 2008). 
Future studies should therefore include examining codon usage and population 
genetics to elucidate the role of HGT in the evolution of PKSs in 
Dothideomycetes. 
3.4.4 Analysis of PKS gene clusters 
A hallmark of secondary metabolite genes in fungi is their organisation in gene 
clusters with tailoring enzymes, efflux pumps and/or transcription factors 
(Hoffmeister and Keller, 2007; Brakhage and Schroeckh, 2011). 
SMURF analysis revealed putative gene clusters for the three PKSs described 
above. Genes within the SMS1 and PKS10 clusters have homologs in A. terreus 
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and C. nicotianae, respectively, see Table 3-3 and Table 3-4. However, for the 
putative SMS1 cluster, the gene order is not conserved compared to A. terreus, 
and genes from distant genomic regions (as indicated by their gene numbers) 
were among the predicted homologs in the cluster in S. nodorum. Furthermore, 
genes directly adjacent to SNOG_00477 have functional predictions unrelated to 
the secondary metabolism, raising questions as to the functionality of the cluster. 
The C. nicotianae cercosporin cluster contained an additional 7 genes to the 
ones predicted by SMURF (Chen et al., 2007). The sequences presented by 
Chen and colleagues were used as tblastn query against S. nodorum. The results 
in Table 3-6 show that half the genes are missing and the remaining ones are in 
a different order. Therefore, although examples of discontiguous gene clusters 
exist in other Dothideomycetes (Bradshaw et al., 2002), and SMS1 and PKS10 
indeed have relatively high homology to their orthologs, the combined findings of 
the gene cluster analysis are still inconclusive as to the nature of the compounds 
ultimately produced by the respective clusters. 
Blastp analysis of the putative MEL1 gene clusters has revealed two more genes, 
SNOG_11987 and SNOG_11990, to be putatively involved in melanin synthesis. 
The protein product of SNOG_11987 is predicted to contain a GAL4-like 
Zn2Cys6 binuclear cluster DNA-binding domain. It has high homology to 
transcription factors involved in melanin synthesis, like Cmr1 of C. heterostrophus 
(Eliahu et al., 2007) and Colletotrichum lagenarium and pig1 in Magnaporthe 
grisea (Tsuji et al., 2000). SNOG_11990 encodes a putative THN melanin 
reductase highly conserved among ascomycetes. The ortholog in C. 
heterostrophus is the reductase Brn1 (Shimizu, 1997).  
72 
 
Gene order was analysed by aligning the whole genome sequences of S. 
nodorum and C. heterostrophus using mauve 2.3 as described in 3.2.3. The 
clusters are collinear in both fungi, as shown in Figure 3-4. 
3.4.5 An alternative melanin pathway in S. nodorum? 
Previously, Stagonospora nodorum was shown to synthesize melanin via the 
dihydroxyphenylalanine (L-DOPA) pathway, the first plant pathogenic fungus to 
do so (Solomon et al., 2004). It was shown that tricyclazole, an 1,8- 
dihydroxynaphthalene (DHN) melanin synthesis- inhibiting fungicide, only 
marginally affected melanisation of mycelia if incubated for 6 days even in high 
doses. Microarray data for SNOG_11981, 11987 and 11990 shows an up-
regulation during both late in planta and in vitro stages (Ipcho, 2012). Together, 
these data suggest that S. nodorum most likely uses the two independent 
pathways for distinct purposes during its lifecycle, i.e. L-DOPA-derived melanin 
for mycelia pigmentation and polyketide-derived melanin for pigmentation of 
pycnidia and/or conidia. 
3.5 Conclusions 
In silico analysis did not yield enough evidence towards the evolutionary and 
phylogenetic history of the majority of S. nodorum PKSs. It did highlight, however, 
that the PKS genes in this fungus are highly species specific and/or rapidly 
evolving. While gene duplication, deletion and neofunctionalisation may be the 
mechanisms that led to this unique set of PKS genes in the S. nodorum genome, 
the driving forces behind this rapid evolution remain unknown. Two genes 
appeared to have been rendered unfunctional by introduction of a stop codon 
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and therefore separating required domains into two genes, further demonstrating 
the plasticity of PKS genes in S. nodorum.  
Furthermore, an evident lack of viable functional annotations of polyketide 
synthase genes was observed in this study and has hampered in silico analysis. 
Less than 50 out of >250 genes/proteins analysed had an annotation beyond a 
generic ―(putative) polyketide synthase‖, and an even smaller fraction of genes 
has actually been functionally analysed by expression studies or knockout 
mutagenesis. The same is also true for the vast majority of tailoring genes within 
putative clusters detected by SMURF analysis.  
Despite these limitations, in silico analysis has revealed a gene cluster for an 
alternative melanin synthesis pathway in S. nodorum that is highly conserved 
among filamentous ascomycetes. This is in line with findings from Khaldi and 
colleagues, that, while SM genes and clusters are often highly species specific, 
melanin clusters are among the best-conserved SM gene clusters in filamentous 
fungi (Khaldi et al., 2010). 
Melanised spores are a significant pathogenicity factor in filamentous fungi (Liu, 
2009), and melanin-deficient mutants have been shown to have significantly 
reduced fitness in the field (Guillen, 1994). This study has provided evidence 
towards a putative spore melanisation pathway via polyketide-derived melanin in 
Stagonospora nodorum. These findings could be verified in future studies by 
using the THN-melanin inhibitor tricyclazole and targeted gene disruption on the 
genes within the MEL1 cluster to investigate the role of polyketide-derived 
melanin during sporulation of this pathogen. Since S. nodorum relies on multiple 
cycles of sporulation for disease progression, reducing spore survivability could 
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lead to novel practices for controlling the spread of this destructive fungus in the 
field (Tan et al., 2008).  
Bioinformatic analysis has facilitated secondary metabolite research significantly 
in the last decade. Predicting the molecular structure of a polyketide purely based 
on the gene sequence of its putative synthase, however, remains a challenge for 
the future (Yadav et al., 2009). To overcome the obvious limitations of the 
bioinformatics approach, these findings served as a starting point for further 
research with classical molecular biology as well as biochemistry and analytical 
chemistry techniques.  
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4 Functional Analysis of 
Polyketide Synthase Genes in 
Stagonospora nodorum 
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4.1 Introduction 
The benefits secondary metabolites convey to their respective producers are 
plentiful and range from inter- and intraspecies communication to protection from 
the biotic and abiotic environment. Among the more intriguing examples are 
those SM that are used to actively weaken or kill other organisms. The respective 
compounds may exhibit a general toxicity towards a multitude of organisms from 
different kingdoms (e.g. cercosporin, see 1.5.2 and Figure 1-9, 6), a subset of 
organisms from one particular kingdom (e.g. penicillin, see 1.4.3.4 and Figure 
1-8, 3), or just a certain subset of a particular species (HSTs, e.g. T-Toxin, see 
1.5.3 and Figure 1-9, 11).  
Necrotrophic fungi in general and those from the class of Dothideomycetes in 
particular have long been known to produce secondary metabolites that enable 
them to colonise a wide variety of mono- and dicotyledonous plants. The 
respective compounds may serve as virulence factors that facilitate disease 
progression, or pathogenicity factors that enable their producers to cause disease 
in the first place. Understanding the roles these compounds play for their 
producers has been a constant topic in plant pathology (Wolpert et al., 2002; 
Agrios, 2005; Möbius and Hertweck, 2009; Horbach et al., 2011). These efforts 
have been aided by the development of molecular tools to manipulate the genetic 
material of fungi and other organisms. The role of T-toxin in corn blight caused by 
Cochliobolus heterostrophus is one of the most prominent examples and has 
been discussed above (see 1.5.3). The highly virulent race T has a further two 
polyketide synthase genes in addition to the ones shared with the less virulent 
race O. Both genes are required for T-Toxin production, and knockout mutants 
defective in those PKSs are unable to produce T-toxin, resulting in highly reduced 
virulence comparable to that of race O (Baker et al., 2006; Turgeon and Baker, 
77 
 
2007). In many cases, different organisms that may or may not be closely related 
produce a similar set of secondary metabolites and use similar strategies for host 
colonisation. Evidence gathered for one particular pathogen-host system can 
therefore be transferred and applied to another, less well characterised system.  
Research on the pathogenic mechanisms of Stagonospora nodorum thus far has 
focussed on cellular signalling (Solomon et al., 2004; Solomon et al., 2005; 
Solomon et al., 2006a), primary metabolism (Solomon, 2006a; Tan et al., 2008; 
Lowe, 2009) and secreted proteinaceous HSTs (Solomon, 2006b; Friesen et al., 
2007; Friesen et al., 2009). Many of the mutant strains created in these studies 
are severely compromised in host-colonisation and/or sporulation. Recent studies 
using targeted gene disruption have also demonstrated the potential of this 
fungus to produce the polyketide mycotoxin alternariol (Tan et al., 2008; Tan et 
al., 2009). Little is known, however, of the role of this and other secondary 
metabolites in pathogenesis of S. nodorum. Like many Dothideomycetes, S. 
nodorum has a large number of polyketide synthase genes. This class of SM 
related genes have been shown to contribute significantly to the virulence and 
pathogenicity of a large number of plant-pathogenic fungi (see 1.5) and although 
S. nodorum is known to produce at least one polyketide mycotoxin, alternariol, 
polyketide synthesis and its role in pathogenicity of this fungus remain largely 
unexplored. 
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The infectious life cycle of S. nodorum is that of a classical necrotroph (see 1.3). 
After penetrating the host cuticle, it proliferates and produces toxins to quickly kill 
the host tissue (Solomon, 2006b). Genes up-regulated during this early infectious 
stage are therefore likely to be involved in this crucial stage of the pathogenic life 
cycle. A better understanding of the interactions of the fungus with its host during 
pathogenesis can therefore lead to more adequate measures for controlling the 
disease caused by S. nodorum in the field.  
In this chapter, three mutant strains defective in putative polyketide synthases 
that are up-regulated during early in planta growth are under investigation for 
their contribution to the pathogenicity and virulence of S. nodorum in wheat. The 
mutants are characterised physiologically for aberrations in colony morphology, 
primary metabolism, sporulation in planta and in vitro and their ability to cause 
disease in susceptible wheat plants. 
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4.2 Materials and Methods 
4.2.1 Validation of microarray data by qRT-PCR 
4.2.1.1 Sample preparation 
Wheat leaf sections were prepared as described in 2.7. Four leaves per time 
point were spot-inoculated with 5 μl of 106 Spores/ml in 0.02% (v/v) Tween 20 (3, 
2, 2 and 1 drop(s) per leaf for 3, 5, 7 and 10 dpi samples, respectively). Samples 
were incubated at 25 ℃ in a 12h light/dark cycle (see 2.7) for 3, 5, 7 and 10 days, 
respectively. The leaves were then removed from the agar, transferred to 1.5 ml 
microcentrifuge tubes and snap-frozen by plunging the tubes in liquid Nitrogen 
(lN2). Samples were stored at -80 ℃ prior to processing. 
4.2.1.2 RNA extraction 
Isolation of total RNA was performed using TRIzol® reagent (GibcoBRL). 
Samples were homogenised in one ml TRIzol using pre-cooled mortar and 
pestle. The homogenate was allowed to stand for five min. at RT before 
transferring to a 1.5 ml microcentrifuge tube, adding of 200 μl chloroform and 
vigorous shaking. The mixture was incubated at RT for 3 min, and then 
centrifuged at 12,000 × g and 4 ℃ for 15 min. The aqueous phase was removed 
and re-extracted twice in TRIzol. RNA was precipitated from the aqueous phase 
with 500 μl isopropanol and washed in 75% ethanol (EtOH) in DEPC-treated 
water. The RNA pellet was resuspended in 50 μl DEPC-treated water. Possible 
DNA contamination was removed using DNA-free™ reagent (Ambion) according 
to the manufacturer‘s instructions. 
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4.2.1.3 Reverse Transcription  
cDNA was synthesised from extracted RNA using the iScript™ kit (BioRad) 
according to the manufacturer‘s instructions. Reactions contained one μg total 
RNA, 1 × iScript reaction mix (including oligo-dT primer) and one μl iScript 
reverse transcriptase in 20 μl total volume. The cDNA was synthesised at 25 ℃ 
for five min, 42 ℃ for 30 min and 85 ℃ for five min. in an Eppendorf Mastercycler 
ep thermocycler. cDNA was stored at -20 ℃ before processing. 
4.2.1.4 qRT-PCR  
All reactions were carried out in duplicate. Each reaction consisted of 10 μl iO 
SYBR® Green Supermix (BioRad), 500nM each of the appropriate primers 
(00477RTf/r, 05791RTf/r or 1272RTf/r, see Table 2-1) and five μl of a 1:10 to 
1:70 dilution of DNAse-treated RNA in 20 μl total volume. Actin (SNOG_01139.1, 
primers ActinqPCRf/r) was used as a constitutively expressed control gene for 
normalisation. qPCR was performed in a Rotor Gene 6 (Corbett Research, 
Australia) as follows: 95℃ for 3 min (initial denaturation), followed by 40 cycles of 
94℃ for 10s (denaturation), 57℃ for 20s (annealing) and 72℃ for 30s 
(extension). Sample fluorescence was detected using 470 nm excitation and 510 
nm detection wavelength. The proprietary Rotor Gene 6 software 
(http://www.corbettlifescience.com/) was used to process the data (comparative 
quantitation feature).  
4.2.2 Targeted gene disruption (knockout) experiments 
Gene knockout experiments were performed according to Solomon et al. 
(Solomon et al., 2004). Microorganisms were handled under sterile conditions 
(where applicable). Protoplasts were kept on ice unless otherwise noted. 
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4.2.2.1 Buffers and solutions 
All solutions were prepared in mQ H2O and sterilized by passing through a 0.2 
μm filter.  
 
Wash solution    
0.6  M MgSO4 
 
Glucanex digestion solution  
1.2  M MgSO4  
5  mM NaH2PO4  
5 mM Na2HPO4 
15  g/l  Glucanex (Novozyme) 
pH 5.8 
 
1M Sorbitol Solution 
1  M Sorbitol 
10 mM Tris-HCl pH 7.5 
Protoplast Overlay Solution  
0.6 M Sorbitol 
10  mM Tris-HCl pH 7.5 
82 
 
STC buffer 
1.2 M Sorbitol 
10 mM CaCl2 
10 mM Tris-HCl pH 7.5 
PEG Solution 
600  g/l Polyethyleneglycol-4000 
10  mM CaCl2 
10  mM Tris-HCl pH 7.5 
CzV8 protoplast agar 
45.5  g/l Czapek-Dox agar 
10  g/l Agar 
182.2  g/l  Sorbitol 
200  ml/l centrifuged V8 juice (see 2.2) 
CzV8 top agar 
45.5  g/l Czapek-Dox agar  
7.5  g/l Agar 
182.2  g/l  Sorbitol 
200  ml/l centrifuged V8 juice (see 2.2) 
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4.2.2.2 Synthesis of knockout constructs 
The KO constructs were synthesised using a fusion PCR approach (Solomon et 
al., 2006a). Regions flanking the candidate genes were amplified by PCR (Figure 
4-1) with the primers 00477KO5f/r (product size: 753bp), 00477KO3f/r (805bp), 
05791KO5f/r (707bp), 05791KO3f/r (701bp), 11272KO5f/r (702bp) and 
11272KO3f/r (736bp) (see Table 2-1). The phleomycin resistance cassette was 
amplified from the pAN8-1 plasmid using the primers pan8 f/r (See Table 2-1). 
Equimolar amounts of the respective 5‘ and 3‘ flanking region and the resistance 
cassette were combined in a single PCR reaction using the respective 5‘-flank 
forward and 3‘-flank reverse primers. The process is summarised in Figure 4-1. 
The resulting knockout construct was gel-purified and eluted in STC buffer (see 
4.2.2.1). 
4.2.2.3 Generating Protoplasts 
Two 250ml Erlenmeyer flasks containing 100ml CzV8CS were inoculated with 5 
× 108 SN15 spores and incubated overnight as described in 2.4. The culture was 
then harvested by centrifuging for 10 min at 7.500 × g and 4℃ in two 50 ml tubes. 
The supernatant was discarded; the mycelia were combined and washed with 
50ml Wash Solution. The washed mycelia were then resuspended in 25ml 
Glucanex solution, transferred to a sterile glass petri dish and incubated at 28℃ 
for two hours. The suspension was then transferred to a sterile 50 ml tube, 
overlayed with five ml overlay solution and centrifuged for 20 min at 1.500 × g 
and 4℃. The resulting interphase containing protoplasts was removed, diluted in 
an equal volume 1 M Sorbitol Solution and centrifuged again at 1.500 × g for five 
min. The supernatant was discarded and the protoplasts were resuspended in 
STC buffer. 
84 
 
 
Figure 4-1 Fusion PCR for synthesis of knockout constructs 
The procedure is described in 4.2.2.2. Firstly, regions flanking the target gene are 
synthesised in two PCRs. The 5‘flank reverse and 3‘flank forward primers contain an 
additional sequence that is complementary to the resistance cassette forward and 
reverse primer, respectively. Secondly, the resistance cassette is amplified in another 
PCR reaction. Finally, equimolar amounts of 5‘flank, 3‘flank and resistance cassette are 
used as template in a fusion PCR with the 5‘flank forward and 3‘flank reverse primers. 
Flanking regions and resistance cassette are fused by PCR due to the complementary 
sequences conveyed by the specific primer design  
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4.2.2.4 Transformation of Protoplasts 
SN15 protoplasts were counted on a haemocytometer and diluted to 5 × 108 in 
100 μl STC. 3-8 μg of the respective knockout constructs in 25 μl STC were 
added to one aliquot of protoplasts per construct and incubated at RT for 20 min. 
PEG Solution was added to the protoplasts in two 200 μl and one 800 μl aliquot, 
with gentle inversion in between additions to ensure even distribution. The 
transformation mix was then incubated at RT for 20 min. A negative control was 
prepared in the same way by mixing an aliquot of protoplasts with STC buffer 
without DNA.  
CzV8 top agar was allowed to cool to 50℃ before dispensing as four 5ml aliquots 
per construct in 10 ml tubes. 300 μl transformation mix or negative control was 
added to each tube, briefly mixed and poured evenly onto CzV8 protoplast agar. 
The plates were wrapped in aluminium foil and incubated at 22℃.  
After 24 hours of incubation, the plates were overlayed with 5ml CzV8 top agar 
supplemented with 250 μg phleomycin. The plates were then incubated as before 
for up to 10 days for colonies to develop. 
The plates were checked daily and transformant colonies were picked randomly 
and transferred to V8PDA plates containing phleomycin. These plates were 
incubated as described in 2.4 to the onset of sporulation. Transformants were 
purified by collecting spores from a single pycnidium with a sterile needle and 
diluting in sterile mQ H2O. One hundred spores in 100 μl mQ H2O were plated 
onto V8PDA containing Phleomycin and incubated for 5-7 days under near UV. 
Single spore colonies were transferred to a fresh plate as soon as they appeared.  
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4.2.2.5 Transformant Screening 
Genomic DNA of transformants was isolated as described in 2.9. The DNA was 
used as template for PCR (see 2.10) with the appropriate screening primers 
00477Scrf/r, 05791Scrf/r or 11272Scrf/r, respectively. The forward primers were 
designed to anneal outside the 5‘flanking region of the KO constructs, while the 
reverse primers anneal within the resistance cassette. Gene deletion will result in 
a 1kb amplicon, while ectopic mutants will not amplify.  
Confirmed knockouts were randomly selected and further screened with qPCR to 
determine the number of integrated KO constructs as described by Solomon 
(Solomon et al., 2008). Reactions (three technical replicates) contained 5 μl 6.7 
ng/μl DNA, 5 μl of combined PhleoqPCRf/r primers (1.2 μM) and 10 μl iSYBR 
qPCR mix (BioRad). For creating the standard curve, 5μl gDNA of strain mm102 
containing a single copy of the phleomycin cassette were used in 20, 6.7, 2 and 
0.67ng/μl concentration. qPCR was performed in a Rotor Gene 6 (Corbett 
Research, Australia) as follows: 95℃ for 3 min (initial denaturation), followed by 
40 cycles of 95℃ for 10s (denaturation), 57℃ for 10s (annealing) and 72℃ for 
20s (extension). Sample fluorescence was detected using 470 nm excitation and 
510 nm detection wavelength. The proprietary Rotor Gene 6 software 
(http://www.corbettlifescience.com/) was used to pre-process the data 
(comparative quantitation feature). The results were imported into Microsoft Excel 
2010 (version 14.0.5128.5000, Microsoft Corporation, Redmond WA, USA) 
spreadsheet to calculate the ratio of phleomycin to actin per sample. A ratio of 1 
is diagnostic of a single copy knockout 
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4.2.3 Analysis of S. nodorum knockout Mutants  
4.2.3.1 Growth assay 
Fungal growth assays were performed in 96 well microtitre plates. Each well 
contained 160 μl of minimal medium and 30 μl (final concentration: 25mM) of the 
appropriate carbon source and/or media component and/or sterile H2O as 
required (see Table 4-1). Two replicate plates were prepared; each plate 
contained two biological replicates. The wells were inoculated with 10 μl of 106 
spores/ml or sterile H2O (negative control) and the absorbance was measured at 
595nm using a Beckman Coulter DTX880 Multimode Detector. The plates were 
then wrapped and incubated at 22℃ in the dark. A second measurement was 
taken after one week. Relative Growth over the 7d period was calculated by 
subtracting the initial from the final reading. Results were tested for statistical 
significance as described in 2.13. 
 
Table 4-1 Schematic of the 96well microtitre plate layout for growth assays 
Two replicate plates were prepared; each plate contained two biological replicates 
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4.2.3.2 Whole Plant Spray  
Pathogenicity of PKS mutants in comparison to wildtype fungus and ectopic 
mutants was assayed with whole plant spray according to Solomon et al. (2005). 
11d old wheat plants (cv. Calingiri) were prepared as described (see 2.7). For 
each mutant, wildtype, ectopic and negative control, eight replicate pots were 
used. The plants were sprayed with 12 ml 106 spores/ml in 0.02% Tween-20 in 
sterile mQ H2O or 0.02% Tween without spores (negative control). The plants 
were covered and kept in the dark at 20℃ for two days, followed by a a further 
five days under a 12h dark/light regime. Disease symptoms were assessed 
visually on a scale from 0 (uninfected) to 9 (widespread necrosis). Five 
represenative samples of the first true leaf for each strain and the negative 
control were selected for the Latent Period Assay for sporulation. 
4.2.3.3 Latent Period Assay 
The leaf samples described in 4.2.3.1 were sized to 5 cm, the cut faces 
submerged in Benzimidazole agar (see 2.3) and incubated as described in 
4.2.1.1. After 7 days, the numbers of pycnidia formed per leaf were recorded, 
before submerging the leaves in one ml sterile water for one hour with agitation in 
a centrifuge tube to collect the spores. The leaves were removed and the spores 
were pelleted at 5.000 × g for five min.. The spores were resuspended in 50 to 
500 μl sterile mQ H2O and quantified with a haemocytometer. Results were 
tested for statistical significance as described in 2.13 
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4.2.3.4 Detached Leaf Assay 
To further assess the ability of the strains to colonize the host tissue, disease 
progression from a single point of infection was evaluated. Experiments were 
carried out in triplicates. 5 cm sections of 11d old wheat leaves were prepared by 
cutting off 2cm of the distal end. The leaves were embedded in Benzimidazole 
agar and point-inoculated with 5 μl of 106 spores/ml in 0.02% (v/v) Tween-20 or 5 
μl 0.02% (v/v) Tween-20 (negative control). The leaves were incubated for two 
weeks as described in 4.2.1.1. Lesion size was measured at regular intervals 
using a calliper. Results were tested for statistical significance as described in 
2.13. 
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4.3 Results 
4.3.1 Selecting knockout candidates 
Candidate genes were selected from the putative polyketide synthases listed in 
Table 3-1. The criterion was up-regulation during early in planta growth as 
predicted by microarray data (Ipcho, 2012). A fluorescence reading below 500 
arbitrary units was considered background and the respective genes were 
considered not expressed at the time point concerned. The expression profiles of 
PKS genes expressed in planta are summarised in Figure 4-2, the microarray 
data is shown in Appendix IV. SMS1 (SNOG_00477), PKS1 (SNOG_05791), 
PKS2 (SNOG_07866), PKS3 (SNOG_11272), PKS4 (SNOG_02561) and PKS17 
(SNOG_12987) are up-regulated during early in-planta growth ((average of 3 and 
5 dpi replicates) / (average of 7 and 10 dpi replicates) > 1). The three genes with 
the highest expression, SMS1, PKS1 and PKS3, were selected for further 
characterisation by targeted gene disruption experiments. 
4.3.2 Validation of microarray data by qRT-PCR 
Relative gene expression of KO candidate genes was examined using qRT-PCR. 
Transcript abundance in planta was analysed from SN15 detached leaf assays 
(see 2.7) and normalised to actin as constitutively expressed reference gene 
(Appendix V). The results are summarised in Figure 4-3. Expression of PKS1 and 
3 were strongest at the 3dpi time point and generally lower than SMS1, which 
was most strongly expressed during 5dpi. Expression of SMS1 returned to initial 
levels over the 7 and 10 dpi time points, while expression of PKS1 and 3 falls 
below detection limits. 
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In order to be able to better compare the expression profile between qRT-PCR 
and microarray data, both datasets were re-calculated to represent expression 
compared to the level of the 3dpi time point (Appendix VI). The results are 
summarised in Figure 4-4 
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Figure 4-2 Expression profiles of PKS genes up-regulated early in planta  
Fluorescence readings below 5 × 10
2
 were considered background and omitted in the 
graph. SMS1, PKS1 and PKS3 have the highest expression of the genes depicted and 
were therefore chosen for the knockout experiments. 
 
 
 
Figure 4-3 Gene expression of knockout candidates determined by qRT-PCR 
Relative transcript abundance was calculated using actin as reference gene for 3, 5, 7 
and 10 dpi in planta. Expression falls below the detection threshold for PKS 1 and 3 after 
5 dpi. RNA was prepared from 4 infected leaf segments at each time point and relative 
gene expression was assessed in technical duplicates as outlined in 4.2.1  
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Figure 4-4 Comparison of microarray and qRT-PCR data 
Expression relative to 3dpi is given for each gene and time point. Overall trends between 
timepoints are the same for PKS1 and PKS3 microarray and qRT-PCR data, whereas 
they differ for SMS1 between time points 3 and 5 dpi.  
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4.3.3 Generation and screening of knockout mutants 
Knockout constructs for SMS1, PKS1 and PKS3 were amplified using PCR with 
the respective primers as described in 4.2.2.2. Transformation of wild-type S. 
nodorum was conducted according to 4.2.2.3 and 4.2.2.4. Knockout mutants 
were identified by PCR screening phleomycin-resistant colonies as described in 
4.2.2.5., 43 for sms1, 42 for pks1 and 25 for pks3. Results are depicted in Figure 
4-5. Due to the specific primer design, a band of 1kb is diagnostic for 
homologous recombination and therefore gene deletion. sms11-12, 26, 28, 29 
and 34, pks1-16, and 48 and pks3-1, 16, 17 and 18 show the 1kb band and are 
therefore confirmed knockouts. Four confirmed knockout strains per gene were 
then screened with qPCR for insert copy number as described in 4.2.2.5. A 
phleomycin/actin ration of less than 1.5 was considered single copy. The 
confirmed single copy knockout transformants sms1-26 and 28, pks1-16 and 48 
and pks3-1 and 16 were selected for further experiments. pks1-27 (―Ecto1‖, not 
shown) was selected as single copy ectopic mutant for further experiments.  
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Figure 4-5 Screening PCR, gel electrophoresis 
Results of the screening PCR. Arrow indicates 1kb band diagnostic of homologous 
recombination and successful disruption of the target gene. Numbers indicate individual 
transformants, N: negative control with SN15 gDNA, M: Promega 100bp marker. 
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4.3.4 General characterisation of mutants 
On all media tested as outlined in 4.2.3.1, no differences in the growth rate 
between the mutants and the wild-type were detectable. Growth rate and colony 
morphology on V8PDA and minimal medium plates was indistinguishable, see 
Figure 4-6. There was no significant difference in the number of spores harvested 
per plate from V8PDA plates apart from the normally observed physiological 
variation.  
4.3.5 Growth Assay 
The ability of the mutants to utilize different carbon and nitrogen sources as well 
as salt tolerance was tested in a 96 well microtitre-based growth assay. Plate 
layout was as described in Table 4-1. Each plate contained two technical 
replicates; two plates were prepared for each knockout. Two measurements were 
taken, one directly after inoculation, the second one week later. Relative growth 
was calculated by subtracting the first measurement from the second. Data are 
shown in Appendix VII.  
The data were imported into jmp 8.0.2 to detect significant differences in the 
relative growth rate for a particular treatment of both mutant strains compared to 
both control strains for each mutant (p<0.05) by Tukey-Kramer HSD analysis. 
Results are shown in Appendix VIII.  
In none of the cases were both mutant strains significantly different from both 
control strains on any carbon sources/media tested. 
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For sms1, differences were detected for trehalose as sole carbon source, where, 
sms1-26 and SN15 are significantly different from each other, but not to any of 
the other strains individually. For pks1, the ectopic and the wild-type strain differ 
significantly from each other, but not any of the other strains individually, for 
glycerol as sole carbon source. For pks3, pks3-1 differs significantly from the 
ectopic and the wild-type, but not pks3-16, which in turn is not significantly 
different to any of the other strains on fructose as the sole carbon source.  
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Figure 4-6 Colony morphology of mutant and wild-type strains 
Cultures are 14dpi on V8PDA 
sms1-26 | 28 
Ecto1 | SN15 
pks3-1 | 16 
pks1-16 | 48 
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4.3.6 Whole plant spray assays 
The ability of the mutant strains to cause disease on wheat plants was tested 
using whole plant spray assays as described in 4.2.3.1. Briefly, 11d old wheat 
seedlings (cv. Calingiri) were sprayed with 12ml of 106 spores of sms1-26, sms1-
28, pks1-16, pks1-48, pks3-1, pks3-16, the ectopic mutant, SN15 or a negative 
control not containing spores. Disease symptoms were assessed visually on a 
scale from 0 (uninfected) to 9 (widespread necrosis). No significant reduction in 
virulence of the mutants compared to the controls was detectable. Results are 
summarised in Figure 4-7, individual scores per pot and strain are shown in 
Appendix IX 
4.3.7  Detached leaf assays 
Lesion development and size of knockout mutants compared to controls was 
tested using detached leaf assays as described in 4.2.3.4. Briefly, sections of 11d 
old wheat leaves (n=4) were point-inoculated with 5 μl of 106 spores of sms1-26, 
sms1-28, pks1-16, pks1-48, pks3-1, pks3-16, the ectopic mutant, SN15 or a 
negative control not containing spores. Disease progression and lesion 
development were monitored over the course of two weeks. No significant 
differences in lesion size or disease progression were detected (see Appendix X). 
Lesion sizes and appearance are within the normally observed range of the wild-
type. Figure 4-8 shows a representative example of leaf sections 8 dpi. Average 
lesion sizes are shown in Figure 4-9. 
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4.3.8 Sporulation 
The mutants‘ ability to produce asexual spores was assayed both in vitro and in 
planta. For in vitro sporulation, 11d old V8PDA plates (n=4) were harvested as 
described in 2.5. In planta sporulation was assayed with representative leaf 
samples (n=5) from the WPS using latent period assays (see 4.2.3.2 and 
4.2.3.3). Mean values per plate were calculated from three individual spore 
counts from pooled samples.  
No differences in spore counts between knockout and wild type strains were 
found. Results are summarised in Figure 4-10, individual counts are shown in 
Appendix XI  
 
 
Figure 4-7 Whole plant spray disease scores 
Average disease scores and standard error are given for individual mutant strains and 
controls on 11d old wheat seedlings (cv. Calingiri). All mutant and wild type strains score 
no less than 7.5 of 9, indicating no reduction of virulence for the knockout mutants. 
 1
0
1
 
 
 
 
Figure 4-8 Detached leaf assays 
Representative examples of detached leaf assays for the three knockout mutants at 8dpi. Scale bar is 1cm. T denotes leaves inoculated with 
0.02% Tween-20 (negative control), M1,M2 mutant strains as noted above, E denominates ectopic mutant and WT positive control with wild-type 
SN15 
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Figure 4-9 Detached leaf assays – average necrotic lesion sizes  
The average lesion sizes and standard error are presented for each strain 7 and 14 dpi. * 
denote significant differences (p<0.05). No significant differences have been detected 
between knockout, ectopic and wild type strains.  
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Figure 4-10 Spore counts in vitro and in planta for individual strains 
The average of three technical spore counts and standard error are given for each 
individual strain. Letters indicate significantly different results (p<0.05). Strains not 
connected by the same letter have significantly different means. Spores were counted 
from pooled samples from 4 plates or 5 infected leaves, respectively 
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4.4 Discussion 
Polyketide synthases can play a crucial role in the pathogenicity of necrotrophic 
fungi. The compounds produced by this class of enzymes are important 
pathogenicity determinants in Cochliobolus, Cercospora and other members of 
the Dothideomycetes (Goudet et al., 2000; Turgeon and Baker, 2007). 
Investigating how polyketides contribute to the disease caused by S. nodorum 
can open up new prospects and practises of controlling the disease in the field.  
In this study, knockout mutants of three S. nodorum polyketide synthases have 
been created and characterised. Microarray data was used to identify genes that 
are up-regulated during early in planta growth. Genes active during this crucial 
stage of the infectious cycle are most likely to be involved in the early infectious 
processes of host colonisation and tissue necrosis. Out of the six genes that met 
this criterion, SMS1, PKS1 and PKS3 were selected for targeted gene disruption 
because they were the ones most strongly expressed (Figure 4-2). Parallel to the 
knockout experiments, qRT-PCR was used to validate the microarray data. 
Microarray experiments are unparalleled in the number of genes that can be 
analysed in parallel, but also have inherent disadvantages such as narrow 
dynamic range and lower specificity that make validation necessary (Rajeevan et 
al., 2001). Expression profiles recorded by microarray and qRT-PCR matched for 
PKS1 and PKS3, but differed for SMS1 (Figure 4-4). Here, microarray data over-
predicted expression at the 3dpi time point; however this did not alter the overall 
trend of stronger expression early in planta. 
The genes were knocked out using a fusion PCR approach that has been used 
successfully for targeted gene disruption in S. nodorum (Solomon et al., 2004; 
Solomon et al., 2005; Solomon, 2006a; Solomon et al., 2006a; Tan et al., 2009). 
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It is the very definition of a secondary metabolite that it is dispensable for 
vegetative growth of the producing fungus (cp. 1.4). In accordance to that, all 
knockout strains created were virtually indistinguishable from the wild-type 
morphologically. None of the genes/proteins concerned was predicted by blast 
searches to be involved in pigmentation or colony morphology. Furthermore, no 
differences between the knockout and control strains have been detected 
concerning carbon and nitrogen source utilisation or salt stress tolerance as 
determined by the growth assay, section 4.3.5. Significant differences detected in 
single strains are attributed to experimental artefacts. Due to the small volumes 
used for the assay in a 96 well microtitre format, small inaccuracies during 
pipetting and/or minute contaminations can have disproportionately large effects. 
Based on the fact that for none of the media and carbon sources tested both 
mutant strains had significantly different means (p<0.05) from those of both 
control strains, the responses of the knockouts and controls are considered the 
same. 
The mutants‘ ability to cause disease on seedlings of susceptible wheat was 
tested using a whole plant spray assay as described in 4.2.3.2. Again, no 
differences were found between the knockout strains and the wild type (Figure 
4-7). It is important, however, to keep in mind that the mutants‘ ability to produce 
the known proteinaceous host-specific toxins is apparently unaffected by the 
knockout of a completely unrelated polyketide synthase. Although the wheat line 
used (Calingiri) is known to be insensitive to ToxA and Tox3, the remaining 
effectors secreted by S. nodorum are sufficient to cause disease, as 
demonstrated by the wild-type and ectopic mutant. Detecting possibly minor 
differences in response of the plant in the background of these highly effective 
proteinaceous HSTs will require a more sophisticated approach. 
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Development of necrotic lesions and disease progression over a 14d period was 
monitored using detached leaf assays, where sections of wheat leaves were 
point-inoculated with spores of knockout and control strains. Size of the necrotic 
lesions was measured 8 and 14 dpi. No significant differences in lesion sizes of 
mutant strains compared to ectopic and wild-type control were detected at either 
time point (Figure 4-9). As is obviously the case with the whole plant spray assay, 
if disruption of the polyketide synthases has an effect on pathogenicity of the 
fungus, it is undetectable in a background of other HSTs produced by the fungus.  
Among the plethora of secondary metabolites produced by filamentous fungi, 
there are a number examples that are required for successful sporulation, like 
butryolactone for Aspergillus terreus (Schimmel, 1998) and melanin for 
Cochliobolus heterostrophus (Leonard, 1977). Genes involved in the synthesis of 
these compounds are expected to be up-regulated during the later stages of both 
in vitro an in planta growth. The three polyketide synthases under investigation in 
this study, however, have been chosen for their elevated expression during the 
critical early in planta growth stages in which the known phytotoxins are produced 
(Ipcho, 2012) Indeed, only SMS1 is actually expressed during in vitro growth, as 
predicted by microarray data. Correspondingly, the spore counts from latent 
period assays and plate cultures (see 4.3.8) failed to demonstrate a difference in 
the numbers of spores produced by the knockout strains compared to the wild-
type strains. Therefore, the genes are most likely not involved in the sporulation 
process.  
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4.5 Conclusions 
The question remains as to the role of the three PKSs under investigation in this 
study. It is generally believed that secondary metabolites have distinct 
physiological and ecological functions (cp. 1.4.2). Furthermore, since the 
synthesis of a PKS and subsequent polyketide synthesis require a significant 
amount of energy and precursors, there is a negative selection pressure towards 
eliminating ―unnecessary‖ genes (Pichersky, 2006; Jenke-Kodama, 2009). Still, 
the genes are not only present, but also expressed during various stages in the 
lifecycle of S. nodorum. It is therefore most likely that the products of S. nodorum 
PKSs serve distinct functions to the fungus other than those of the proteinaceous 
HSTs. Especially PKS genes up-regulated during mid to late in planta growth 
stages should be investigated further in future knockout experiments, as they 
might still contribute significantly to lesion formation after the initial effect of the 
HST effectors begins to weaken. 
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5 Method evaluation and 
application for LC-MS analysis of 
Stagonospora nodorum 
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5.1 Introduction 
Over the first decade of the 21st century, metabolomics has emerged as the latest 
valuable addition to the suite of ‗omics techniques in systems biology. In 
metabolomics, analytical chemistry tools are used to detect and measure the 
small molecule components of a biological system. These compounds are at the 
end of a chain of physiological responses and reactions of an organism to its 
environment and ultimately define the observable phenotype (see Figure 5-1). 
Metabolomics is therefore the most direct way of analysing an organisms 
metabolic state as well as perturbations arising from environmental stimuli or 
genetic variations (Nicholson et al., 2002). Depending on the scope of the 
analysis, four main strategies are common (Álvarez-Sánchez, 2010a):  
1. Targeted analysis of one or more specific metabolites, mostly quantitative. 
2. (Global) metabolite profiling, a non-targeted, often quantitative approach 
to gain a comprehensive view of a wide range of chemically diverse small 
molecules in a system 
3. Metabolic fingerprinting, a rapid and high-throughput method to compare 
patterns, signatures or ―fingerprints‖ of mostly unspecified or unknown 
metabolites in response to external stimuli 
4. Metabolic footprinting, the study of metabolites from extracellular fluids, 
also called the secretome or exometabolome.  
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Considering the vast chemical diversity of compounds commonly found within 
living organisms comprising organic and amino acids, lipids, sugars etc. and their 
large dynamic range, gaining a comprehensive and unbiased representation is a 
major challenge. This is even more true for products of the secondary 
metabolism, where enzymes like nonribosomal peptide synthetases, polyketide 
synthases and the tailoring enzymes of SM-related gene clusters produce a 
multitude of molecules that, albeit related in their synthetic origins, show a 
remarkable diversity in size, molecular weight and physico-chemical properties 
(cp. 1.4 and 1.5). Not one analytical platform alone will therefore be able to 
produce datasets representing the entirety of an organism‘s metabolites, and 
sample preparation techniques need to reflect both the range of metabolites of 
interest as well as the analytical platform used (Bedair and Sumner, 2008; 
Álvarez-Sánchez, 2010a; Álvarez-Sánchez, 2010b). 
5.1.1 Solid Phase Extraction (SPE) for sample preparation 
SPE is a chromatographic method routinely used for sample preparation from 
various biological matrices. Analytes within a complex (mostly liquid) matrix are 
bound to a sorbent usually contained in a disposable column or cartridge (Figure 
5-2, 2.). Unwanted interferences and matrix components are eliminated from the 
sorbent by washing the column with an appropriate solvent or solvent mixture 
(Figure 5-2, 3.), and the analyte(s) of interest are eluted with a solvent suitable for 
further analysis (Figure 5-2, 4.) or fractionated using step gradients. SPE offers 
several advantages over the traditional method of liquid/liquid extraction (LLE). 
Firstly, it does not rely on the large quantities of costly and often toxic organic 
solvents commonly used for LLE, and secondly, it can improve speed and 
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sensitivity during sample preparation and increase extract purity (Cigic and 
Prosen, 2009; Álvarez-Sánchez, 2010a).  
The sorbent choice for a specific application is determined by the chemical 
properties of the respective target compound(s). Immunoaffinity and the more 
recent molecularly imprinted polymers have emerged as highly selective sorbents 
for enrichment/extraction of specific compounds or compound classes 
(Abramovic et al., 2005; Urraca et al., 2006; Chung and Kwong, 2007; Erbs et al., 
2007; Wang et al., 2008). Broad-range sorbents with reverse phase (C8, C18), 
normal phase (silica) and ion exchange chemistry still remain the choice for more 
general screening applications as they are suitable for a wider scope of 
compound classes (Launay et al., 2004; Reinsch et al., 2005). 
In the broad field of secondary metabolite analysis, SPE has been successfully 
used in the determination of important mycotoxins from a diverse range of 
matrices like Ergot alkaloids in rye flour (Storm et al., 2008), Alternaria 
mycotoxins from apple juice and tomato paste (Delgado et al., 1996; Fente, 1998; 
di Mavungu et al., 2009), and ochratoxin from beer, wine, coffee beans and 
cereals (Varelis et al., 2006; Attallah et al., 2008; Vatinno et al., 2008; Anli and 
Bayram, 2009). Clinical applications include analysis of the Psilocybe-derived 
hallucinogens psilocybin and psilocin from urine (Elian, 2011) and the mycotoxin 
ochratoxin from blood plasma (Pacin et al., 2008).   
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Figure 5-1 The “Omics” cascade 
Within the ‗omics techniques employed in systems biology, metabolomics is the one that 
is closest to the observable phenotype. Adapted from Dettmer (2007) 
Figure 5-2 Principle steps in SPE 
1. Activation and conditioning of the sorbent bed 2. Sample loading and analyte 
adsorption 3. Elution of interferences with an appropriate solvent or solvent mixture 4. 
Elution of analyte(s) of interest.   
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5.1.2 Analytical technologies 
5.1.2.1 Liquid Chromatography 
Liquid Chromatography (LC) has long been the method of choice for secondary 
metabolite research (Frisvad and Thrane, 1993; Yoshimura et al., 1994; Constant 
and Beecher, 1995; Shigematsu, 1997; Nielsen and Smedsgaard, 2003). The 
principle of all chromatographic techniques is differentials in the affinities of 
different compounds to a stationary phase and a mobile phase. In classical 
column chromatography, the stationary phase was silica (polar) and the mobile 
phase consisted of organic solvents (nonpolar, ―normal phase‖). In modern LC for 
secondary metabolite analysis, the stationary phase is usually octadecylated 
silica (nonpolar), and the mobile phase most commonly consists of aqueous 
solutions (polar, ―reverse phase‖), e.g. a water (polar) - acetonitrile (less polar) 
gradient. Analyte separation is achieved by binding of analytes to the stationary 
phase under the influence of a highly polar mobile phase and gradually eluting 
the bound compounds in a mobile phase of decreasing polarity in order of their 
increasing hydrophobicity (Meyer, 2004).  
Early chromatography relied on gravity or capillary forces to move the solvent 
through the sorbent bed. Modern day LCs are pressurised systems operating up 
to ~400 bar (high pressure/performance LC, HPLC) and up to ~1000 bar (ultra-
high pressure LC, UHPLC). The high pressures are in part due to the lower 
sorbent particle size of modern HPLC sorbents of >2 μm and <2 μm for UHPLC. 
Smaller particle sizes and higher pressures lead to extremely narrow peak 
widths, better resolution and higher sensitivity while simultaneously reducing 
analysis time as well as consumption of solvents and sample (Wilson et al., 2005; 
Bedair and Sumner, 2008; Guillarme et al., 2010). The classical detection method 
for HPLC analysis was single wave length UV and visible spectrum detection. 
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More modern systems used diode array detectors (DAD) for multispectral 
detection. Still in use today, the DAD is being replaced by the mass spectrometer 
as detector of choice (see below) because MS has a higher sensitivity and can 
also detect compounds that do not carry chromophores. 
LC has a number of advantages over techniques like Gas Chromatography (GC) 
or Capillary Electrophoresis (CE). LC is able to separate large as well as non-
volatile compounds with minimal sample preparation and without the need for 
derivatisation. It is more robust than CE and yields results that are more 
reproducible. With complementing column chemistries like reverse phase (C8, 
C18), hydrophobic interaction LC (HILIC) and ion exchange, it can also analyse 
compounds from a wide polarity range as well as charged and non-charged 
species. (Theodoridis et al., 2008; Theodoridis et al., 2012).  
5.1.2.2 Mass spectrometry 
The emergence of metabolomics as the most recent ‗omic has been greatly 
facilitated by the improvements in analytical instrumentation. The primary 
platforms used today are Nuclear Magnetic Resonance (NMR) and Mass 
Spectrometry (MS), the latter most commonly coupled to either LC or GC and 
less commonly CE (Bedair and Sumner, 2008; Álvarez-Sánchez, 2010a).  
NMR is a rapid, non-destructive technique that allows direct identification and 
quantification of analytes with little to no sample preparation and without the need 
for prior separation. It has, however, limited sensitivity (commonly in the μmolar 
range) when compared to the nmolar and fmolar sensitivities reported for modern 
mass spectrometry (Bedair and Sumner, 2008; Wishart, 2008). Like NMR, MS 
can be used as a standalone technique. Direct Infusion MS (DIMS) has been 
successfully used for chemotaxonomy of fungi, e.g. Alternaria (Smedsgaard and 
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Frisvad, 1996; Andersen et al., 2005), and metabolic fingerprinting of yeast 
(Castrillo et al., 2003; Mas et al., 2007; Højer-Pedersen et al., 2008). A major 
drawback of direct infusion, however, is the possibility of ionisation suppression 
through interfering matrix compounds. This can result in poor ionisation efficiency 
and low sensitivity. MS for secondary metabolite research is therefore most 
commonly used in combination with a chromatographic technique.  
Mass spectrometry detection for liquid chromatography is challenging in that it 
requires an interface between a continuous flow liquid phase and a gas-phase, 
high-vacuum technique. LC-MS has benefitted greatly from the introduction of 
atmospheric pressure ionisation techniques, such as Atmospheric Pressure 
Chemical Ionisation (APCI), Atmospheric Pressure Photoionisation (APPI) 
Electrospray Ionisation (ESI), the latter being the one most commonly used for 
metabolomics experiments. ESI is a so-called ―soft‖ ionisation technique, i.e. it 
produces little to no in-source fragmentation, yielding mainly 
(protonated/deprotonated) pseudomolecular ions or adducts thereof (e.g. [M+H]+, 
[M+Na]+ in positive mode) (Pramanik et al., 2002). In an ESI source (see Figure 
5-3), the eluent from the LC is passed through a capillary needle, to which a high 
voltage is applied. The liquid is dispersed into a fine mist through a combination 
of its initial pressure, the voltage applied and the nebulizer gas (most commonly 
Nitrogen). The droplet size is further decreased by Coulomb explosion and 
evaporation of the solvent aided by a counter flow of drying gas (Nitrogen), until 
only gas phase analyte ions remain. Those ions then enter the vacuum part of 
the instrument through the entrance capillary, pass through ion optics and the 
mass analyser and are finally registered at the detector.  
The underlying principle of MS is separation and detection of analytes as ions 
separated according to their mass per charge ratio (m/z) by means of electric 
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and/or magnetic fields. Different types of mass analysers based on this principle 
exist today: Time of Flight instruments, the Quadrupole and the Iontrap, as well 
as combinations of these. The reader is referred to the excellent publications of 
Bedair (2008), Dettmer (Dettmer et al., 2007), Gummer (2009) and colleagues for 
an overview and discussion of advantages of individual setups in a metabolomics 
background. Here, only the Ion Trap mass spectrometer used in this study will be 
discussed.  
The eluent from the LC system enters the ion source through the nebulizer 
needle (Figure 5-4). The solvent is evaporated, and the analyte Ions enter the 
high vacuum part of the instrument through the entrance capillary. After passing 
the skimmers and octopole ion guide, they are introduced into the Ion Trap mass 
analyser. The trap itself consists of two end cap electrodes and a ring electrode 
forming an asymptotic space. Ions are trapped within the electrode space by 
electric fields and are focussed to the centre of the trap by collisional cooling with 
an inert gas (Helium). They are ejected for detection according to their m/z ratio 
through resonance excitations by the endcap electrodes. This setup also allows 
the instrument to be used for MS/MS experiments. Ions of a single mass are 
isolated and fragmented using Collision-Induced Dissociation (CID) with the 
Helium. The resulting fragments are analysed as described above to gain 
information on the structure and identity of an analyte. This tandem in-time 
MS/MS process can be repeated several times with the fragment ions as well for 
even more detailed structural information (March, 2000; Agilent, 2003). 
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Figure 5-3 Principle of Electrospray Ionisation 
The eluent flow from an LC enters the source through the Nebulizer needle. The analytes 
are ionized and desolvated and enter the mass analyser through the capillary. For more 
details, see text. (Picture: http://www.chem.agilent.com/en-
us/products/instruments/ms/pages/gp39427.aspx) 
 
 
Figure 5-4 Schematic of an Agilent LC-MSD Ion Trap MS 
The schematic shows the relative positions of the components of the mass spectrometer. 
Ions generated in the In source (left) enter the instrument through the capillary (red), pass 
skimmers and the ion guide octopole (centre). They are trapped in the space formed by 
the trap electrodes (right, blue) and are ejected according to their m/z ratio for detection. 
Picture adapted from: Agilent (2003) 
  
Endcap electrodes 
Ring electrode 
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5.1.3 Metabolomics of Stagonospora nodorum 
Metabolomics has emerged as a valuable tool for studying plant-pathogenic fungi 
including S. nodorum. Several studies concerning the primary and secondary 
metabolism of this devastating pathogen have been published to date. One of the 
first studies examined the effects of the disruption of the α-subunit of a S. 
nodorum G-protein (Solomon et al., 2004). Although this study was primarily 
targeted on the effects on primary metabolism, it presented evidence that S. 
nodorum utilizes the L-DOPA pathway for melanisation, making S. nodorum the 
first phytopathogenic fungus to do so. A metabolomics study dissecting the 
functions of the remaining Gβ and Gγ subunits is currently underway (Gummer, 
J, personal communication). Other studies employing metabolomics techniques 
were targeted on the function of sugar alcohols (polyoles) like arabitol, erythritol, 
mannitol and trehalose during osmotic stress and sporulation (Solomon et al., 
2006b; Lowe, 2008; Lowe, 2009). 
Recent studies have also taken first steps into the largely uncharted area of 
secondary metabolism in S. nodorum, using a combination of reversed genetics, 
proteomics and metabolomics techniques. Continuing on the work by Solomon 
and colleagues (Solomon et al., 2004), Tan et al. have identified a Gα-regulated 
short chain dehydrogenase involved in asexual sporulation (Tan et al., 2008). 
Metabolomic profiling using GC-MS detected one unknown metabolite highly 
abundant in sch1 knockout mutants, while hardly detectable in the wild type 
fungus. MS/MS analysis later identified the compound to be the mycotoxin 
alternariol, a post-harvest mycotoxin commonly associated with fungi from the 
closely related genus Alternaria, and structurally related to the significant 
aflatoxin-group of mycotoxins (cp. 1.4.3.2) (Tan et al., 2009). This was the first 
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report of a mycotoxin in S. nodorum, turning a significant but manageable plant 
pathogen into a food biosecurity risk.  
These previously published studies are all GC based and mainly focussed on one 
or a number of primary metabolites. As discussed earlier, only a combination of 
complementing techniques like GC and LC will be able to cover the whole 
(secondary) metabolic potential of a biological system. For secondary metabolite 
profiling, a general, non-specific method must be used to preserve the chemical 
diversity of secondary metabolites, to maximise the number of different 
compounds detected and to minimize any methodical or instrumental bias.  
In this study, liquid and solid medium culturing and extraction methods for LC-MS 
screening of secondary metabolites were evaluated. Since secondary metabolite 
production is often regulated by nutrient sources and other environmental factors 
(Bu'Lock et al., 1965; Yu and Keller, 2005; Brodhagen and Keller, 2006; Fox and 
Howlett, 2008; Koslovskic• et al., 2010; Ruiz et al., 2010), different standard 
minimal and complex media were tested as both solid and submerged culture for 
possible differences in the observed SM profile.  
As presented in chapters 3 and 4 of this thesis, S. nodorum has the potential to 
produce a high number of polyketides during various stages of its life cycle in 
planta and in vitro. In silico analysis has demonstrated that most of the polyketide 
synthases and their homologs in other fungi are yet to be characterised and may 
produce novel and hitherto unknown compounds. There is evidence for an 
expressed putative 6-methylsalicylic acid (6-MSA) synthase (SMS1) and an 
expressed putative cercosporin synthase (PKS10), yet neither 6-MSA nor its 
derivative patulin, nor cercosporin have been reported for S. nodorum. 
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The wild type strain SN15 and the sms1 mutant generated in chapter 4 were 
used in a comparative LC-MS based screening to  
 Investigate and detect secondary metabolites produced by S. nodorum 
 Substantiate the in silico predictions concerning putative PKS products. 
 Detect differences in the SM profile of the sms1 mutant and the wild type 
SN15 to identify the putative product of the SMS1 gene cluster. 
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5.2 Materials and Methods 
5.2.1 Solid substrate cultures 
5.2.1.1 Media and culturing conditions 
S. nodorum SN15 was grown on MM, YMG, CYA or V8PDA solid medium for 11d 
as described in 2.4. Four plates containing one biological replicate each were 
prepared per medium and two plates for media blanks. 
5.2.1.2 Sampling 
Four agar plugs per culture including aerial mycelia were excised using the broad 
end of a 20-200 μl pipette tip as depicted in Figure 5-5: one from the centre of the 
colony, one from the edge containing the zone of active growth and two plugs 
equidistantly spaced in between to include the maximum temporal variation in SM 
production. A fresh tip was used for each colony. 
The plugs were transferred to 2 ml screw cap glass sample vials and the 
extraction solvents were added.  
5.2.1.3 Extraction methods 
Extraction adapted from Smedsgaard (1997) (M1): The agar plugs were 
extracted in 750 μl methanol/dichloromethane/ethyl acetate 1/2/3 (v/v) containing 
1% FA (v/v) by sonicating for 60 min. The extract was transferred to a 
microcentrifuge tube and evaporated to dryness at 37 ℃ under vacuum in an 
eppendorf concentrator. 
Extraction adapted from Nielsen and Smedsgaard (2003) (M2):The agar plugs 
were first extracted in 750 μl ethyl acetate with 1% FA by sonicating for 30 min. 
The solvent was transferred to a microcentrifuge tube and evaporated to dryness 
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under vacuum in an eppendorf concentrator. The plugs were then extracted as 
above in 750 μl isopropanol. The combined extracts were evaporated to dryness 
as above.  
5.2.1.4 Sample preparation for LC-MS analysis 
Dried extracts were stored at -20°C prior to analysis. Extracts were reconstituted 
in 400μl 5% acetonitrile (ACN) in H2O. An equal amount of hexane (HEX) was 
added, the extracts were vortexed vigorously and centrifuged for 10 min at 
maximum speed. The upper phase (HEX) was removed and the aqueous phase 
was filtered through 0.2 μm syringe filters (Grace, Deerfield IL, USA).  
 
 
 
 
Figure 5-5 Schematic of solid substrate culture sampling 
Agar plugs (X) were excised from the colony centre (dark red), the colony edge (light red) 
including the zone of active growth and equidistantly in between to include the maximum 
temporal variation of SM production. 
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5.2.2 Liquid media cultures 
Sample preparation and LC-MS analysis method were adapted from Gummer 
(2012). 
5.2.2.1 Media and culturing conditions 
S. nodorum SN15 was grown in MM, YMG, CYA or V8PDB liquid medium for 11d 
as described in 2.4. Four biological replicates were prepared per medium, one 
flask representing one replicate. Two flasks mock-inoculated with sterile mQ-H2O 
per medium were prepared as blanks. 
5.2.2.2 Sampling 
Prior to sampling, 100 μl Internal Standard for Culture Filtrate (ISCF) containing 
griseofulvin was added to each flask, final concentration 0.3 μg/ml. The cultures 
were separated into culture filtrate (CF) and mycelia by vacuum-assisted filtering 
using 90mm Whatman № 54 filter disks and Buchner funnel with a 250ml vacuum 
flask. Mycelia were washed with 10-15ml mQ-H2O on the filter. Wash flow-
through and CF were combined and stored at 4 ℃ prior to processing.  
After washing and removal of the filter and mycelia from the funnel, 100 μl 
Internal Standard for Mycelia Extracts (ISMX) containing each 0.04 μg/μl 
fumonisin B1 (FB1), altenuene (ANE) and rifampicin (Rif) in MeOH were added. 
The Filter paper and mycelia was then transferred to a labelled 50ml plastic tube, 
snap-frozen in ℓN2 and lyophilized overnight in a LABCONCO Freezone 2.5 Plus 
(Labconco Corp., USA) with a JLT-10 JAVAC high vacuum pump (JAVAC Pty. 
Ltd., Australia). 
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5.2.2.3 Extraction methods 
Culture filtrate (CF) was extracted using bulk Alltech Prevail® C18 (Grace, 
Deerfield IL, USA) reverse phase solid phase extraction sorbent. Per culture, 
500mg sorbent was weighed in a 50ml plastic tube, activated with 5ml 100% 
methanol and equilibrated with 5ml mQ H2O. CF was added in 40-45 ml batches. 
Secondary metabolites were adsorbed at RT for 1h on a shaker at 300rpm. The 
tubes were then centrifuged at 5250 × g and 4 ℃ for 5 min to collect the sorbent 
without allowing it to run dry. The supernatant was discarded and the process 
was repeated until all CF was processed. The sorbent was then mixed with 5 ml 
mQ H2O and transferred to an empty 8ml GracePure® SPE column with frit on a 
vacuum manifold (Grace). The water was removed and the sorbent was washed 
with 5ml 5% ACN. Secondary metabolites were eluted in 3 ml 100% methanol 
(MeOH). The extract was transferred to 2ml microcentrifuge tubes and 
evaporated to dryness at 37 ℃ under vacuum in an eppendorf concentrator. 
Mycelia (MX) were extracted in 50ml plastic tubes at RT first by sonicating for 30 
min in 30ml 100% MeOH for half an hour, then by shaking at 300 rpm for one 
hour. The tubes were then centrifuged 2 min at 5250 g, the supernatant was 
transferred to an amber 40ml glass vial and evaporated to dryness under a 
stream of N2 and gentle heating. The dried extracts were reconstituted in 10ml 
5% ACN, overlayed with 10ml hexane and vortexed vigorously. The mixture was 
transferred to a 50ml plastic tube and centrifuged at 5250 × g for 30 min at 4 ℃ 
for phase separation. The hexane phase and any interphase were removed; the 
aqueous phase was transferred to a 10 ml plastic tube and centrifuged again as 
above. A 500mg Alltech C18 cartridge (Grace) was fitted with a 22 gauge needle 
and 10ml plastic syringe (Terumo, Japan), activated with 5ml 100% MeOH and 
equilibrated in 5ml 5% ACN. The extract was adsorbed by drawing 8 ml through 
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the cartridge at a flowrate of <1 to 5 ml/min from about 1cm from the bottom of 
the tube to avoid any debris or interphase. The Sorbent was then placed on a 
vacuum manifold and washed with 5 ml 5% ACN. Secondary metabolites were 
eluted in 3 ml 100% MeOH. The extract was transferred to 2 ml microcentrifuge 
tubes and evaporated to dryness at 37 ℃ under vacuum in an eppendorf 
concentrator.  
5.2.2.4 Sample preparation for LC-MS analysis 
Dried extracts were stored at -20°C prior to analysis. Extracts were reconstituted 
in 400μl 5% acetonitrile (ACN).  
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5.2.3 LC-MS instrumentation and parameters  
An Agilent 1100 Series HPLC (Agilent Technologies Ltd., Alpharetta, GA, USA) 
was used for extract chromatography. The system consisted of an 1100 Series 
degasser, quaternary pump (only channels A and B were used for the gradient), 
autosampler, and thermostat column compartment. All tubing was 12.7 μm 
(0.005 inch) i.d. PEEK (Grace). The column was a GraceSmart™ 2.1 × 150 mm 
RP18 column, particle size 3μm (Grace) kept at a constant 25 ℃. Injection 
volume was 20μl for plate samples and 5 μl for flask samples and standards. The 
LC was controlled using the proprietary software Chemstation rev. A.09.03 
(Agilent Technologies Ltd.). 
Mobile phase A consisted of LC-MS grade H2O (Fisher, Australia) buffered with 
0.1% Formic Acid (FA), mobile phase B was LC-MS grade ACN (Fisher), 
buffered with 0.1% FA. Flow rate was 200 μl/min. The gradient started with a 20 
min hold at 5% B, followed by a 60 min ramp to 100% B and a final hold of 20 
min. Fifteen min post-time at 5% B were included after each run to ensure the 
column was equilibrated for the next analysis.  
The detector was an Agilent LC-MSD Ion Trap (Bruker-Daltronik, Bremen, 
Germany) with ESI source. Parameters were set using ―smart parameters‖ in the 
MSD Trap Software (Bruker) (Gummer et al., 2012). The instrument was first 
calibrated via direct infusion (Kd Scientific Inc., MA, USA) at 5 μL/min with Agilent 
ESI tuning mix (G2421-60001) diluted in a 1:10 ratio (tuning mix:ACN; v/v).  
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5.2.4 Data analysis 
Bruker .yep datafiles were imported into ACD/Labs SpecManager (Advanced 
Chemistry Development, Inc., Toronto, Canada). The chromatograms were 
processed with the Component Detection Algorithm (CODA) with Smoothing 
(FFT, fix, V1=10%, V2=30%; ―Remove Edge Distortion‖ activated), Baseline 
Correction (Box half width 5 scans, Noise Factor 1) and Peak Picking (Minimum 
Full Width Half Maximum 0.1 min, minimum height 50% of max, Signal to Noise 
threshold 20, peak area threshold 1 × 105 counts). These settings were 
determined empirically. To reduce calculation time, only the gradient section of 
the chromatogram (20-70 min) was processed (Figure 5-6). A Table of Mass 
Chromatograms (TOMC) containing the peaks resolved was compiled for each 
data file. TOMCs were imported into a Microsoft Excel spread sheet, normalized 
to the internal standard (where applicable) and peaks were aligned in order of 
their retention time, base peak ion and peak height. Resolved compounds were 
designated as ―Compound #‖ in order of their occurrence across all experiments. 
The data were then imported into The Unscrambler® (Camo Software AS, Oslo, 
Noway), scaled according to [x = log(x + 1)] and analysed using Principal 
Component Analysis with full cross validation. 
Individual compound mass per charge ratios were used as queries for the 
METLIN (http://metlin.scripps.edu/) and MassBank (http://www.massbank.jp/) 
metabolite databases. 
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Figure 5-6 Data processing – sample chromatogram 
Top panel: SN15 MM culture filtrate, raw LC-MS data (TIC, black) before processing 
Central panel: the same chromatogram after smoothing and baseline correction 
Bottom panel: as above, zoomed in on the region of interest, superimposed with 
individual mass chromatograms of resolved peaks (colour). Please refer to text for 
processing details.  
Processed range 
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5.3 Results 
5.3.1 Assessing media and extraction techniques 
Solid substrate cultures according to Nielsen and Smedsgaard (2003) 
Figure 5-7 to Figure 5-10 show total ion chromatograms for individual media. All 
raw chromatograms featured high background of ~5 × 106 TIC units, specifically 
a characteristic bulge within a region from RT 30 to >40 min. Apart from this, 
there was little to no similarity between the chromatograms of different media or 
SN15 and blank samples.  
YMG has a total of ten resolved compounds, of which two are found in both blank 
and SN15 sample, and four each are unique to either.V8PDA has a total of 22 
compounds, five of which are found in both blank and SN15 samples. Eleven out 
of 16 total compounds are unique to the blank, while six out of eleven are unique 
to the pooled SN15 sample. One out of eleven compounds is common to both 
CYA blank and SN15 sample. The blank has a total of 3 compounds, one of 
which unique, while in the pooled SN15 sample eight out of nine compounds are 
unique.  
In the minimal medium samples, six out of 14 compounds are common to all 
samples. The blank has eleven compounds with five unique and the pooled 
SN15 has nine compounds with three unique. There was no obvious pattern in 
the distribution of peaks and compounds between media for blank and pooled 
SN15 samples). Compound 37 with m/z 200 (BP) at 51.5 min is the only 
compound to be found in all samples. Compound 24* (BP: m/z 335, RT: 41.1 
min) contained an additional ion of m/z 259 at the experimentally established 
retention time of alternariol. In total, 42 compounds were resolved, of which 25 
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were unique to one sample, 35 are found in two or less samples and four are 
medium specific. All compounds resolved with integrals for the respective base 
peak per medium are listed in Table 5-1 
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Figure 5-7 Chromatograms for YMG medium M1 
Total ion chromatograms for YMG solid medium samples processed with M1 showing high background between 27 and 40 min. Top panel: blank, 
bottom panel: SN15 pooled sample. Minor peaks visible in SN15 sample.   
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Figure 5-8 Chromatograms for V8PDA medium M1 
Total ion chromatograms for V8PDA solid medium samples processed with M1. Top panel: blank, bottom panel: SN15 pooled sample. High background 
visible between 30 and 45 min, with major peaks in both chromatograms.  
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Figure 5-9 Chromatograms for CYA medium M1 
Total ion chromatograms for CYA solid medium samples processed with M1. Top panel: blank, bottom panel: SN15 pooled sample. High background 
between 37 and 40 min. Some visible peaks in SN15 pooled sample.   
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Figure 5-10 Chromatograms for minimal medium M1 
Total ion chromatograms for solid minimal medium samples processed with M1. Top panel: blank, bottom panel: SN15 pooled sample. High 
background between 30 and 60 min. Several peaks are visible in both chromatograms. 
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Table 5-1 Compounds resolved per medium M1 
Compound description, base peak ion (BP) [m/z], retention time (RT) [decimal minutes], prevalent ions [m/z] and area of the base peak [arbitrary units] 
are given per medium for plate samples processed according to Nielsen and Smedsgaard (2003). Blank media samples: (b), pooled extracts: (p). 
Compounds were designated as ―Compound #‖ in order of their occurrence across all experiments.  
Compound BP RT ions YMG (b) YMG (p) V8PDA (b) V8PDA (p) CYA (b) CYA (p) MMs (b) MMs (p) 
Compound 1 321 30.8 318,620,299 
       
4.5E+07 
Compound 2 325 31.1 
   
3.5E+07 
     
Compound 3 199 31.8 
   
2.8E+07 
     
Compound 4 321 31.8 135,620 
      
7.4E+07 4.4E+07 
Compound 5 407 33.6 193,175,215 
  
2.8E+08 4.9E+08 
 
3.4E+08 
  
Compound 6 243 34.8 
 
1.1E+07 
   
1.4E+07 
   
Compound 7 341 34.9 
    
3.1E+07 
    
Compound 8 327 35.4 
   
5.6E+07 
     
Compound 9 754 35.4 
  
4.2E+06 
      
Compound 10 269 35.6 
       
1.5E+07 
 
            
Compound 11 253 35.7 
    
1.3E+07 
 
1.8E+07 
  
Compound 12 565 35.9 
  
6.7E+07 5.0E+07 
     
Compound 13 349 36.8 
       
9.3E+06 2.3E+07 
Compound 14 275 37.1 276,277,261 
  
3.1E+08 
     
Compound 15 273 37.5 
    
4.1E+07 
    
Compound 16 195 37.9 
   
1.9E+07 
     
Compound 17 299 38.2 
   
3.8E+07 
     
Compound 18 339 38.9 
    
4.8E+07 
 
2.7E+07 
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4
 
Compound 19 466 38.9 
   
3.8E+07 
     
Compound 20 235 39.2 121     4.4E+07           
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Table 5-1 Compounds resolved per medium M1 (continued from previous page) 
Compound BP RT ions YMG (b) YMG (p) V8PDA (b) V8PDA (p) CYA (b) CYA (p) MMs (b) MMs (p) 
Compound 21 203 39.6 
   
3.4E+07 
     
Compound 22 377 40.3 
        
9.7E+06 
Compound 23 305 40.4 
    
2.7E+07 
    
Compound 24* 335 41.1 259,336,307 
  
5.4E+08 1.3E+09 
 
2.5E+08 
  
Compound 25 226 41.9 
       
4.1E+06 
 
Compound 26 287 42.5 468,422 
  
1.8E+07 2.7E+08 
 
2.0E+07 
  
Compound 27 277 43.1 
      
2.0E+07 
  
Compound 28 323 44.4 
 
4.7E+07 
       
Compound 29 303 44.8 304,325,333 
  
4.0E+08 2.0E+08 
 
3.3E+07 
  
Compound 30 333 45.0 686 
  
6.5E+08 
     
Compound 31 288 45.8 
       
1.2E+08 6.0E+07 
            
Compound 32 415 46.2 437,416,453 
      
9.6E+07 1.2E+08 
Compound 33 288 46.5 289 
      
6.0E+07 
 
Compound 34 415 47.5 438,439,437,453 
      
8.9E+07 1.2E+08 
Compound 35 536 48.8 
  
5.2E+07 
      
Compound 36 304 50.6 
 
2.1E+07 
       
Compound 37 200 51.5 
 
5.6E+07 4.0E+07 3.8E+07 6.3E+07 1.2E+07 3.6E+07 9.5E+06 5.3E+07 
Compound 38 301 53.5 
        
8.3E+06 
Compound 39 383 53.6 
 
3.3E+07 2.8E+07 
    
2.2E+07 
 
Compound 40 212 54.3 
  
1.0E+07 
  
1.2E+07 
 
1.1E+07 
 
Compound 41 326 55.6 
 
3.0E+07 
       
Compound 42 379 62.5 282 
   
3.5E+07 
 
5.4E+07 
  
total number compounds 6 6 16 11 3 9 11 9 
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5.3.1.1 Solid substrate cultures according to Smedsgaard (1997) 
Figure 5-11 to Figure 5-14 show total ion chromatograms for individual media. All 
pooled SN15 sample chromatograms showed a distinct peak at 37 mins not 
detectable in the blank sample chromatograms. Pooled SN15 sample 
chromatograms of different media had varying numbers of additional peaks, while 
blank sample chromatograms generally had less distinct peaks.  
In the YMG samples, there were a total of twelve compounds resolved, one of 
which is common to both blank and pooled SN15 samples. Four out of the total of 
five compounds were unique to the blank sample, compared to seven out of eight 
unique compounds in the pooled SN15 sample. In the V8PDA samples, three out 
of six total compounds were resolved in both blank and pooled SN15 samples. 
One of the four compounds resolved in the blank was unique compared to two 
from a total of 5 compounds in the SN15 sample. In the CYA samples, two out of 
16 compounds were found in both blank and pooled SN15 samples. Therefore, 
seven out of nine compounds were either specific to the blank or pooled SN15 
sample. 
Similarly, in the MM samples, one out of five total compounds was found in both 
blank and pooled SN15 samples, while two out of three compounds are specific. 
A total of 20 compounds were resolved, of which 9 were specific to one sample, 
15 were found in two or less samples and one was specific to CYA medium 
(Table 5-2). Compound 5 (BP m/z 407, RT 37.3 min) was found in all media, but 
only in pooled SN15 samples. Compound 24* (BP: m/z 335, RT: 41.1 min) 
containing the diagnostic pseudomolecular ion of m/z 259 at the experimentally 
established retention time of alternariol was resolved in pooled SN15 samples of 
YMG, CYA and MM.  
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Figure 5-11 Chromatograms for YMG medium M2 
Total ion chromatograms for solid YMG medium samples processed with M2. Top panel: blank, bottom panel: SN15 pooled sample. Four distinct peaks 
between 35 and 50 min in lower panel  
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Figure 5-12 Chromatograms for V8PDA medium M2 
Total ion chromatograms for solid V8PDA medium samples processed with M2 showing one distinct peak around 37 min in the lower panel. Top panel: 
blank, bottom panel: SN15 pooled sample  
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Figure 5-13 Chromatograms for CYA medium M2 
Total ion chromatograms for solid CYA medium samples processed with M2. Top panel: blank, bottom panel: SN15 pooled sample. Two distinct peaks 
visible in the gradient part of the lower chromatogram.   
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Figure 5-14 Chromatograms for minimal medium M2 
Total ion chromatograms for solid minimal medium samples processed with M2. Top panel: blank, bottom panel: SN15 pooled sample. Two distinct 
peaks are visible in the gradient part of the lower chromatogram. 
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Table 5-2 compounds resolved per medium for M2 
Compound description, base peak ion (BP) [m/z], retention time (RT) [decimal minutes], prevalent ions [m/z] and area of the base peak [arbitrary 
units] are given per medium for plate samples processed according to Smedsgaard (1997). Blank media samples: (b), pooled extracts: (p). 
Compounds were designated as ―Compound #‖ in order of their occurrence across all experiments (adjusted for RT shift).  
Compound BP RT ions YMG (b) YMG (p) V8PDA (b) V8PDA (p) CYA (b) CYA (p) MMs (b) MMs (p) 
Compound 44 620 26.8 318,620,299         1.1E+05       
Compound 45 211 29.7 
 
2.4E+07 
   
2.2E+07 
   
Compound 46 146 33.7 
 
3.2E+06 
   
5.4E+06 
   
Compound 47 245 34.0 
     
7.5E+06 
   
Compound 2? 325 34.2 
      
9.8E+07 
  
Compound 6 243 37.1 
     
7.5E+06 
   
Compound 5 407 37.3 193,175,215 
 
3.2E+08 
 
1.1E+08 
 
6.1E+07 
 
3.7E+07 
Compound 11 253 38.0 
  
3.2E+06 
   
8.5E+06 
  
Compound 48 421 39.5 
  
5.6E+06 
      
Compound 49 292 39.7 
     
1.6E+07 5.4E+06 
  
            
Compound 23? 305 42.7 
  
4.6E+06 
      
Compound 50 163 43.1 
 
3.8E+06 
 
1.6E+07 1.3E+07 7.4E+06 4.4E+06 1.2E+07 
 
Compound 24* 335 43.8 259 
 
2.7E+07 
   
7.4E+06 
 
3.2E+07 
Compound 51 305 45.3 
     
9.7E+06 
   
Compound 26 287 45.4 288,289 
 
1.1E+07 
   
2.5E+07 
  
Compound 29 303 47.7 
  
3.6E+07 
      
Compound 38 301 57.4 
    
8.0E+06 
 
5.8E+06 
  
Compound 52 149 57.5 
 
7.5E+06 
 
1.1E+07 1.0E+07 7.4E+06 
 
8.3E+06 
 
Compound 48 212 58.1 
 
2.5E+07 8.4E+06 4.1E+07 1.4E+07 
 
3.6E+07 4.5E+07 1.7E+07 
Compound 53 403 60.8       1.5E+07           
total number of compounds 5 8 4 5 9 9 3 3 
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5.3.1.2 Liquid media cultures according to Gummer (2012) 
No data exist for YMG, CYA and V8PDA liquid medium. For these media, culture 
filtrate and mycelia could not be separated by vacuum assisted filtration, filtration 
through gauze or by centrifuging due to the amorphous, gelatinous growth of the 
cultures in these media. Therefore, only data for liquid minimal medium will be 
presented.  
Figure 5-15 and Figure 5-16 show total ion chromatograms for minimal medium 
mycelial extract and culture filtrate, respectively. In all cases, there were distinct 
peaks visible, but those in the pooled SN15 samples were generally higher and 
more abundant, especially for the culture filtrate (Figure 5-16, lower panel).  
In the mycelial extract, a total of 21 compounds were resolved, of which 6 were 
common to both blank and pooled SN15 sample. Seven out of 13 compounds 
were specific to the blank sample, while eight out of 14 were specific to the 
pooled SN15 sample. 
In the culture filtrate, a total of 34 compounds were resolved, four of which were 
found in both blank and pooled SN15 sample. Eight out of twelve compounds 
were specific to the blank sample while 23 out of 27 are specific to the pooled 
SN15 sample.  
Figure 5-17 shows an overlay of extracted ion chromatograms for the compounds 
resolved in the respective samples. The MX samples (left panes) show a similar 
distribution of resolved peaks, albeit the peaks in the pooled SN15 sample were 
higher (bottom left). The number of peaks in the CF samples (right panes) was 
significantly higher in the pooled SN15 sample (bottom) compared to the blank, 
as were the peak heights. 
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A total of 55 compounds were resolved in all liquid minimal medium samples, of 
which 44 were specific to one sample. The compounds representing the internal 
standards Griseofulvin (CF, m/z 353) and Altenuene (MX, m/z 292) were 
resolved at the retention times determined experimentally. All compounds were 
found to be specific to either CF or MX. Compound 5 (BP m/z 407, RT 37.3 min) 
was found in the pooled SN15 CF samples, but not in the blank or either MX 
sample. Compound 24* (BP: m/z 335, RT: 41.1 min) was resolved in the CF 
sample, but not the ion of m/z 259.  
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Figure 5-15 Chromatograms for minimal medium mycelial extract 
Total ion chromatograms for liquid minimal medium mycelial extract samples. Top panel: blank, bottom panel: SN15 pooled sample. Numerous distinct 
peaks are visible in the TIC of both samples, the ones in the lower panel being more pronounced towards the end of the gradient.  
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Figure 5-16 Chromatograms for minimal medium culture filtrate 
Total ion chromatograms for liquid minimal medium culture filtrate samples. Top panel: blank, bottom panel: SN15 pooled sample. Numerous distinct 
peaks are visible in the TIC of the pooled SN15 sample.   
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Figure 5-17 Ion chromatograms for liquid minimal media samples 
Ion chromatograms for peaks resolved in liquid minimal medium samples. Top panes: blanks, bottom panes: pooled SN15 sample. Left: mycelial 
extract, right: culture filtrate. X-axis zoomed in on gradient section. Note different scales for MX and CF. Chromatograms are very similar for MX, while 
the pooled SN15 CF sample has a higher number of resolved peaks with higher responses compared to the blank sample chromatogram 
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Figure 5-18 Comparison of pooled SN15 MM samples obtained from different methods 
Overlay of ion chromatograms for pooled SN15 minimal medium samples from solid and liquid culture. Top left: plate culture M1, bottom left: plate 
culture M2, top right: flask culture MX, bottom right: flask culture CF. The highest number of peaks and the greatest peak heights are found in the 
pooled SN15 MM CF sample (bottom right). 
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Table 5-3 Compounds resolved using the flask method 
Compound description, base peak ion (BP) [m/z], retention time (RT) [decimal minutes], 
prevalent ions [m/z] and area of the base peak [arbitrary units] are given per medium for 
liquid culture samples processed according to Gummer (2012).Culture filtrate (CF), 
mycelial extract (MX). Blank media samples: (b), pooled extracts: (p). Compounds were 
designated as described above 
Compound BP RT ions 
MM CF 
(b) 
MM CF 
(p) 
MM MX 
(b) 
MM MX 
(p) 
Compound 54 453 30.8 318,620,299 
 
5.7E+07 
  
Compound 5 407 33.6 193,175,215 
 
1.9E+08 
  
Compound 55 253 36.2 
  
3.1E+07 
  
Compound 56 209 37.0 
  
3.8E+07 
  
Compound 57 393 37.0 
  
1.4E+08 
  
Compound 58 292 37.3 273,255 
  
1.3E+07 1.5E+07 
Compound 59 393 37.9 433,375 
 
2.4E+08 
  
Compound 60 411 37.9 428,412,429 
 
2.6E+08 
  
Compound 61 179 38.3 162,180 
 
4.8E+08 
  
Compound 62 358 40.9 252 
  
6.1E+07 9.1E+07 
        
Compound 63 235 41.0 
  
1.5E+07 
  
Compound 64 319 41.0 
 
1.6E+07 5.6E+07 
  
Compound 24* 335 41.1 259,336,307 
 
3.1E+08 
  
Compound 65 271 41.2 
 
1.5E+07 
   
Compound 66 569 41.8 
  
2.0E+07 
  
Compound 67 385 42.0 
  
1.6E+07 
  
Compound 68 232 42.1 
   
2.9E+06 6.7E+06 
Compound 69 821 42.7 multiple.ions 1.3E+08 1.3E+08 
  
Compound 70 394 43.2 259 
  
2.9E+06 
 
Griseofulvin 353 43.3 355,354,356 6.4E+08 4.6E+08 
  
        
Compound 71 507 43.4 
  
4.5E+08 
  
Compound 72 525 44.5 multiple.ions 
 
1.4E+09 
  
Compound 73 387 44.8 
 
5.3E+07 
   
Compound 74 200 45.0 
   
1.6E+06 
 
Compound 75 334 45.1     1.8E+07     
Compound 76 449 45.4   3.7E+07   
Compound 77 287 460    7.4E+06  
Rifampicin 823 46.1   1.3E+07   
Compound 78 386 47.4    2.2E+07  
Compound 79 415 47.5 438,439,437,453    5.8E+07 
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Table 5-3 Compounds resolved using the flask method (continued) 
Compound BP RT ions 
MM CF 
(b) 
MM CF 
(p) 
MM MX 
(b) 
MM MX 
(p) 
Compound 80 414 47.7 
   
1.0E+07 1.9E+07 
Compound 81 710 47.8 
 
1.7E+07 
   
Compound 82 622 47.9 
  
9.7E+06 
  
Compound 83 343 48.1 
 
2.4E+07 
   
Compound 84 656 48.2 603,661 
 
2.2E+08 
  
Compound 85 316 49.6 
    
1.0E+07 
Compound 86 304 50.2 247,291 7.5E+07 
   
Compound 87 293 50.4 
  
1.9E+07 
  
Compound 88 199 51.7 
   
1.6E+07 
 
Compound 89 277 53.5 295 
 
5.4E+07 
  
        
Compound 90 149 53.8 
  
8.2E+06 
  
Compound 91 301 53.8 301 9.3E+06 
   
Compound 92 478 53.9 
    
2.4E+07 
Compound 40 212 54.3 
 
4.3E+07 
 
5.4E+06 
 
Compound 93 458 55.8 
    
2.0E+07 
Compound 94 239 61.2 404 
   
2.4E+07 
Compound 95 281 61.2 
  
2.5E+07 
  
Compound 96 331 61.6 
    
1.0E+08 
Compound 97 637 61.9 654 
   
2.9E+07 
Compound 98 282 62.8 562 
  
9.6E+07 1.2E+08 
        
Compound 99 257 64.1 
   
7.6E+07 2.0E+07 
Compound 100 267 66.0 
    
2.0E+07 
Compound 101 359 66.0 multiple 2.3E+07 
   
Compound 102 310 67.8 
   
1.2E+07 
 
Compound 103 391 68.5 595 2.2E+07 5.1E+07     
total number of compounds 12 25 11 13 
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5.3.2 Comparative screening of SN15 and sms1 for secondary metabolites 
SN15 (WT) and Sms1 (KO) liquid MM culture filtrate was analysed as described 
in 5.2.2. to identify compounds that are absent in one of the strains. A total of 31 
compounds were resolved in at least one strain (present in at least three out of 
four samples per strain but not in the blank, Table 5-4). Of these, 26 were found 
in both strains, two were ambiguous (present in two out of four samples for one 
strain, but at least present in at least three out of four for the other strain) and 
three compounds were found absent in one strain (present in not more than one 
out of four samples). Compound 5 (m/z 407 (BP), 193, 175, 215; RT 33.6 min) 
and Compound 61 (m/z 179, RT 38.3 min) were present in all WT samples in 
high abundance but absent in all KO samples (Figure 5-19). Presence/absence 
was confirmed using the original LC-MS data (not shown). Compound 110 (m/z 
393, RT 36.5 min) was not registered and integrated by CODA, but is present as 
a distinct peak in both sample sets . 
  
1
5
3
 
Table 5-4 Compounds resolved in liquid minimal medium culture filtrate of SN15 and Sms1 
Compound description, base peak ion (BP) [m/z], retention time (RT) [decimal minutes] and base peak area [arbitrary units, scaled to 
griseofulvin] are given per sample for WT (SN15) and KO (Sms1) liquid MM culture filtrate. Presence was rated as ―present‖ (present in ≥3 of 4 
samples), ambiguous (2 of 4 samples) or absent (≤1 of 4 samples, highlighted in colour). 
Compound BP RT WT 1 WT 2 WT 3 WT 4 KO 1 KO 2 KO 3 KO 4 presence 
Compound 116 377 30.2 2.57E-02 1.83E-03 2.24E-02 4.38E-02 3.04E-03 6.77E-02 5.82E-02 9.33E-02 present 
Compound 54 453 30.8 7.82E-02 1.45E-01 1.43E-01 0.00E+00 1.51E-01 1.42E-01 1.21E-01 1.39E-01 present 
Compound 104 467 31.2 3.81E-02 4.63E-02 4.23E-02 1.02E-02 9.00E-02 1.31E-01 4.55E-02 9.88E-02 present 
Compound 117 438 31.6 7.86E-03 2.36E-02 2.95E-02 1.13E-02 5.32E-02 1.17E-01 9.36E-02 2.16E-02 present 
Compound 106 599 32.3 1.67E-02 2.37E-02 2.67E-02 3.08E-02 4.24E-02 3.89E-02 5.72E-02 2.90E-02 present 
Compound 118 628 32.1 0.00E+00 4.21E-03 0.00E+00 1.10E-02 2.17E-02 2.27E-02 2.67E-02 0.00E+00 ambiguous 
Compound 107 144 32.6 3.14E-02 2.85E-02 1.26E-02 1.03E-02 5.19E-02 4.20E-02 5.62E-02 3.30E-02 present 
Compound119 203 32.6 3.18E-02 2.94E-02 6.34E-03 1.11E-02 5.35E-02 5.03E-02 4.55E-02 3.05E-02 present 
Compound 5 407 33.6 9.69E-01 5.41E-01 9.10E-01 4.53E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 absent in KO 
Compound 109 253 35.7 7.10E-02 2.29E-02 4.67E-02 5.94E-02 1.02E-01 1.09E-01 1.07E-01 7.79E-02 present 
            
Compound 55 253 36.2 6.17E-02 1.02E-01 4.45E-02 3.90E-02 9.27E-02 9.08E-02 9.32E-02 7.16E-02 present 
Compound 110 393 36.5 1.43E-01 1.02E-01 2.41E-01 7.37E-02 ― present, not resolved by CODA ― present 
Compound 56 209 37.0 7.61E-02 5.45E-02 3.67E-02 5.20E-02 7.16E-02 5.08E-02 7.65E-02 1.32E-01 present 
Compound 59 393 37.9 2.29E-01 1.79E-01 3.62E-01 1.40E-01 2.06E-01 8.38E-02 1.32E-01 1.88E-01 present 
Compound 60 411 37.9 2.58E-01 1.97E-01 4.90E-01 1.70E-01 1.65E-01 7.51E-02 1.13E-01 1.25E-01 present 
Compound 61 179 38.3 1.12E+00 8.36E-01 1.16E+00 1.06E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 absent in KO 
Compound 63 235 41.0 2.00E-01 1.98E-01 1.54E-01 5.25E-02 2.15E-01 1.96E-01 1.97E-01 6.53E-02 present 
Compound 24* 335 41.2 1.56E-01 4.18E-02 2.57E-01 5.25E-02 1.48E-02 2.58E-03 0.00E+00 0.00E+00 ambiguous 
Compound 111 269 41.5 3.15E-02 3.08E-02 7.63E-02 5.31E-02 5.82E-02 4.20E-02 7.39E-02 8.79E-02 present 
Compound 66 569 41.8 8.54E-02 7.04E-02 5.60E-02 5.45E-02 1.07E-01 1.22E-01 7.48E-02 5.78E-02 present 
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Table 5-4 Compounds resolved in liquid minimal medium culture filtrate of SN15 and Sms1 (continued) 
Compound BP RT WT 1 WT 2 WT 3 WT 4 KO 1 KO 2 KO 3 KO 4 presence 
Compound 67 385 42.0 9.81E-02 0.00E+00 9.12E-02 5.33E-02 1.36E-01 1.12E-01 8.07E-02 2.65E-02 present 
Griseofulvin 353 43.3 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 1.00E+00 present 
Compound 71 507 43.4 4.74E-01 8.35E-02 8.26E-01 2.96E-01 6.37E-01 4.03E-01 5.15E-01 6.00E-01 present 
Compound 72 525 44.5 1.93E+00 1.52E+00 2.36E+00 1.19E+00 1.84E+00 1.17E+00 1.66E+00 1.75E+00 present 
Compound 76 449 45.4 1.01E-01 8.46E-02 1.22E-01 7.06E-02 1.82E-01 2.20E-01 1.89E-01 1.81E-01 present 
Compound 112 465 46.0 2.49E-02 4.26E-02 4.52E-02 3.08E-02 1.32E-01 1.51E-01 2.20E-02 3.05E-02 present 
Compound 113 603 48.2 8.59E-02 7.44E-02 2.27E-01 4.59E-02 9.89E-02 2.80E-02 5.20E-02 1.55E-01 present 
Compound 114 378 49.0 1.06E+00 7.71E-01 1.24E+00 7.60E-01 3.99E-01 5.24E-01 6.54E-01 7.06E-01 present 
Compound 115 219 52.3 1.57E+00 1.25E+00 1.22E+00 8.81E-01 6.50E-01 1.47E+00 1.79E+00 0.00E+00 present 
Compound 40 212 54.3 9.40E-02 8.80E-02 1.06E-02 3.52E-02 1.81E-02 8.54E-02 0.00E+00 5.95E-02 present 
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Figure 5-19 Differences detected between KO and WT samples 
Mass spectra and position in the chromatogram are given for the two compounds found 
absent in KO samples, Compound 5 (m/z 407 (BP), 193, 175, 215; RT 33.6 min) and 
Compound 61 (m/z 179, RT 38.3 min).  
Left panels: wild type SN15, right panels: sms1 knockout mutant;  
top: spectra at 33.6 min, centre: spectra at 38.3 min, bottom: extracted ion 
chromatograms for all compounds resolved (sample spectra and chromatograms) 
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Figure 5-20 Compound 110 is present in both sample sets 
Top: mass spectra at 36.5 min showing the m/z of 393 of Compound 110 in both wildtype (left) and knockout (right) sample.  
Bottom: extracted ion chromatograms for m/z 393 showing peaks at 36.5 min in both wildtype (left) and knockout (right) sample. 
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5.3.3 Multivariate analysis 
The normalized data were imported into The Unscrambler® for principal 
component analysis. Scores and X-loadings plots are shown in Figure 5-21. 
Knockout (sms1, red) and wildtype (SN156, blue) samples form distinct clusters 
(circled), separated by PC1 on the x-axis. PC1 accounts for 63% of sample 
variance. The analytes contributing most to the variance are Compound 61 and 
Compound 5 as demonstrated by the X-Loadings plot. Compound 115 
(m/z_219@RT_52.3), contributing most to PC2 and separating mainly the KO 
samples on the y-axis, has been removed from the calculation for a second PCA 
(Figure 5-22). Compounds 5 and 61 still contribute most to PC1, which now 
explains 77% of total variance between samples. 
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Figure 5-21 Principal Component Analysis I 
Top: PCA scores plot for SN15 (blue) and sms1 (red) samples showing separation of the 
two sample sets along the X-axis (PC1, 63% of total variance). 
Bottom: X-Loadings plot. Analytes on the far right contribute most to the separation of the 
sample sets:  m/z_407@RT_33.6 (Compound 5), m/z_179@RT_38.3 (Compound 61)  
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Figure 5-22 Principal Component Analysis II 
As Figure 5-21, with m/z_219@RT_52.3 (Compound 115) removed from calculation. PC1 
now explains 77% of total variance, Compounds 5 and 61 still contribute most to PC1. 
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5.4 Discussion 
5.4.1 Plate based assays –quick and dirty 
A solid medium-based micro-scale extraction method (Nielsen and Smedsgaard, 
2003) (M1) was first evaluated for use with S. nodorum. This method had 
previously been applied for generation of a database of 474 fungal metabolites 
including mycotoxins. The method is an updated version of previously published 
screening methods, described by the authors as rapid and especially suitable for 
rich media, providing samples of high SM yield and limited medium background.  
S. nodorum samples generated according to this method were turbid and had a 
tendency to clog the LC system even when filtered through 0.2 μm syringe filters. 
Therefore, a partitioning step with hexane was incorporated into the protocol to 
remove nonpolar interferences. Otherwise the method proved simple and rapid to 
apply, and the 32 SN15 and blank media samples (from 128 individual agar 
plugs) tested in this study were prepared in less than four hours.  
The total ion chromatograms for the pooled SN15 as well as blank media 
samples show unusually high background close to the beginning of the gradient 
(~30 min and onwards). This background interfered with mass spectral 
deconvolution and compound detection, as demonstrated by the apparently 
random distribution of resolved compounds between different media and blanks. 
Therefore, one of the original methods for micro-scale extraction and LC-DAD 
analysis by Smedsgaard (1997) (M2) was chosen for evaluation to potentially 
alleviate the background interference. 
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Preparation of the extracts proved to be equally rapid as with M1. The total ion 
chromatograms Figure 5-11 to Figure 5-14 show a greatly reduced background 
compared Figure 5-7 to Figure 5-10. Specifically, the sharp incline in background 
between 25 and 30 mins was no longer observed. Consequently, deconvolution 
proved more successful, and clear differences between blank and SN15 samples 
became apparent. Compounds 50 (BP m/z 163, RT 43.1 min) and 48 (BP m/z 
212, RT 58.1 min) are found in almost all samples and are considered 
contaminants. An ion with m/z 163 can originate from phthalate plasticisers, 
which are commonly found contaminants in MS experiments (Keller, 2008).  
One major compound resolved was Compound 5 (BP m/z 407, RT 37.3). This 
compound was found in all SN15 samples but none of the blanks and is therefore 
likely to be a fungus-specific compound. Another such compound was Compound 
24 (BP m/z 335, RT 41.1 min), which also contains the protonated 
pseudomolecular ion for alternariol (m/z 259) and matches the retention time for 
the alternariol standard. The compound was found in YMG, CYA and minimal 
medium SN15 samples. 
It remains unclear as to why the two methods delivered such different results. 
The differences between the two methods themselves are within the actual 
extraction step: sequential extraction with ethyl acetate and isopropanol for M1 
and a mixture of methanol, dichloromethane and ethyl acetate for M2. 
Introduction of a contaminant by one of the solvents is unlikely since this will 
almost always result in a distinct peak (Keller, 2008), yet it appears that the 
isopropanol used in M2 introduced an unknown, fairly polar interference from the 
agar plugs. Due to time restraints, the matter was not investigated further. 
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5.4.2 A flask-based culturing and extraction method 
A flask method adapted from previously published protocols (Solomon et al., 
2004; Tan et al., 2009; Gummer et al., 2012; Ipcho, 2012) was tested as an 
alternative approach for SM screening. 
Sampling and SM extraction from S. nodorum flask cultures was more time 
consuming and has proven technically demanding compared to either plate 
based method. In rich media, the cultures exhibited a tendency to very efficiently 
bind the culturing liquid, resulting in an amorphous, gelatinous mass of mycelia 
and culture medium that was practically inseparable. This was observed for 
V8PDA, CYA and, less extreme, YMG. In this medium, S. nodorum grew in the 
form of distinct pellets, a colony morphology commonly observed during 
fermentations for fungal secondary metabolite production (Pirt, 1966; Rodríguez 
Porcel, 2005; Bizukojc and Ledakowicz, 2009), however the recovery of culture 
filtrate was still unsatisfactory. Therefore, only minimal medium samples were 
used for LC-MS analysis.  
Due to waiting times during freeze drying and larger volumes of extraction solvent 
to evaporate, sample preparation from mycelia was the most time consuming of 
all techniques. Extracts of mycelia were also turbid and needed additional steps 
for hexane partitioning and removal to prevent subsequent clogging of SPE and 
HPLC equipment. SPE was used to eliminate the high number of sugars and 
polysaccharides commonly found in S. nodorum mycelia (Solomon et al., 2006b; 
Lowe, 2008; Lowe, 2009). A high amount of polysaccharides in the extracellular 
matrix is also the likely reason behind the high retention of culturing liquid by S. 
nodorum mycelia grown in complex media (Solomon, personal communication). 
 163 
 
Sample preparation from culture filtrate was more straightforward compared to 
mycelia. SPE was chosen over liquid/liquid extraction for the benefits discussed 
in 5.1.1. Specifically, SPE allowed all samples to be processed in parallel and 
limited the volumes of solvents to be evaporated, resulting in significant time-
savings. Using a water-wettable RP-SPE sorbent and dispersive extraction rather 
than columns or cartridges also minimized the time needed for closely monitoring 
these devices during the binding process to keep flow rates constant and prevent 
the sorbent from running dry. This can otherwise take up to 100 minutes for 100 
ml cultures when adhering to the manufacturer‘s recommendation of a of 1-5 
ml/min flow rate. After SPE, both CF and MX samples were cleaned up 
sufficiently to be analysed without further filtering.  
Both MX and CF samples show a significantly higher number of resolved 
compounds than any of the tested plate based methods. The culture filtrate 
contained a total of 21 compounds that were not resolved in the blank, including 
the Compounds 5 and 24 previously identified by the plate method as fungus 
specific. Interestingly, none of those compounds were detected in the mycelia, 
indicating a highly efficient export from the mycelia, which is often observed for 
secondary metabolites (Martín et al., 2005; Chanda et al., 2009). The high 
number of compounds detected in the blank might be attributed to a cross 
contamination with an SN15 sample during sample processing.  
Comparing SN15 MM extracts of all three methods (M1, M2, flask; Figure 5-18), 
the flask method evidently delivers not just a higher number of compounds in 
greater abundance, but, at least in the case of CF, a higher number of fungus 
specific compounds that are not found in the blank. The lower efficiency of the 
plate methods is likely to be due to a lower SM content in the actual samples. 
The plate based methods were mainly applied for chemotaxonomy of fungi which 
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are known to be prolific producers of SM, such as Penicilium, Aspergillus, 
Fusarium, Alternaria, Trichoderma and Stachybotrys (Smedsgaard, Jørn, 1997; 
Nielsen and Smedsgaard, 2003). S. nodorum on the other hand, was not 
previously known to produce significant amounts of SM under standard 
laboratory or field conditions (Solomon et al., 2004; Solomon, 2006b; Tan et al., 
2009; IpCho, 2010). The flask method uses a much higher initial amount of 
fungus and medium, respectively, and the samples thus generated were 
therefore more concentrated. In addition to that, the flask method also allows for 
culturing medium and mycelia to be quantified and examined individually. Internal 
standards can also be added more easily and at a point where they will not 
interfere with the organism‘s metabolism. Considering this, the flask method was 
chosen for the comparative screening of SN15 and the Sms1 KO mutant. 
5.4.3 Comparative LC-MS screening of SN15 and sms1 for secondary 
metabolites 
The knockout mutant sms1 (similar to methylsalicylate synthases) was used in an 
LC-MS based screening for secondary metabolites in comparison to the wild type 
strain SN15. Of the three PKS genes for which knockout mutants have been 
generated, only SMS1 is expressed during in vitro growth (Ipcho, 2012). The 
analysis yielded two compounds present in the wild type that are absent in the 
knockout mutant, Compound 5 and Compound 61. A third compound, Compound 
110, was not picked up in the knockout samples by the deconvolution algorithms, 
but still forms a recognizable peak in the chromatograms (Figure 5-20). This 
demonstrates that despite advances in data analysis software and algorithms, 
manual curation and quality control of obtained datasets are still necessary. 
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Compound 5 consists of three predominant ions, m/z 407 (base peak ion), 193 
(ca. 80% of BP) and 175 (ca. 30% of BP). While the 18 m/z unit difference 
between the smaller ions may indicate the loss of one molecule of water, their 
relationship to the base peak ion is unclear. Compound 61 consists of an ion with 
m/z 179, in rare cases accompanied by a minor ion of m/z 161, indicative for the 
loss of a water molecule. Database searches with METLIN 
(http://metlin.scripps.edu/) and MassBank (http://www.massbank.jp/) did not yield 
conclusive evidence for the identity of either compound (data not shown). The 
lack of suitable databases which commonly employed in GC based MS 
experiments are a shortcoming of LC-MS and are a consequence of the highly 
instrument-specific data of this otherwise versatile technique (Gummer et al., 
2009; Theodoridis et al., 2012). There is, however, one compound with similar 
ions in the database of fungal metabolites and mycotoxins published by Nielsen 
and Smedsgaard (2003): the bilactone canadensolide has predominant ions of 
m/z 175 and 193 as observed in Compound 5, albeit with different ion ratios and 
no m/z 407. It is also possible that Compound 5 is actually two co-eluting 
compounds with m/z 407 and m/z 193, respectively, yet the absence of both ions 
in the KO samples only make this plausible, if they both have biosynthetic origins 
somehow connected to Sms1. It could be further hypothesized that the second 
compound absent from the KO samples, Compound 61 with m/z 179 might be a 
precursor to Compound 5. Bioinformatics analysis has demonstrated that the 
PKS encoded by SMS1 (SNOG_00477) is likely to be similar, but probably not 
identical to 6-MSASs (chapter 3). The monoisotopic mass of 6-MSA is 152 Da, 
that of its derivative patulin is 154 Da and therefore too small for the ions 
observed. Although a sodium adduct of 6-MSA might yield an ion of m/z 175 as 
observed in Compound 5, no other sodium adducts have been detected in this 
study with any of the standards tested (not shown).  
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One compound that closely resembles 6-MSA is mellein, a precursor to the 
mycotoxins of the ochratoxin group produced by various Penicilli and Aspergilli 
(Figure 5-23) (Ringot, 2006). Its molecular mass of 178 Da corresponds to the ion 
of m/z 179 observed for Compound 61 (as [M+H]+). Mellein is not listed in the 
Nielsen and Smedsgaard database or any of the mass spectral libraries 
discussed earlier. Automated MS/MS only resulted in loss of water (data not 
shown). No further targeted MS/MS experiments were conducted. As described 
in chapter 3, SMS1 was found to have high homology to otapksPN, a polyketide 
synthase required for ochratoxin synthesis in P. nordicum (Karolewiez, 2005). 
Together, these findings are further evidence for the presence of previously 
unreported mycotoxins produced by S. nodorum. 
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Figure 5-23 Biosynthesis of Ochratoxin A 
The mycotoxins of the ochratoxin class are synthesised through a pathway involving 
intermediates and precursors from amino acid and polyketide synthesis pathways. 
Adapted from Ringot (2006) 
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5.5 Conclusions 
For this study, both plate and flask based culturing and SM extraction methods 
have been evaluated for S. nodorum. The plate based methods, while attractive 
in terms of time resources used, have yielded a smaller number of resolved 
peaks in S. nodorum extracts compared to the flask method. Although the two 
plate methods only differed slightly in their respective extraction protocols, the 
chromatograms they delivered differed significantly in terms of background and 
distinguishable peaks. The flask method, however, yielded a high number of 
compounds with an adequate background. This is the first study to use bulk C18 
SPE material to isolate SMs directly from fungal culture filtrate. Despite the 
obvious advantages of SPE discussed earlier, numerous protocols in current 
literature still rely on liquid/liquid extraction with ethyl acetate or similar organic 
solvents to extract SM from fungal culturing media. SPE is more often found in 
(semi)targeted analyses of foodstuffs for mycotoxins. Here, sorbent packed 
columns or cartridges are commonly used. This study however has demonstrated 
the ease of use, speed and efficiency of the bulk SPE material to extract SMs 
directly from the culture filtrate. Moreover, this technique is easily transferable to 
other fungi, has the potential for scale-up and to be used for semi-purifying target 
compounds in a more targeted approach, and can therefore facilitate SM 
research in fungi. 
This study has revealed two compounds, Compound 5 and Compound 61, which 
are the likely product and/or intermediates of the Sms1 polyketide synthase or a 
related pathway. There is evidence that Compound 61 might be mellein, an 
intermediate of the ochratoxin biosynthetic pathway. Despite the sensitivity and 
tandem-in-time capabilities of the IonTrap mass spectrometer used in this study, 
the lack of dedicated LC-MS based mass spectral libraries has hampered the 
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efforts to elucidate the structure and identity of these compounds. Leading on 
from here, a targeted MS/MS study on an instrument with accurate mass, e.g LC-
qToF, could yield more detailed and accurate structural information that can be 
used for compound library searches not just for Compound 5 and 61, but all 
compounds resolved in SN15 SM extracts. Fraction collection should be used to 
isolate larger quantities of the compounds that can then be analysed with NMR, 
FT-IR or UV spectroscopy to obtain further levels of spectral information. 
Compound 61 is also within a mass range that is accessible to GC-MS analysis. 
The data thus acquired can then be used to query GC-MS based libraries such 
as NIST, Wiley or the GOLM metabolite library.  
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6 Final conclusions and outlook 
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6.1 Project outcome and outlook 
In this project, a combination of bioinformatics/genomics, transcriptomics and 
metabolomics techniques was used to investigate polyketide synthesis in the 
plant pathogen S. nodorum, making this the first project in the literature dedicated 
to secondary metabolites in this fungus. This approach has proven fruitful as it 
allowed the limitations of individual techniques to be compensated by the 
advantages of others.  
Bioinformatics has emerged as a valuable tool since it can help to identify 
biosynthetic pathways on a genomic level. In this study, an alternative polyketide 
melanisation pathway was predicted from genome data. These findings 
seemingly contradicted previously published results indicating melanin being 
synthesised via L-DOPA, yet this conflict could be resolved with the help of 
transcriptomics data, indicating each pathway‘s activity at a different stage of the 
lifecycle of S. nodorum. Further investigations using reversed genetics 
techniques such as targeted gene deletion or overexpression of the genes within 
the MEL1 cluster should now be used to finally elucidate the function of this 
pathway.  
The bioinformatics approach has also highlighted the potential of S. nodorum to 
produce a plethora of as yet unknown polyketides, as demonstrated by the high 
number of PKS genes and related clusters with little to no homology to known 
PKS genes in other fungi. The identity of the compounds ultimately produced by 
these pathways should be further investigated using reversed genetics and 
metabolomics. Given the high functional potential of the structurally diverse class 
of polyketides, this set of rapidly evolving genes may confer to the fungus the 
means to rapidly adapt to environmental challenges and also offers an excellent 
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opportunity for future generations of fungal molecular biologists and natural 
product chemists to investigate novel bioactive compounds and lead structures.  
Another important part of this project was the generation of PKS knockout 
mutants. These mutants were used for pathogenicity testing and comparative LC-
MS screening with the wild-type fungus. All three mutants retained their full 
pathogenicity when tested on plant based assays. It is proposed these genes 
serve a purpose to the fungus that was out of the scope of the assays used, such 
as antibiotic or mycotoxin production as protection from fungivores or competing 
organism. Classical agar diffusion tests on various fungal and bacterial 
organisms can give good indications on such functions. Future gene deletion 
experiments should also include genes from all different in vitro and in planta 
growth stages to broaden the scope of putative functions. Heterologous gene 
expression or overexpression could be used to generate larger amounts of 
compounds of interest to facilitate compound identification with LC-MS.  
A major outcome of this project is a set of metabolomics techniques to investigate 
SM production in S. nodorum. The novel dispersive SPE method developed for 
this study has been successfully used to identify compounds differentially 
abundant in one of the knockout mutants. Further LC-MS and MS/MS 
experiments, preferably on high-resolution instruments such as qToF or FT-ICR-
MS should be conducted to facilitate compound identification. Fraction collection 
can be used to isolate and semi-purify compounds from liquid chromatography. 
These fractions can then be used for NMR, IR and/or UV spectroscopy to add 
further levels of evidence on the identity of compounds o interest. 
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6.2 On the mycotoxigenic potential of S. nodorum  
So far, the only secondary metabolite reported in S. nodorum is the polyketide 
mycotoxin alternariol (Tan et al., 2009). In this study, alternariol was detected in 
most of the solid media tested as the diagnostic [M+H]+ ion of m/z 259. This ion 
was mostly found secondary to a base peak ion of m/z 335, which was also 
present in the culture filtrate samples. The origin and identity of this particular ion 
are yet to be elucidated.  
Bioinformatic analysis has revealed several genes with homologs that have been 
linked to mycotoxin production in various fungi. One of these homologs was 
otapksPN, the gene encoing a PKS responsible for mellein synthesis in 
Penicillium nodicum. Like SMS1, the otapksPN KS and AT sequences were 
reported to have high homology to 6-MSAS type PKS genes in A. terreus and B. 
nivea, but little homology to the PKS responsible for ochratoxin synthesis in A. 
ochraceus or the polyketide synthase gene responsible for OTA synthesis in P. 
verrucosum (Geisen et al., 2004). Comparative metabolic footprinting using MM 
culture filtrate of SN15 and the SMS1 knockout mutant revealed compounds 
absent in the mutant cultures, one of which (Compound 61) having an ion with 
the right m/z ratio for mellein. Further studies using the methods and approaches 
outlined above should now be implemented to confirm the identity of this 
particular compound as well as the remaining compounds resolved in SN15 
culturing medium in order to identify further mycotoxin health risks posed by this 
fungus.  
 174 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bibliography 
  
 175 
 
 
Literature Cited 
 
. 
 
Abramovic, B., I. Jajic, et al. (2005). "Optimization of the determination of deoxynivalenol 
in corn samples by liquid chromatography and a comparison of two clean-up principles." 
Journal of the Serbian Chemical Society 70(7): 1005-1013. 
 
Agilent (2003). Agilent 1100 Series LC/MSD Trap Techniques and Operation (H8966A). 
A. Technologies. Alpharetta, USA, Agilent Technologies. 1. 
 
Agrios, G. N. (2005). Plant Pathology. Burlington, MA, San Diego, CA, Elsevier Academic 
Press. 
 
Ahmed, H. Y., H. H. El Shikh, et al. (2010). "Fungal secondary metabolites: A promising 
source of antineoplastic drugs." Current Cancer Therapy Reviews 6(3): 222-228. 
 
Akamatsu, H., M. Chilvers, et al. (2010). "Identification and function of a polyketide 
synthase gene responsible for 1,8-dihydroxynaphthalene-melanin pigment biosynthesis in 
&lt;i&gt;Ascochyta rabiei&lt;/i&gt." Current Genetics 56(4): 349-360. 
 
Alberts, A. W., J. Chen, et al. (1980). "Mevinolin: A highly potent competitive inhibitor of 
hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent." 
Proceedings of the National Academy of Sciences of the United States of America 77(7 
II): 3957-3961. 
 
Altschul, S. (1990). "Basic Local Alignment Search Tool." Journal of Molecular Biology 
215(3): 403-410. 
 
Álvarez-Sánchez, B. (2010a). "Metabolomics analysis I. Selection of biological samples 
and practical aspects preceding sample preparation." TrAC, Trends in analytical 
chemistry (Regular ed.) 29(2): 111-119. 
 
Álvarez-Sánchez, B. (2010b). "Metabolomics analysis II. Preparation of biological 
samples prior to detection." TrAC, Trends in analytical chemistry (Regular ed.) 29(2): 
120-127. 
 
 176 
 
Ames, B. N. (1983). "Dietary carcinogens and anticarcinogens." Science 221(4617): 
1256-1264. 
 
Amnuaykanjanasin, A. and M. E. Daub (2009). "The ABC transporter ATR1 is necessary 
for efflux of the toxin cercosporin in the fungus Cercospora nicotianae." Fungal Genetics 
and Biology 46(2): 146-158. 
 
Amselem, J., C. A. Cuomo, et al. (2011). "Genomic Analysis of the Necrotrophic Fungal 
Pathogens <italic>Sclerotinia sclerotiorum</italic> and <italic>Botrytis cinerea</italic>." 
PLoS Genet 7(8): e1002230. 
 
Andersen, B., M. E. Hansen, et al. (2005). "Automated and unbiased image analyses as 
tools in phenotypic classification of small-spored Alternaria spp." Phytopathology 95(9): 
1021-1029. 
 
Anli, E. and M. Bayram (2009). "Ochratoxin A in Wines." Food Reviews International 
25(3): 214-232. 
 
Asai, T., J. M. Stone, et al. (2000). "Fumonisin B1-induced cell death in Arabidopsis 
protoplasts requires jasmonate-, ethylene-, and salicylate-dependent signaling 
pathways." Plant Cell 12(10): 1823-1835. 
 
Attallah, E. R., A. M. Gomaa, et al. (2008). "Validation of analytical method for 
determination of ochratoxin A in cereals by C18 solid phase extraction and high-
performance liquid chromatography with fluorescence detection." Journal of Food, 
Agriculture and Environment 6(2): 130-133. 
 
Avalos, J. and A. F. Estrada (2011). "Regulation by light in Fusarium." Fungal Genetics 
and Biology. 
 
Bai, G. H., A. E. Desjardins, et al. (2002). "Deoxynivalenol-nonproducing Fusarium 
graminearum causes initial infection, but does not cause disease spread in wheat 
spikes." Mycopathologia 153(2): 91-98. 
 
Baker, S. E., S. Kroken, et al. (2006). "Two Polyketide Synthase-Encoding Genes Are 
Required for Biosynthesis of the Polyketide Virulence Factor, T-toxin, by Cochliobolus 
heterostrophus." Molecular Plant-Microbe Interactions 19(2): 139-149. 
 
Bathgate, J. A. (2001). "Ascospores are a source of inoculum of Phaeosphaeria 
nodorum, P. avenaria f. sp. avenaria and Mycosphaerella graminicola in Western 
Australia." Australasian Plant Pathology 30(4): 317-322. 
 
 177 
 
bbc.co.uk (2004, Wednesday, 2 June, 2004, 12:32 GMT 13:32 UK ). "Sir Paul reveals 
Beatles drug use." Retrieved 19/09/2011, 2011. 
 
Bedair, M. and L. W. Sumner (2008). "Current and emerging mass-spectrometry 
technologies for metabolomics." TrAC - Trends in Analytical Chemistry 27(3): 238-250. 
 
Benedikz, P. W., Mappeldoram, C.J. and Scott, P.R. (1981). "A laboratory technique for 
screening cereals for resistance to Septoria nodorum using detached seedling leaves." 
Trans Br Mycol Soc 77: 667-668. 
 
Bennett, J. W. (1987). "Mycotoxins, mycotoxicoses, mycotoxicology and 
Mycopathologia." Mycopathologia 100(1): 3-5. 
 
Bennett, J. W. (1997). "One gene to whole pathway: The role of norsolorinic acid in 
aflatoxin research." Advances in Applied Microbiology 45: 1-15. 
 
Bennett, J. W. and R. Bentley (1989). "What's in a name? Microbial secondary 
metabolism." Adv. Appl. Microbiol. 34: 1-28. 
 
Bennett, J. W. and M. Klich (2003). "Mycotoxins." Clinical Microbiology Reviews 16(3): 
497-516. 
 
Bentley, R. (2009). "Different roads to discovery; Prontosil (hence sulfa drugs) and 
penicillin (hence β-lactams)." Journal of Industrial Microbiology & Biotechnology 36(6): 
775-786. 
 
Bentley, R. and J. W. Bennett (2003). What Is an Antibiotic? Revisited. Advances in 
Applied Microbiology. J. W. B. Allen I. Laskin and M. G. Geoffrey, Academic Press. 
Volume 52: 303-331. 
 
Bergmann, S., J. Schümann, et al. (2007). "Genomics-driven discovery of PKS-NRPS 
hybrid metabolites from Aspergillus nidulans." Nature Chemical Biology 3(4): 213-217. 
 
Bhatnagar, D., J. Yu, et al. (2002). "Toxins of filamentous fungi." Chemical Immunology 
81: 167-206. 
 
Birch, A. J., R. A. Massy-Westropp, et al. (1955). "Studies in relation to biosynthesis. Part 
VII. 2-Hydroxy-6-methylbenzoic acid in Penicillium griseofulvum Dicrckx." Aust. J. Chem. 
8: 539-544. 
 
 178 
 
Birren, B., G. Fink, et al. (2002). Fungal genome initiative. 
 
Bizukojc, M. and S. Ledakowicz (2009). "The morphological and physiological evolution 
of Aspergillus terreus mycelium in the submerged culture and its relation to the formation 
of secondary metabolites." World Journal of Microbiology and Biotechnology: 1-14. 
 
Boa, E. R., Food, et al. (2004). Wild edible fungi: a global overview of their use and 
importance to people, Food and Agriculture Organization of the United Nations. 
 
Böhnert, H. U., I. Fudal, et al. (2004). "A putative polyketide synthase/peptide synthetase 
from Magnaporthe grisea signals pathogen attack to resistant rice." Plant Cell 16(9): 
2499-2513. 
 
Bok, J. W. and N. P. Keller (2004). "LaeA, a regulator of secondary metabolism in 
Aspergillus spp." Eukaryotic Cell 3(2): 527-535. 
 
Borner, G. H. H., D. J. Sherrier, et al. (2005). "Analysis of detergent-resistant membranes 
in arabidopsis. Evidence for plasma membrane lipid rafts." Plant Physiology 137(1): 104-
116. 
 
Bradshaw, R. E., D. Bhatnagar, et al. (2002). "Dothistroma pini, a forest pathogen, 
contains homologs of aflatoxin biosynthetic pathway genes." Applied and Environmental 
Microbiology 68(6): 2885-2892. 
 
Brakhage, A. A. and V. Schroeckh (2011). "Fungal secondary metabolites - Strategies to 
activate silent gene clusters." Fungal Genetics and Biology 48(1): 15-22. 
 
Brennan, J. P. (1998). Economic Importance of WheatDiseases in Australia. Wagga 
Wagga, NSW Agriculture. 
 
Brodhagen, M. and N. P. Keller (2006). "Signalling pathways connecting mycotoxin 
production and sporulation." Molecular Plant Pathology 7(4): 285-301. 
 
Brown, A. G., T. C. Smale, et al. (1976). "Crystal and molecular structure of compactin, a 
new antifungal metabolite from Penicillium brevicompactum." Journal of the Chemical 
Society. Perkin transactions 1(11): 1165-1170. 
 
Bu'Lock, J. D., D. Hamilton, et al. (1965). "Metabolic development and secondary 
biosynthesis in Penicillium urticae." Canadian Journal of Microbiology 11(5): 765-778. 
 
 179 
 
Bushley, K. E. and B. G. Turgeon (2010). "Phylogenomics reveals subfamilies of fungal 
nonribosomal peptide synthetases and their evolutionary relationships." BMC 
Evolutionary Biology 10(1). 
 
Callahan, T. M., M. S. Rose, et al. (1999). "CFP, the putative cercosporin transporter of 
Cercospora kikuchii, is required for wild type cercosporin production, resistance, and 
virulence on soybean." Molecular Plant-Microbe Interactions 12(10): 901-910. 
 
Calvo, A. M., R. A. Wilson, et al. (2002). "Relationship between secondary metabolism 
and fungal development." Microbiology and Molecular Biology Reviews 66(3): 447-459. 
 
Caporael, L. R. (1976). "Ergotism: the Satan loosed in Salem?" Science 192(4234): 21-
26. 
 
Castrillo, J. I., A. Hayes, et al. (2003). "An optimized protocol for metabolome analysis in 
yeast using direct infusion electrospray mass spectrometry." Phytochemistry 62(6): 929-
937. 
 
Chain, E., H. W. Florey, et al. (1940). "PENICILLIN AS A CHEMOTHERAPEUTIC 
AGENT." The Lancet 236(6104): 226-228. 
 
Champe, S. P., P. Rao, et al. (1987). "An endogenous inducer of sexual development in 
Aspergillus nidulans." Journal of General Microbiology 133(5): 1383-1387. 
 
Chanda, A., L. V. Roze, et al. (2009). "A key role for vesicles in fungal secondary 
metabolism." Proceedings of the National Academy of Sciences of the United States of 
America 106(46): 19533-19538. 
 
Chen, H., M. H. Lee, et al. (2007). "Molecular analysis of the cercosporin biosynthetic 
gene cluster in Cercospora nicotianae." Molecular Microbiology 64(3): 755-770. 
 
Chisholm, S. T. (2006). "Host-Microbe Interactions: Shaping the Evolution of the Plant 
Immune Response." Cell (Cambridge) 124(4): 803-814. 
 
Chivasa, S., B. K. Ndimba, et al. (2005). "Extracellular ATP functions as an endogenous 
external metabolite regulating plant cell viability." Plant Cell 17(11): 3019-3034. 
 
Choquer, M., K. L. Dekkers, et al. (2005). "The CTB1 gene encoding a fungal polyketide 
synthase is required for cercosporin biosynthesis and fungal virulence of Cercospora 
nicotianae." Molecular Plant-Microbe Interactions 18(5): 468-476. 
 
 180 
 
Chung, K. R., M. E. Daub, et al. (2003). "The CRG1 gene required for resistance to the 
singlet oxygen-generating cercosporin toxin in Cercospora nicotianae encodes a putative 
fungal transcription factor." Biochemical and Biophysical Research Communications 
302(2): 302-310. 
 
Chung, S. W. C. and K. P. Kwong (2007). "Determination of ochratoxin A at parts-per-
trillion levels in cereal products by immunoaffinity column cleanup and high-performance 
liquid chromatography/mass spectrometry." Journal of AOAC International 90(3): 773-
777. 
 
Cigic, I. K. and H. Prosen (2009). "An overview of conventional and emerging analytical 
methods for the determination of mycotoxins." International Journal of Molecular 
Sciences 10(1): 62-115. 
 
Collie, J. N. (1907). "CLXXI. - Derivatives of the multiple keten group." Journal of the 
Chemical Society, Transactions 91: 1806-1813. 
 
Collie, N. and W. S. Myers (1893). "VII. - The formation of orcinol and other condensation 
products from dehydracetic acid." Journal of the Chemical Society, Transactions 63: 122-
128. 
 
Constant, H. L. and C. W. W. Beecher (1995). "A method for the dereplication of natural 
product extracts using electrospray HPLC/MS." Natural Product Letters 6(3): 193-196. 
 
Coulombe R.A, Jr. (1994). "Non-hepatic disposition and effects of aflatoxin B1." The 
Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance: 89-
101. 
 
Cousin, A., R. Mehrabi, et al. (2006). "The MAP kinase-encoding gene MgFus3 of the 
non-appressorium phytopathogen Mycosphaerella graminicola is required for penetration 
and in vitro pycnidia formation." Molecular Plant Pathology 7(4): 269-278. 
 
Cox, R. J., T. J. Simpson, et al. (2009). Chapter 3 Fungal Type I Polyketide Synthases. 
Methods in Enzymology, Academic Press. Volume 459: 49-78. 
 
Cunfer, B. M. (1999). "Taxonomy and identification of Septoria and Stagonospora species 
on small-grain cereals " Annual Review of Phytopathology 37(1): 267-284. 
 
Curtis, M. J. and T. J. Wolpert (2004). "The victorin-induced mitochondrial permeability 
transition precedes cell shrinkage and biochemical markers of cell death, and shrinkage 
occurs without loss of membrane integrity." Plant Journal 38(2): 244-259. 
 
 181 
 
Dalcero, A. (1997). "Occurrence of deoxynivalenol and Fusarium graminearum in 
Argentinian wheat." Food additives and contaminants 14(1): 11-14. 
 
Darling, A. E., B. Mau, et al. (2010). "progressiveMauve: Multiple Genome Alignment with 
Gene Gain, Loss and Rearrangement." PLoS ONE 5(6): e11147. 
 
Daub, M. E. (1982). "Cercosporin, a photosensitizing toxin from Cercospora species." 
Phytopathology 72: 370-374. 
 
Daub, M. E. and M. Ehrenshaft (2000). "The photoactivated Cercospora toxin 
cercosporin: Contributions to plant disease and fundamental biology." Annual Review of 
Phytopathology 38: 461-490. 
 
Daub, M. E. and R. P. Hangarter (1983). "Production of singlet oxygen and superoxide by 
the fungal toxin, cercosporin." Plant Physiol. 73: 855-857. 
 
Daub, M. E., S. Herrero, et al. (2005). "Photoactivated perylenequinone toxins in fungal 
pathogenesis of plants." FEMS Microbiology Letters 252(2): 197-206. 
 
Daub, M. E., G. B. Leisman, et al. (1992). "Reductive detoxification as a mechanism of 
fungal resistance to singlet oxygen-generating photosensitizers." Proceedings of the 
National Academy of Sciences of the United States of America 89(20): 9588-9592. 
 
Dayan, F. E., D. Ferreira, et al. (2008). "A pathogenic fungi diphenyl ether phytotoxin 
targets plant enoyl (acyl carrier protein) reductase." Plant Physiology 147(3): 1062-1071. 
 
Dean, R. A. (2005). "The genome sequence of the rice blast fungus Magnaporthe grisea." 
Nature (London) 434(7036): 980-986. 
 
Dean, R. A., N. J. Talbot, et al. (2005). "The genome sequence of the rice blast fungus 
Magnaporthe grisea." Nature 434(7036): 980-986. 
 
Delgado, T., C. GÃ³mez-CordovÃ©s, et al. (1996). "Determination of alternariol and 
alternariol methyl ether in apple juice using solid-phase extraction and high-performance 
liquid chromatography." Journal of Chromatography A 731(1-2): 109-114. 
 
Demain, A. L. (1981). "Industrial Microbiology." Science 214(4524): 987-995. 
 
 182 
 
Demain, A. L. (1996). "Fungal secondary metabolism: Regulation and functions." A 
Century of Mycology: 233-254. 
 
Demain, A. L. (2008). "Contributions of Microorganisms to Industrial Biology." Molecular 
biotechnology 38(1): 41-55. 
 
Demain, A. L. (2009). "Antibiotics: Natural products essential to human health." Medicinal 
Research Reviews 29(6): 821-842. 
 
Demain, A. L. and A. Fang (2000). The Natural Functions of Secondary Metabolites, 
Springer-Verlag. 
 
Demeke, T., Y. Kidane, et al. (1979). "Ergotism - A report on an epidemic, 1977-78." 
Ethiopian Medical Journal 17(4): 107-113. 
 
Dettmer, K., P. A. Aronov, et al. (2007). "Mass spectrometry-based metabolomics." Mass 
Spectrometry Reviews 26(1): 51-78. 
 
di Mavungu, J. D., S. Monbaliu, et al. (2009). "LC-MS/MS multi-analyte method for 
mycotoxin determination in food supplements." Food Additives and Contaminants - Part A 
Chemistry, Analysis, Control, Exposure and Risk Assessment 26(6): 885-895. 
 
Dickman, M. B., Y. K. Park, et al. (2001). "Abrogation of disease development in plants 
expressing animal antiapoptotic genes." Proceedings of the National Academy of 
Sciences of the United States of America 98(12): 6957-6962. 
 
Dixon, L. S. (1984). "Bosch's "St. Anthony Triptych"--An Apothecary's Apotheosis." Art 
Journal 44(2): 119-131. 
 
Dodds, P. N. (2009). "Effectors of biotrophic fungi and oomycetes: pathogenicity factors 
and triggers of host resistance." The New phytologist 183(4): 993-1000. 
 
Doehlemann, G., P. Berndt, et al. (2006). "Different signalling pathways involving a Gα 
protein, cAMP and a MAP kinase control germination of Botrytis cinerea conidia." 
Molecular Microbiology 59(3): 821-835. 
 
Dollery (1991). "Ergotamine." Therapeutic drugs 1. 
 
 183 
 
Donadio, E. (1985). "Painting for patients: Grünewald's Isenheim Altarpiece." Medical 
heritage 1(6): 448-454. 
 
Douce, R., J. Bourguignon, et al. (2001). "The glycine decarboxylase system: a 
fascinating complex." Trends in Plant Science 6(4): 167-176. 
 
Dyck, E. (2005). "Flashback: psychiatric experimentation with LSD in historical 
perspective." Canadian journal of psychiatry 50(7): 381. 
 
Eaton, D. L. and J. D. Groopman (1994). The Toxicology of Aflatoxins: Human Health, 
Veterinary, and Agricultural Significance. 
 
Ehrenshaft, M., P. Bilski, et al. (1999). "A highly conserved sequence is a novel gene 
involved in de novo vitamin B6 biosynthesis." Proceedings of the National Academy of 
Sciences of the United States of America 96(16): 9374-9378. 
 
Eliahu, N., A. Igbaria, et al. (2007). "Melanin biosynthesis in the maize pathogen 
Cochliobolus heterostrophus depends on two mitogen-activated protein kinases, Chk1 
and Mps1, and the transcription factor Cmr1." Eukaryotic Cell 6(3): 421-429. 
 
Elian, A. A. (2011). "Analysis of psilocybin and psilocin in urine using SPE and LC-
tandem mass spectrometry." LC GC North America 29(9). 
 
Ellis, J. G. (2007). "The role of secreted proteins in diseases of plants caused by rust, 
powdery mildew and smut fungi." Current opinion in microbiology 10(4): 326-331. 
 
Ellwood, S., Z. Liu, et al. (2010). "A first genome assembly of the barley fungal pathogen 
&lt;i&gt;Pyrenophora teres&lt;/i&gt; f. &lt;i&gt;teres&lt;/i&gt." Genome Biology 11(11): 1-
14. 
 
Endo, A. (1979). "Monacolin K, a new hypocholesterolemic agent produced by a 
Monascus species." Journal of Antibiotics 32(8): 852-854. 
 
Endo, A., M. Kuroda, et al. (1976). "ML 236A, ML 236B, and ML 236C, new inhibitors of 
cholesterogenesis produced by Penicillium citrinum." Journal of Antibiotics 29(12): 1346-
1348. 
 
Erbs, M., N. Hartmann, et al. (2007). "Determination of the cross-reactivities for α-
zearalenol, β-zearalenol, zearalanone, α-zearalanol, and β-zearalanol on three 
commercial immunoaffinity columns targeting zearalenone." Journal of AOAC 
International 90(4): 1197-1202. 
 184 
 
 
Evelin, H., R. Kapoor, et al. (2009). "Arbuscular mycorrhizal fungi in alleviation of salt 
stress: a review." Annals of Botany 104(7): 1263-1280. 
 
Fente, C. A. (1998). "Determination of alternariol in tomato paste using solid phase 
extraction and high-performance liquid chromatography with fluorescence detection†." 
Analyst (London) 123(11): 2277-2280. 
 
Fischbach, M. A. and C. T. Walsh (2006). "Assembly-line enzymology for polyketide and 
nonribosomal peptide antibiotics: Logic machinery, and mechanisms." Chemical Reviews 
106(8): 3468-3496. 
 
Fischer, U., S. Men, et al. (2004). "Lipid function in plant cell polarity." Current Opinion in 
Plant Biology 7(6): 670-676. 
 
Fleming, A. (1929). "On the antibacterial action of cultures of a penicillium, with special 
reference to their use in the isolation of B. influenzae." British Journal of Experimental 
Pathology 60(1): 3-13. 
 
Foote, C. S. (1976). "Photosensitized oxidation and singlet oxygen: Consequences in 
biological systems." Free Radicals in Biology 2: 85-133. 
 
Forde, B. G., R. J. C. Oliver, et al. (1978). "Variation in mitochondrial translation products 
associated with male-sterile cytoplasms in maize." Proceedings of the National Academy 
of Sciences of the United States of America 75(8): 3841-3845. 
 
Fox, E. M. and B. J. Howlett (2008). "Secondary metabolism: regulation and role in fungal 
biology." Current Opinion in Microbiology 11(6): 481-487. 
 
Fraenkel, G. S. (1959). "The raison d'Ãªtre of secondary plant substances." Science (New 
York, N.Y.) 129(3361): 1466-1470. 
 
Friday, J. (1974). "A microscopic incident in a monumental struggle: Huxley and antibiosis 
in 1875." British journal for the history of science 7(25): 61-71. 
 
Friesen, T. L., C. G. Chu, et al. (2009). "Host-selective toxins produced by Stagonospora 
nodorum confer disease susceptibility in adult wheat plants under field conditions." 
Theoretical and Applied Genetics 118(8): 1489-1497. 
 
 185 
 
Friesen, T. L., J. D. Faris, et al. (2008a). "Host-specific toxins: Effectors of necrotrophic 
pathogenicity." Cellular Microbiology 10(7): 1421-1428. 
 
Friesen, T. L., S. W. Meinhardt, et al. (2007). "The Stagonospora nodorum-wheat 
pathosystem involves multiple proteinaceous host-selective toxins and corresponding 
host sensitivity genes that interact in an inverse gene-for-gene manner." Plant Journal 
51(4): 681-692. 
 
Friesen, T. L., E. H. Stukenbrock, et al. (2006). "Emergence of a new disease as a result 
of interspecific virulence gene transfer." Nature Genetics 38(8): 953-956. 
 
Friesen, T. L., Z. Zhang, et al. (2008b). "Characterization of the interaction of a novel 
Stagonospora nodorum host-selective toxin with a wheat susceptibility gene." Plant 
Physiology 146(2): 682-693. 
 
Frisvad, J. C. and U. Thrane (1993). "Chapter 8 Liquid Column Chromatography of 
Mycotoxins." Journal of Chromatography Library 54(C): 253-372. 
 
Gaffoor, I., D. W. Brown, et al. (2005). "Functional analysis of the polyketide synthase 
genes in the filamentous fungus Gibberella zeae (Anamorph Fusarium graminearum)." 
Eukaryotic Cell 4(11): 1926-1933. 
 
Galagan, J. E. (2003). "The genome sequence of the filamentous fungus Neurospora 
crassa." Nature (London) 422(6934): 859-868. 
 
Geisen, R., Z. Mayer, et al. (2004). "Development of a Real Time PCR System for 
Detection of Penicillium nordicum and for Monitoring Ochratoxin A Production in Foods 
by Targeting the Ochratoxin Polyketide Synthase Gene." Systematic and applied 
microbiology 27(4): 501-507. 
 
Gilchrist, D. G. (1997). "Mycotoxins reveal connections between plants and animals in 
apoptosis and ceramide signaling." Cell Death and Differentiation 4(8): 689-698. 
 
Glazebrook, J. (2005). "Contrasting mechanisms of defense against biotrophic and 
necrotrophic pathogens." Annual Review of Phytopathology 43: 205-227. 
 
Gocho, H. (1987). "Fusarium species and trichothecene mycotoxins in suspect samples 
of 1985 Manitoba wheat." Canadian journal of plant science 67: 611-619. 
 
 186 
 
Goodwin, S. B. (2004). "Minimum phylogenetic coverage: An additional criterion to guide 
the selection of microbial pathogens for initial genomic sequencing efforts." 
Phytopathology 94(8): 800-804. 
 
Goudet, #160, et al. (1998). Magnesium ions promote assembly of channel-like structures 
from beticolin 0, a non-peptide fungal toxin purified from Cercospora beticola. Oxford, 
ROYAUME-UNI, Blackwell. 
 
Goudet, C., M. L. Milat, et al. (2000). "Beticolins, nonpeptidic, polycyclic molecules 
produced by the phytopathogenic fungus Cercospora beticola, as a new family of ion 
channel-forming toxins." Molecular Plant-Microbe Interactions 13(2): 203-209. 
 
Graniti, A. (1972). "The evolution of the toxic concept in plant pathology." Phytotoxins in 
Plant Diseases: 1-18. 
 
Grewal, H. S. and K. L. Kalra (1995). "Fungal production of citric acid." Biotechnology 
Advances 13(2): 209-234. 
 
Guillarme, D., J. Schappler, et al. (2010). "Coupling ultra-high-pressure liquid 
chromatography with mass spectrometry." TrAC - Trends in Analytical Chemistry 29(1): 
15-27. 
 
Guillen, A. (1994). "Linkage among melanin biosynthetic mutations in Cochliobolus 
heterostrophus." Fungal Genet. Newsl 41: 40. 
 
Gummer, J., M. Banazis, et al. (2009). "Use of mass spectrometry for metabolite profiling 
and metabolomics." Australian Biochemist 40(3): 5-8. 
 
Gummer, J., C. Krill, et al. (2012). Metabolomics Protocols for Filamentous Fungi. 
Methods in molecular biology. J. M. Walker. Clifton, N.J. 835: 237-254. 
 
Gutiérrez-Nájera, N., R. A. Muñoz-Clares, et al. (2005). "Fumonisin B1, a sphingoid toxin, 
is a potent inhibitor of the plasma membrane H+-ATPase." Planta 221(4): 589-596. 
 
Hammond-Kosack, K. E. and J. E. Parker (2003). "Deciphering plant-pathogen 
communication: Fresh perspectives for molecular resistance breeding." Current Opinion 
in Biotechnology 14(2): 177-193. 
 
Hane, J. K., R. G. T. Lowe, et al. (2007). "Dothideomycete-plant interactions illuminated 
by genome sequencing and EST analysis of the wheat pathogen Stagonospora 
nodorum." Plant Cell 19(11): 3347-3368. 
 187 
 
 
Heathcote, J. G. (1978). Aflatoxins: Chemical and Biological Aspects, Elsevier Scientific 
Publishing Company, Amsterdam, The Netherlands. 
 
Henderson, J. W. J. (1997). "The yellow brick road to penicillin: a story of serendipity." 
Mayo Clinic proceedings. Mayo Clinic 72(7): 683-683-687. 
 
Hertweck, C. (2009). "Hidden biosynthetic treasures brought to light." Nat Chem Biol 5(7): 
450-452. 
 
Hicks, J. K., K. Shimizu, et al. (2002). "Genetics and biosynthesis of aflatoxins and 
sterigmatocystin." The Mycota: 55-69. 
 
Hill, A. M. (2006). "The biosynthesis, molecular genetics and enzymology of the 
polyketide-derived metabolites." Natural Product Reports 23(2): 256-320. 
 
Hoffmeister, D. and N. P. Keller (2007). "Natural products of filamentous fungi: Enzymes, 
genes, and their regulation." Natural Product Reports 24(2): 393-416. 
 
Højer-Pedersen, J., J. Smedsgaard, et al. (2008). "The yeast metabolome addressed by 
electrospray ionization mass spectrometry: Initiation of a mass spectral library and its 
applications for metabolic footprinting by direct infusion mass spectrometry." 
Metabolomics 4(4): 393-405. 
 
Horbach, R., A. R. Navarro-Quesada, et al. (2011). "When and how to kill a plant cell: 
Infection strategies of plant pathogenic fungi." Journal of Plant Physiology 168(1): 51-62. 
 
Howard, R. J. and M. A. Ferrari (1989). "Role of melanin in appressorium function." 
Experimental Mycology 13(4): 403-418. 
 
Howard, R. J. and B. Valent (1996). "BREAKING AND ENTERING: Host Penetration by 
the Fungal Rice Blast Pathogen Magnaporthe grisea." Annual Review of Microbiology 
50(1): 491-512. 
 
Howlett, B. J. (2006). "Secondary metabolite toxins and nutrition of plant pathogenic 
fungi." Current Opinion in Plant Biology 9(4): 371-375. 
 
 188 
 
IpCho, S. V. S. (2010). "The Transcription Factor StuA Regulates Central Carbon 
Metabolism, Mycotoxin Production, and Effector Gene Expression in the Wheat Pathogen 
Stagonospora nodorum." Eukaryotic Cell 9(7): 1100-1108. 
 
Ipcho, S. V. S. (2012). "Transcriptome analysis of Stagonospora nodorum: gene models, 
effectors, metabolism and pantothenate dispensability Transcriptome of Stagonospora 
nodorum." Molecular Plant Pathology: no-no. 
 
Jenke-Kodama, H. (2009). "Evolution of metabolic diversity: Insights from microbial 
polyketide synthases." Phytochemistry (Oxford) 70(15-16): 1858-1866. 
 
Jenns, A. E., D. L. Scott, et al. (1995). "Isolation of mutants of the fungus Cercospora 
nicotianae altered in their response to singlet-oxygen-generating photosensitizers." 
Photochem. Photobiol. 61: 488-493. 
 
Jones, J. D. G. and J. L. Dangl (2006). "The plant immune system." Nature 444(7117): 
323-329. 
 
Kämper, J., R. Kahmann, et al. (2006). "Insights from the genome of the biotrophic fungal 
plant pathogen Ustilago maydis." Nature 444(7115): 97-101. 
 
Karolewiez, A. (2005). "Cloning a part of the ochratoxin A biosynthetic gene cluster of 
Penicillium nordicum and characterization of the ochratoxin polyketide synthase gene." 
Systematic and applied microbiology 28(7): 588-595. 
 
Keller, B. O. (2008). "Interferences and contaminants encountered in modern mass 
spectrometry." Analytica Chimica Acta 627(1): 71-81. 
 
Keller, N. P., G. Turner, et al. (2005). "Fungal secondary metabolism - from biochemistry 
to genomics." Nat Rev Micro 3(12): 937-947. 
 
Kennedy, J., K. Auclair, et al. (1999). "Modulation of polyketide synthase activity by 
accessory proteins during lovastatin biosynthesis." Science 284(5418): 1368-1372. 
 
Khaldi, N., F. T. Seifuddin, et al. (2010). "SMURF: Genomic mapping of fungal secondary 
metabolite clusters." Fungal Genetics and Biology 47(9): 736-741. 
 
Koch, A. L. (2003). "Bacterial Wall as Target for Attack: Past, Present, and Future 
Research." Clin. Microbiol. Rev. 16(4): 673-687. 
 
 189 
 
Korth, K. L., C. I. Kaspi, et al. (1991). "URF13, a maize mitochondrial pore-forming 
protein, is oligomeric and has a mixed orientation in Escherichia coli plasma 
membranes." Proceedings of the National Academy of Sciences of the United States of 
America 88(23): 10865-10869. 
 
Koslovskic•, A. G., V. P. Zhelifonova, et al. (2010). "[The influence of medium 
composition on alkaloid biosynthesis by Penicillium citrinum]." Prikladnaia biokhimiia i 
mikrobiologiia 46(5): 572-576. 
 
Kossel, A. (1891). Arch. Anat. Physiol. (Leipzig) 15: 181. 
 
Kroken, S., N. L. Glass, et al. (2003). "Phylogenomic analysis of type I polyketide 
synthase genes in pathogenic and saprobic ascomycetes." Proceedings of the National 
Academy of Sciences of the United States of America 100(26): 15670-15675. 
 
Krska, R. and C. Crews (2008). "Significance, chemistry and determination of ergot 
alkaloids: A review." Food Additives and Contaminants - Part A Chemistry, Analysis, 
Control, Exposure and Risk Assessment 25(6): 722-731. 
 
Lancaster, M. C., F. P. Jenkins, et al. (1961). "Toxicity associated with certain samples of 
groundnuts." Nature 192(4807): 1095-1096. 
 
Langfelder, K., M. Streibel, et al. (2003). "Biosynthesis of fungal melanins and their 
importance for human pathogenic fungi." Fungal Genetics and Biology 38(2): 143-158. 
 
Launay, F. M., P. B. Young, et al. (2004). "Confirmatory assay for zeranol, taleranol and 
the Fusarium spp. toxins in bovine urine using liquid chromatography-tandem mass 
spectrometry." Food Additives and Contaminants 21(1): 52-62. 
 
Leberer, E., D. Harcus, et al. (2001). "Ras links cellular morphogenesis to virulence by 
regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus 
Candida albicans." Molecular Microbiology 42(3): 673-687. 
 
Lee, L. S., J. W. Bennett, et al. (1976). "Biosynthesis of aflatoxin B1. Conversion of 
versicolorin A to aflatoxin B1 by Aspergillus parasiticus." Journal of Agricultural and Food 
Chemistry 24(6): 1167-1170. 
 
Lee, M. R. (2009a). "The history of ergot of rye (Claviceps purpurea) I: From antiquity to 
1900." Journal of the Royal College of Physicians of Edinburgh 39(2): 179-184. 
 
 190 
 
Lee, M. R. (2009b). "The history of ergot of rye (Claviceps purpurea) II: 1900-1940." 
Journal of the Royal College of Physicians of Edinburgh 39(4): 365-369. 
 
Lee, M. R. (2010). "The history of ergot of rye (Claviceps purpurea) III: 1940-80." Journal 
of the Royal College of Physicians of Edinburgh 40(1): 77-80. 
 
Lemmermann, O. (1950). "Paesch, Karl: Biochemie und Physiologie der sekundären 
Pflanzenstoffe. Mit 18 Abb., IX, 268 Seiten, 1950, 24.— DM., Ganzleinen 26.70 DM. 
(Lehrbuch der Pflanzenphysiologie, Bd. 1, Teil 2.)." Zeitschrift für Pflanzenernährung, 
Düngung, Bodenkunde 51(3): 259-259. 
 
Leonard, K. J. (1977). "Virulence, temperature optima, and competitive abilities of isolines 
of races T and O of Bipolaris." Phytopathology 67(10): 1279-1279. 
 
Levings Iii, C. S. and J. N. Siedow (1992). "Molecular basis of disease susceptibility in the 
Texas cytoplasm of maize." Plant Molecular Biology 19(1): 135-147. 
 
Li, F.-Q. (2002). "Fusarium toxins in wheat from an area in Henan Province, PR China, 
with a previous human red mould intoxication episode." Food additives and contaminants 
19(2): 163-167. 
 
Li, F. Q., T. Yoshizawa, et al. (2001). "Aflatoxins and fumonisins in corn from the high-
incidence area for human hepatocellular carcinoma in Guangxi, China." Journal of 
Agricultural and Food Chemistry 49(8): 4122-4126. 
 
Liao, H. L. and K. R. Chung (2008). "Genetic dissection defines the roles of elsinochrome 
phytotoxin for fungal pathogenesis and conidiation of the citrus pathogen Elsinoë 
fawcettii." Molecular Plant-Microbe Interactions 21(4): 469-479. 
 
Little, H. N. and K. Bloch (1950). "STUDIES ON THE UTILIZATION OF ACETIC ACID 
FOR THE BIOLOGICAL SYNTHESIS OF CHOLESTEROL " J. Biol. Chem. 183: 33-46. 
 
Liu, G. Y. (2009). "Color me bad: microbial pigments as virulence factors." Trends in 
microbiology (Regular ed.) 17(9): 406-413. 
 
Liu, S. and R. A. Dean (1997). "G protein subunit genes control growth, development, 
and pathogenicity of Magnaporthe grisea." Molecular Plant-Microbe Interactions 10(9): 
1075-1086. 
 
Liu, Z., J. D. Faris, et al. (2009). "SnTox3 acts in effector triggered susceptibility to induce 
disease on wheat carrying the Snn3 gene." PLoS Pathogens 5(9). 
 191 
 
 
Liu, Z., T. L. Friesen, et al. (2006). "The Tsn1-ToxA interaction in the wheat-
Stagonospora nodorum pathosystem parallels that of the wheat-tan spot system." 
Genome 49(10): 1265-1273. 
 
Liu, Z. H. (2004). "Genetic and physical mapping of a gene conditioning sensitivity in 
wheat to a partially purified host-selective toxin produced by Stagonospora nodorum." 
Phytopathology 94(10): 1056-1060. 
 
Logrieco, A., A. Moretti, et al. (2009). "Alternaria toxins and plant diseases: An overview 
of origin, occurrence and risks." World Mycotoxin Journal 2(2): 129-140. 
 
Lorang, J., A. Cuesta-Marcos, et al. (2010). "Identification and mapping of adult-onset 
sensitivity to victorin in barley." Molecular Breeding 26(3): 545-550. 
 
Lorang, J. M., N. Carkaci-Salli, et al. (2004). "Identification and characterization of victorin 
sensitivity in Arabidopsis thaliana." Molecular Plant-Microbe Interactions 17(6): 577-582. 
 
Lorang, J. M., T. A. Sweat, et al. (2007). "Plant disease susceptibility conferred by a 
"resistance" gene." Proceedings of the National Academy of Sciences of the United 
States of America 104(37): 14861-14866. 
 
Lorenz, N., T. Haarmann, et al. (2009). "The ergot alkaloid gene cluster: Functional 
analyses and evolutionary aspects." Phytochemistry 70(15-16): 1822-1832. 
 
Lousberg, R. J. J. C., U. Weiss, et al. (1971). "The structure of cercosporin, a naturally 
occurring quinone." Journal of the Chemical Society D: Chemical Communications(22): 
1463-1464. 
 
Lowe, R. G. T. (2008). "A metabolomic approach to dissecting osmotic stress in the 
wheat pathogen Stagonospora nodorum." Fungal Genetics and Biology 45(11): 1479-
1486. 
 
Lowe, R. G. T. (2009). "Trehalose biosynthesis is involved in sporulation of Stagonospora 
nodorum." Fungal Genetics and Biology 46(5): 381-389. 
 
MacDonald, S. (2004). "Survey of ochratoxin A and deoxynivalenol in stored grains from 
the 1999 harvest in the UK." Food additives and contaminants 21(2): 172-181. 
 
 192 
 
Macko, V., T. J. Wolpert, et al. (1985). "Characterization of victorin C, the major host-
selective toxin from Cochliobolus victoriae: Structure of degradation products." 
Experientia 41(11): 1366-1370. 
 
Madigan, M. T., J. M. Martinko, et al. (2000). Brock biology of microorganisms, Prentice 
Hall. 
 
Magan, N., A. Medina, et al. (2011). "Possible climate-change effects on mycotoxin 
contamination of food crops pre- and postharvest." Plant Pathology 60(1): 150-163. 
 
Maggon, K. K., S. K. Gupta, et al. (1977). "Biosynthesis of aflatoxins." Bacteriological 
Reviews 41(4): 822-855. 
 
Mahanti, N. (1996). "Structure and function of fas-1A, a gene encoding a putative fatty 
acid synthetase directly involved in aflatoxin biosynthesis in Aspergillus parasiticus." 
Applied and Environmental Microbiology 62(1): 191-195. 
 
Maier, F. J., T. Miedaner, et al. (2006). "Involvement of trichothecenes in fusarioses of 
wheat, barley and maize evaluated by gene disruption of the trichodiene synthase (Tri5) 
gene in three field isolates of different chemotype and virulence." Molecular Plant 
Pathology 7(6): 449-461. 
 
Majerus, P. W., A. W. Alberts, et al. (1964). "The Acyl Carrier Protein of Fatty Acid 
Synthesis: Purification, Physical Properties, and Substrate Binding Site." Proc Natl Acad 
Sci U S A 51: 1231-1238. 
 
Majerus, P. W. and P. R. Vagelos (1967). "Fatty acid biosynthesis and the role of the acyl 
carrier protein." Adv Lipid Res 5: 1-33. 
 
Manning, V. A., A. L. Chu, et al. (2009). "A host-selective toxin of Pyrenophora tritici-
repentis, Ptr ToxA, induces photosystem changes and reactive oxygen species 
accumulation in sensitive wheat." Molecular plant-microbe interactions : MPMI 22(6): 665-
676. 
 
Manning, V. A. and L. M. Ciuffetti (2005). "Localization of Ptr ToxA produced by 
Pyrenophora tritici-repentis reveals protein import into wheat mesophyll cells." Plant Cell 
17(11): 3203-3212. 
 
Manning, V. A., L. K. Hardison, et al. (2007). "Ptr ToxA interacts with a chloroplast-
localized protein." Molecular Plant-Microbe Interactions 20(2): 168-177. 
 
 193 
 
March, R. E. (2000). "Quadrupole ion trap mass spectrometry: a view at the turn of the 
century." International journal of mass spectrometry 200(1-3): 285-312. 
 
Marre, E. (1979). "Fusicoccin: A Tool in Plant Physiology." Annual Review of Plant 
Physiology 30(1): 273-288. 
 
Martín, J. F., J. Casqueiro, et al. (2005). "Secretion systems for secondary metabolites: 
how producer cells send out messages of intercellular communication." Current opinion in 
microbiology 8(3): 282-293. 
 
Mas, S., S. G. Villas-Bo?as, et al. (2007). "A comparison of direct infusion MS and GC-
MS for metabolic footprinting of yeast mutants." Biotechnology and Bioengineering 96(5): 
1014-1022. 
 
Matossian, M. K. (1982). "Ergot and the Salem witchcraft affair." American Scientist 
70(4): 355-357. 
 
McLaughlin, C. S. (1977). "Inhibition of protein synthesis by trichothecenes." Mycotoxin in 
Human and Animal Health: 263-273. 
 
Meehan, F. (1946). "A new Helminthosporium blight of oats." Science (New York, N.Y.) 
104(2705): 413-414. 
 
Meehan, F. (1947). "Differential phytotoxicity of metabolic by-products of 
helminthosporium vtctoriae." Science (New York, N.Y.) 106(2751): 270-271. 
 
Meiss, E., H. Konno, et al. (2008). "Molecular processes of inhibition and stimulation of 
ATP synthase caused by the phytotoxin tentoxin." Journal of Biological Chemistry 
283(36): 24594-24599. 
 
Mendgen, K. and M. Hahn (2002). "Plant infection and the establishment of fungal 
biotrophy." Trends in Plant Science 7(8): 352-356. 
 
Merrill Jr, A. H., M. C. Sullards, et al. (2001). "Sphingolipid metabolism: Roles in signal 
transduction and disruption by fumonisins." Environmental Health Perspectives 
109(SUPPL. 2): 283-289. 
 
Merrill Jr, A. H., E. Wang, et al. (1993). "Fumonisins and other inhibitors of de novo 
sphingolipid biosynthesis." Advances in lipid research 26: 215-234. 
 
 194 
 
Meyer, V. (2004). Practical high-performance liquid chromatography, John Wiley. 
 
Miethke, M. and M. A. Marahiel (2007). "Siderophore-Based Iron Acquisition and 
Pathogen Control." Microbiol. Mol. Biol. Rev. 71(3): 413-451. 
 
Miller, J. D. (2008). "Mycotoxins in small grains and maize: Old problems, new 
challenges." Food Additives & Contaminants: Part A 25(2): 219-230. 
 
Milton, W. (1989). "Moulds in Folk Medicine." Folklore 100(2): 162-166. 
 
Misiek, M. and D. Hoffmeister (2007). "Fungal genetics, genomics, and secondary 
metabolites in pharmaceutical sciences." Planta Medica 73(2): 103-115. 
 
Möbius, N. and C. Hertweck (2009). "Fungal phytotoxins as mediators of virulence." 
Current Opinion in Plant Biology 12(4): 390-398. 
 
Murray, G. M. (2009). "Estimating disease losses to the Australian wheat industry." 
Australasian Plant Pathology 38(6): 558-570. 
 
Muthomi, J. (2008). "The occurrence of Fusarium species and mycotoxins in Kenyan 
wheat." Crop protection 27(8): 1215-1219. 
 
Navarre, D. A. and T. J. Wolpert (1999). "Victorin induction of an apoptotic/senescence-
like response in oats." Plant Cell 11(2): 237-249. 
 
Nesbitt, B. F., J. O'Kelly, et al. (1962). "Aspergillus flavus and Turkey X disease: Toxic 
metabolites of Aspergillus flavus." Nature 195(4846): 1062-1063. 
 
Newman, D. J. (2007). "Natural Products as Sources of New Drugs over the Last 25 
Years." Journal of natural products (Washington, D.C.) 70(3): 461-477. 
 
Nicholson, J. K., J. Connelly, et al. (2002). "Metabonomics: A platform for studying drug 
toxicity and gene function." Nature Reviews Drug Discovery 1(2): 153-161. 
 
Nielsen, K. F. and J. Smedsgaard (2003). "Fungal metabolite screening: Database of 474 
mycotoxins and fungal metabolites for dereplication by standardised liquid 
chromatography-UV-mass spectrometry methodology." Journal of Chromatography A 
1002(1-2): 111-136. 
 
 195 
 
Nishiuchi, T., D. Masuda, et al. (2006). "Fusarium phytotoxin trichothecenes have an 
elicitor-like activity in Arabidopsis thaliana, but the activity differed significantly among 
their molecular species." Molecular Plant-Microbe Interactions 19(5): 512-520. 
 
Oliver, R. P. and S. V. S. Ipcho (2004). "Arabidopsis pathology breathes new life into the 
necrotrophs-vs.-biotrophs classification of fungal pathogens." Molecular Plant Pathology 
5(4): 347-352. 
 
Oliver, R. P. and P. S. Solomon (2008). "Recent fungal diseases of crop plants: Is lateral 
gene transfer a common theme?" Molecular Plant-Microbe Interactions 21(3): 287-293. 
 
Osbourn, A. (2010). "Secondary metabolic gene clusters: evolutionary toolkits for 
chemical innovation." Trends Genet 26(10): 449-457. 
 
Pacin, A. M., E. V. Ciancio Bovier, et al. (2008). "Survey of Argentinean human plasma 
for ochratoxin A." Food Additives and Contaminants - Part A Chemistry, Analysis, 
Control, Exposure and Risk Assessment 25(5): 635-641. 
 
Paterson, R. R. M. (2010). "How will climate change affect mycotoxins in food?" Food 
research international 43(7): 1902-1914. 
 
Payne, G. A. and M. P. Brown (1998). "Genetics and physiology of aflatoxin 
biosynthesis." Annual Review of Phytopathology 36: 329-362. 
 
Peintner, U., R. Pöder, et al. (1998). "The Iceman's fungi." Mycological Research 
102(10): 1153-1162. 
 
Perfect, S. E. and J. R. Green (2001). "Infection structures of biotrophic and 
hemibiotrophic fungal plant pathogens." Molecular Plant Pathology 2(2): 101-108. 
 
Pichersky, E. (2006). "Plant volatiles: a lack of function or a lack of knowledge?" Trends 
in plant science 11(9): 421-421. 
 
Pirt, S. J. (1966). "A theory of the mode of growth of fungi in the form of pellets in 
submerged culture." Proceedings of the Royal Society. B, Biological sciences 166(4): 
369-373. 
 
Pramanik, B. N., A. K. Ganguly, et al. (2002). Applied electrospray mass spectrometry, 
Marcel Dekker. 
 
 196 
 
Puel, O., S. Tadrist, et al. (2007). "The inability of Byssochlamys fulva to produce patulin 
is related to absence of 6-methylsalicylic acid synthase and isoepoxydon dehydrogenase 
genes." International Journal of Food Microbiology 115(2): 131-139. 
 
Rajeevan, M. S., S. D. Vernon, et al. (2001). "Validation of Array-Based Gene Expression 
Profiles by Real-Time (Kinetic) RT-PCR." The Journal of Molecular Diagnostics 3(1): 26-
31. 
 
Reinsch, M., A. Töpfer, et al. (2005). "Determination of ochratoxin A in wine by liquid 
chromatography tandem mass spectrometry after combined anion-exchange/reversed-
phase clean-up." Analytical and Bioanalytical Chemistry 381(8): 1592-1595. 
 
Rhoads, D. M., C. S. Levings, et al. (1995). "URF13, a ligand-gated, pore-forming 
receptor for T-toxin in the inner membrane of&lt;i&gt;cms-T&lt;/i&gt; mitochondria." 
Journal of Bioenergetics and Biomembranes 27(4): 437-445. 
 
Ringot, D. (2006). "Toxicokinetics and toxicodynamics of ochratoxin A, an update." 
Chemico-biological interactions 159(1): 18-46. 
 
Rittenberg, D. and K. Bloch (1945). "THE UTILIZATION OF ACETIC ACID FOR THE 
SYNTHESIS OF FATTY ACIDS." Journal of Biological Chemistry 160(2): 417-424. 
 
Rob, C. G. (1990). "Use of penicillin for venereal disease in World War II." Sexually 
transmitted diseases 17(3): 156-157. 
 
Rodríguez Porcel, E. M. (2005). "Effects of pellet morphology on broth rheology in 
fermentations of Aspergillus terreus." Biochemical engineering journal 26(2-3): 139-144. 
 
Rohlfs, M., M. Albert, et al. (2007). "Secondary chemicals protect mould from fungivory." 
Biology letters 3(5): 523-525. 
 
Rouxel, T. (2011). "Effector diversification within compartments of the Leptosphaeria 
maculans genome affected by Repeat-Induced Point mutations." Nature communications 
2(1): 202. 
 
Ruiz, B., A. ChÃ¡vez, et al. (2010). "Production of microbial secondary metabolites: 
Regulation by the carbon source." Critical Reviews in Microbiology 36(2): 146-167. 
 
Sachs, J. (1882). Vorlesungen Über Pflanzen-Physiologie. 
 
 197 
 
Sargeant, K., A. N. N. Sheridan, et al. (1961). "Toxicity associated with Certain Samples 
of Groundnuts." Nature 192(4807): 1096-1097. 
 
Schardl, C. L., D. G. Panaccione, et al. (2006). Chapter 2 Ergot Alkaloids - Biology and 
Molecular Biology. Alkaloids: Chemistry and Biology. G. A. Cordell. 63: 45-86. 
 
Schimmel, T. G. (1998). "Effect of butyrolactone I on the producing fungus, Aspergillus 
terreus." Applied and environmental microbiology 64(10): 3707-3712. 
 
Schlegel, B. (2000). "Piptamine, a new antibiotic produced by Piptoporus betulinus Lu 9-
1." Journal of Antibiotics 53(9): 973-974. 
 
Schmitt, I. and H. T. Lumbsch (2009). "Ancient Horizontal Gene Transfer from Bacteria 
Enhances Biosynthetic Capabilities of Fungi." PLoS ONE 4(2): e4437. 
 
Schuman, S. H. (2003). "Plant Chemicals." Journal of Agromedicine 9(1): 17-21. 
 
Serwe, A., T. Anke, et al. (2009). "The fungal secondary metabolite trichodimerol inhibits 
TGF-Î² dependent cellular effects and tube formation of MDA-MB-231 cells." 
Investigational New Drugs 27(6): 491-502. 
 
Shah, D. A. (2000). "Differential seed infection of wheat cultivars by Stagonospora 
nodorum." Plant disease 84(7): 749-752. 
 
Shah, D. A. (2001). "Foci of stagonospora nodorum blotch in winter wheat before canopy 
development." Phytopathology 91(7): 642-647. 
 
Shah, D. A. and G. C. Bergstrom (2002). "A Rainfall-Based Model for Predicting the 
Regional Incidence of Wheat Seed Infection by Stagonospora nodorum in New York." 
Phytopathology 92(5): 511-518. 
 
Shigematsu, N. (1997). "Dereplication of natural products using LC/MS." J Mass 
Spectrom Soc Jpn 45: 295-300. 
 
Shimizu, K. (1997). "Cloning of Brn1, a reductase gene involved in melanin biosynthesis 
in Cochliobolus heterostrophus." Journal of general and applied microbiology 43(3): 145-
150. 
 
 198 
 
Shwab, E. K. and N. P. Keller (2008). "Regulation of secondary metabolite production in 
filamentous ascomycetes." Mycological Research 112(2): 225-230. 
 
Sipos, P., H. Gyõry, et al. (2004). "Special wound healing methods used in ancient Egypt 
and the mythological background." World Journal of Surgery 28(2): 211-216. 
 
Slot, J. C. and A. Rokas (2011). "Horizontal transfer of a large and highly toxic secondary 
metabolic gene cluster between fungi." Current Biology 21(2): 134-139. 
 
Smedsgaard, J. (1997). "Micro-scale extraction procedure for standardization screening 
of fungal metabolite production in cultures." Journal of Chromatography A 760(2): 264-
270. 
 
Smedsgaard, J. (1997). "Micro-scale extraction procedure for standardized screening of 
fungal metabolite production in cultures." Journal of Chromatography A 760(2): 264-270. 
 
Smedsgaard, J. and J. C. Frisvad (1996). "Using direct electrospray mass spectrometry 
in taxonomy and secondary metabolite profiling of crude fungal extracts." Journal of 
Microbiological Methods 25(1): 5-17. 
 
Solomon, P. S. (2006a). "Mannitol is required for asexual sporulation in the wheat 
pathogen Stagonospora nodorum (glume blotch)." Biochemical journal 399(2): 231-239. 
 
Solomon, P. S. (2006b). "Stagonospora nodorum: cause of stagonospora nodorum blotch 
of wheat." Molecular Plant Pathology 7(3): 147-156. 
 
Solomon, P. S., S. V. S. Ipcho, et al. (2008). "A quantitative PCR approach to determine 
gene copy number." Fungal Genetics Reports 55: 5-8. 
 
Solomon, P. S., K. Rybak, et al. (2006a). "Investigating the role of calcium/calmodulin-
dependent protein kinases in Stagonospora nodorum." Molecular Microbiology 62(2): 
367-381. 
 
Solomon, P. S., K. C. Tan, et al. (2004). "The disruption of a Gα subunit sheds new light 
on the pathogenicity of Stagonospora nodorum on wheat." Molecular Plant-Microbe 
Interactions 17(5): 456-466. 
 
Solomon, P. S., O. D. C. Waters, et al. (2006b). "Mannitol is required for asexual 
sporulation in the wheat pathogen Stagonospora nodorum (glume blotch)." Biochemical 
Journal 399(2): 231-239. 
 
 199 
 
Solomon, P. S., O. D. C. Waters, et al. (2005). "The Mak2 MAP kinase signal 
transduction pathway is required for pathogenicity in Stagonospora nodorum." Current 
Genetics 48(1): 60-68. 
 
Solomon, P. S., T. Wilson, et al. (2006c). "Structural Characterisation of the Interaction 
between &lt;i&gt;Triticum aestivum&lt;/i&gt; and the Dothideomycete Pathogen 
&lt;i&gt;Stagonospora nodorum&lt;/i&gt." European Journal of Plant Pathology 114(3): 
275-282. 
 
Sommerhalder, R. J. (2011). "Effect of hosts on competition among clones and evidence 
of differential selection between pathogenic and saprophytic phases in experimental 
populations of the wheat pathogen Phaeosphaeria nodorum." BMC evolutionary biology 
11(1): 188. 
 
Squire, R. A. (1981). "Ranking animal carcinogens: A proposed regulatory approach." 
Science 214(4523): 877-880. 
 
Staunton, J. and K. J. Weissman (2001). "Polyketide biosynthesis: A millennium review." 
Natural Product Reports 18(4): 380-416. 
 
Stierle, A., R. Upadhyay, et al. (1991). "Cyperine, a phytotoxin produced by Ascochyta 
cypericola, a fungal pathogen of Cyperus rotundus." Phytochemistry 30(7): 2191-2192. 
 
Storm, I. D., P. H. Rasmussen, et al. (2008). "Ergot alkaloids in rye flour determined by 
solid-phase cation-exchange and high-pressure liquid chromatography with fluorescence 
detection." Food Additives and Contaminants - Part A Chemistry, Analysis, Control, 
Exposure and Risk Assessment 25(3): 338-346. 
 
Strauss, J. and Y. Reyes-Dominguez (2011). "Regulation of secondary metabolism by 
chromatin structure and epigenetic codes." Fungal Genetics and Biology 48(1): 62-69. 
 
Sze, H., X. Li, et al. (1999). "Energization of Plant Cell Membranes by H+-Pumping 
ATPases: Regulation and Biosynthesis." The Plant Cell Online 11(4): 677-690. 
 
Tada, Y., K. Kusaka, et al. (2005). "Victorin triggers programmed cell death and the 
defense response via interaction with a cell surface mediator." Plant and Cell Physiology 
46(11): 1787-1798. 
 
Takano, Y., T. Kikuchi, et al. (2000). "The Colletotrichum lagenarium MAP kinase gene 
CMK1 regulates diverse aspects of fungal pathogenesis." Mol Plant Microbe Interact 
13(4): 374-383. 
 
 200 
 
Tan, K. C., J. L. Heazlewood, et al. (2008). "A signaling-regulated, short-chain 
dehydrogenase of Stagonospora nodorum regulates asexual development." Eukaryotic 
Cell 7(11): 1916-1929. 
 
Tan, K. C., R. D. Trengove, et al. (2009). "Metabolite profiling identifies the mycotoxin 
alternariol in the pathogen Stagonospora nodorum." Metabolomics 5(3): 330-335. 
 
Theodoridis, G., H. G. Gika, et al. (2008). "LC-MS-based methodology for global 
metabolite profiling in metabonomics/metabolomics." TrAC - Trends in Analytical 
Chemistry 27(3): 251-260. 
 
Theodoridis, G. A., H. G. Gika, et al. (2012). "Liquid chromatography-mass spectrometry 
based global metabolite profiling: A review." Analytica Chimica Acta 711: 7-16. 
 
Thomas, H. (2007). "From waste products to ecochemicals: Fifty years research of plant 
secondary metabolism." Phytochemistry 68(22-24): 2831-2846. 
 
Tsuji, G., Y. Kenmochi, et al. (2000). "Novel fungal transcriptional activators, Cmr1p of 
Colletotrichum lagenarium and Pig1p of Magnaporthe grisea, contain Cys2His2 zinc 
finger and Zn(II)2Cys6 binuclear cluster DNA-binding motifs and regulate transcription of 
melanin biosynthesis genes in a developmentally specific manner." Molecular 
Microbiology 38(5): 940-954. 
 
Turgeon, B. G. and S. E. Baker (2007). Genetic and Genomic Dissection of the 
Cochliobolus heterostrophus Tox1 Locus Controlling Biosynthesis of the Polyketide 
Virulence Factor T-toxin. J. C. Dunlap. 57: 219-261. 
 
Urban, M., E. Mott, et al. (2003). "The Fusarium graminearum MAP1 gene is essential for 
pathogenicity and development of perithecia." Molecular Plant Pathology 4(5): 347-359. 
 
Urraca, J. L., M. D. Marazuela, et al. (2006). "Molecularly imprinted polymers with a 
streamlined mimic for zearalenone analysis." Journal of Chromatography A 1116(1-2): 
127-134. 
 
van Dongen, P. W. J. and A. N. J. A. de Groot (1995). "History of ergot alkaloids from 
ergotism to ergometrine." European Journal of Obstetrics & Gynecology and 
Reproductive Biology 60(2): 109-116. 
 
Varelis, P., S. L. L. Leong, et al. (2006). "Quantitative analysis of ochratoxin A in wine and 
beer using solid phase extraction and high performance liquid chromatography-
fluorescence detection." Food Additives and Contaminants 23(12): 1308-1315. 
 
 201 
 
Vatinno, R., A. Aresta, et al. (2008). "Determination of Ochratoxin A in green coffee 
beans by solid-phase microextraction and liquid chromatography with fluorescence 
detection." Journal of Chromatography A 1187(1-2): 145-150. 
 
Venkatasubbaiah, P., C. G. Van Dyke, et al. (1992). "Phytotoxic metabolites of Phoma 
sorghina, a new foliar pathogen of pokeweed." Mycologia 84: 715-723. 
 
Wang, Y., T. Chai, et al. (2008). "Simultaneous detection of airborne Aflatoxin, Ochratoxin 
and Zearalenone in a poultry house by immunoaffinity clean-up and high-performance 
liquid chromatography." Environmental Research 107(2): 139-144. 
 
Wangun, H. V. K. (2004). "Anti-inflammatory and anti-hyaluronate lyase activities of 
lanostanoids from Piptoporus betulinus." Journal of Antibiotics 57(11): 755-758. 
 
Waters, O. D. C. (2011). "Prevalence and importance of sensitivity to the Stagonospora 
nodorum necrotrophic effector SnTox3 in current Western Australian wheat cultivars." 
Crop and pasture science 62(7): 556-562. 
 
Weber, H. A. and J. B. Gloer (1988). "Interference competition among natural fungal 
competitors: An antifungal metabolite from the coprophilous fungus Preussia fleischhakii." 
Journal of Natural Products 51(5): 879-883. 
 
Wiese, M. V. (1987). Compendium of Wheat Diseases. St. Paul, MN, APS Press. 
 
Wiesemüller, W. (2005). "Present and historical significance of ergot." Aktuelle und 
historische bedeutung won mutterkorn 52(4): 146-148+126. 
 
Williams, L. D., A. E. Glenn, et al. (2007). "Fumonisin disruption of ceramide biosynthesis 
in maize roots and the effects on plant development and Fusarium verticillioides-induced 
seedling disease." Journal of Agricultural and Food Chemistry 55(8): 2937-2946. 
 
Wilson, C. O., J. M. Beale, et al. (2010). Wilson and Gisvold's Textbook of Organic 
Medicinal and Pharmaceutical Chemistry, Lippincott Williams & Wilkins. 
 
Wilson, I. D., J. K. Nicholson, et al. (2005). "High resolution "ultra performance" liquid 
chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic 
pathway profiling in functional genomic studies." Journal of Proteome Research 4(2): 
591-598. 
 
Wishart, D. S. (2008). "Quantitative metabolomics using NMR." TrAC - Trends in 
Analytical Chemistry 27(3): 228-237. 
 202 
 
 
Wolf, J. C. and C. J. Mirocha (1977). "Control of sexual reproduction in Gibberella zeae 
(Fusarium roseum 'graminearum')." Applied and Environmental Microbiology 33(3): 546-
550. 
 
Wolpert, T. J., L. D. Dunkle, et al. (2002). "Host-selective toxins and avirulence 
determinants: What's in a name?" Annual Review of Phytopathology 40: 251-285. 
 
Wolpert, T. J., V. Macko, et al. (1985). "Structure of victorin C, the major host-selective 
toxin from Cochliobolus victoriae." Experientia 41(12): 1524-1529. 
 
Wolpert, T. J., D. A. Navarre, et al. (1994a). "Identification of the 100-kD victorin binding 
protein from oats." Plant Cell 6(8): 1145-1155. 
 
Wolpert, T. J., D. A. Navarre, et al. (1994b). "Identification of the 100-kD Victorin Binding 
Protein from Oats." The Plant Cell Online 6(8): 1145-1155. 
 
Wood, V. (2002). "The genome sequence of Schizosaccharomyces pombe." Nature 
(London) 415(6874): 871-880. 
 
Xu, J. R. (2000). "MAP kinases in fungal pathogens." Fungal Genetics and Biology 31(3): 
137-152. 
 
Yadav, G., R. S. Gokhale, et al. (2009). "Towards Prediction of Metabolic Products of 
Polyketide Synthases: An <italic>In Silico</italic> Analysis." PLoS Comput Biol 5(4): 
e1000351. 
 
Yamazaki, S. and T. Ogawa (1972). "The chemistry and stereochemistry of cercosporin." 
Agric. Biol. Chem. 36: 1707-1718. 
 
Yamazaki, S., A. Okube, et al. (1975). "Cercosporin, a novel photodynamic pigment 
isolated from Cercospora kikuchii." Agric. Biol. Chem. 39: 287-288. 
 
Yoshimura, I., Y. Kinoshita, et al. (1994). "Analysis of secondary metabolites from lichen 
by high performance liquid chromatography with a photodiode array detector." 
Phytochemical Analysis 5(4): 197-205. 
 
Yu, J. H. and N. Keller (2005). Regulation of secondary metabolism in filamentous fungi. 
Annual Review of Phytopathology. 43: 437-458. 
 203 
 
 
Zhang, B., G. Salituro, et al. (1999). "Discovery of a small molecule insulin mimetic with 
antidiabetic activity in mice." Science 284(5416): 974-977. 
 
Zhang, Y., J. R. Yeh, et al. (2006). "A Chemical and Genetic Approach to the Mode of 
Action of Fumagillin." Chemistry and Biology 13(9): 1001-1009. 
 
Zhang, Y. Q., H. Wilkinson, et al. (2004). "Secondary metabolite gene clusters." 
Handbook of Industrial Microbiology: 355-386. 
 
Zhao, X., R. Mehrabi, et al. (2007). "Mitogen-activated protein kinase pathways and 
fungal pathogenesis." Eukaryotic Cell 6(10): 1701-1714. 
 
Zohary, D. and M. Hopf (2000). Domestication of Plants in the Old World: Th Origin and 
Spread of Cultivated Plants in West Asia, Europe, and the Nile Valley. Oxford, Oxford 
University Press. 
 
 
 
  
 204 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 Appendices 
  
2
0
5
 
 
 
 
 
 
Appendix I Orthologs of the S. nodorum PKSs (following pages) 
Orthologs of S. nodorum PKS were retrieved using the KS sequence as blastp query against the NCBI NR protein database. For each S. nodorum PKS and 
putative ortholog, gene name, gene number, accession (NCBI Protein database), and blast score are given. Clades for S. nodorum PKSs were determined 
based on the system proposed by Kroken (2003). For the putative orthologs, organism, function (evidence level: 1: functionally characterised by KO, 2 in 
depth computational analysis or published genome, 3 unpublished genome sequence) and reciprocal blast hit in S. nodorum for KS, AT and ACP domain are 
given. Dothideomycetes are highlighted blue, matching domain organisation are highlighted yellow and reciprocal hits for KS, AT or ACP domains are 
highlighted green 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_00308 NPH1 XP_001790998.1 KS-AT-DH-MT-ACP-Cond-ACP-TE hybrid PKS-NRPS 828 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
MGG_12451 Magnaporthe oryzae 70-15 XP_001412433.1 - 
ACLA_078660 Aspergillus clavatus NRRL 1 XP_001270543.1 - 
ACE1/syn2 Magnaporthe grisea Guy11 CAG28798.1 putative polyketide synthase/peptide synthetase (1) 
Pc14g00080 Penicillium chrysogenum Wisconsin 54-1255 XP_002560003.1 - 
MAA_00428 Metarhizium anisopliae ARSEF 23 EFZ03354.1 - 
PTT_20032 Pyrenophora teres f. teres 0-1 XP_003306795.1 - 
PKS16 Cochliobolus heterostrophus AAR90270.1 - 
PTRG_04244 Pyrenophora tritici-repentis Pt-1C-BFP XP_001934577.1 lovastatin nonaketide synthase (3) 
PKS10 Mycosphaerella graminicola IPO323 EGP91889.1 - 
LEMA_P000820.1 Leptosphaeria maculans CBY01295.1 - 
 
putative orthologs (continued) 
    
gene number domain organisation score KS (% of SNOG) KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
MGG_12451 KS-AT 593 (71.6%) SNOG_00308 SNOG_00308 #N/A 
ACLA_078660 KS-AT-DH-MT-KR-ACP-Cond-EntF-ACP-Epi 607 (73.3%) SNOG_00308 SNOG_00308 SNOG_00308 
ACE1/syn2 KS-AT-DH-MT-ACP-Cond-alpha_am_amid 592 (71.5%) SNOG_00308 SNOG_00308 SNOG_00308 
Pc14g00080 KS-AT-DH-MT-KR-ACP-Cond-Lux-ACP-KR 592 (71.5%) SNOG_00308 SNOG_00308 SNOG_00308 
MAA_00428 KS-AT-DH-MT-KR-ACP-Cond 563 (68%) SNOG_00308 SNOG_00308 SNOG_00308 
PTT_20032 KS-AT-DH-MT-KR-ACP 501 (60.5%) SNOG_07866 SNOG_07866 SNOG_07866 
PKS16 KS-AT-DH-MT 493 (59.5%) SNOG_07866 SNOG_07866 #N/A 
PTRG_04244 KS-AT-DH-MT-ACP-Cond-ACP 489 (59.1%) SNOG_00308 SNOG_00308 #N/A 
PKS10 KS-AT-DH-MT-ACP 478 (57.7%) SNOG_07866 SNOG_07866 SNOG_07866 
LEMA_P000820.1 KS-AT-DH-MT-ACP 443 (53.5%) SNOG_07866 SNOG_00308 #N/A 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_00477 SMS1 XP_001791162.1 KS-AT-KR-ACP fungal 6-MSAS 817 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
ATEG_06275 Aspergillus terreus NIH2624] XP_001215453.1 6-methylsalicylic acid synthase (3) 
ACLA_093660 Aspergillus clavatus NRRL 1 XP_001273093.1 6-methylsalicylic acid synthase (3) 
Bnpks Byssochlamys nivea AAK48943.1 6-methylsalicylic acid synthase (1) 
AFLA_114820 Aspergillus flavus NRRL3357 XP_002385535.1 - 
otapksPN Penicillium nordicum AAP33839.2 ochratoxin A polyketide synthase (1) 
PKS25 Cochliobolus heterostrophus AAR90279.1 - 
PTRG_09108 Pyrenophora tritici-repentis Pt-1C-BFP XP_001939440.1 lovastatin nonaketide synthase (3) 
PTT_17304 Pyrenophora teres f. teres 0-1 XP_003304655.1 - 
PKS6 Mycosphaerella graminicola IPO323 EGP90777.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
ATEG_06275 KS-AT-DH-KR-ACP 608 SNOG_00477 SNOG_00477 SNOG_00477 
ACLA_093660 KS-AT-DH-KR-ACP 578 SNOG_00477 SNOG_00477 SNOG_00477 
Bnpks KS-AT-DH-KR-ACP 574 SNOG_00477 SNOG_00477 SNOG_00477 
AFLA_114820 KS-AT-KR-ACP 553 SNOG_00477 SNOG_00477 SNOG_00477 
otapksPN KS-AT 536 SNOG_00477 SNOG_00477 #N/A 
PKS25 KS-AT-KR-ACP 475 SNOG_00477 SNOG_00477 SNOG_11981 
PTRG_09108 KS-AT-MT-ER-KR-ACP 296 SNOG_04868 SNOG_12897 SNOG_05791 
PTT_17304 KS-AT-DH-MT-ER-KR-ACP 295 SNOG_07866 SNOG_12897 SNOG_05791 
PKS6 KS-AT-DH-MT-ER-KR-ACP 294 SNOG_07866 SNOG_12897 SNOG_05791 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 294 SNOG_07866 SNOG_07866 SNOG_05791 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_02561 PKS4 XP_001793165.1 KS-AT-DH-MT-ER-KR-ACP reducing clade I 458 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
LEMA_P087730.1 Leptosphaeria maculans CBX99534.1 - 
PTRG_12149 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942484.1 lovastatin nonaketide synthase (3) 
MYCTH_108318 Myceliophthora thermophila ATCC 42464 AEO58697.1 - 
Pc21g03930 Penicillium chrysogenum Wisconsin 54-1255 XP_002567442.1 - 
THITE_125678 Thielavia terrestris NRRL 8126 AEO67408.1 - 
SMAC_01188 Sordaria macrospora k-hell XP_003350293.1 - 
MYCTH_115501 Myceliophthora thermophila ATCC 42464 AEO58293.1 - 
PKS3 Cochliobolus heterostrophus AAR90258.1 - 
PKS4 Mycosphaerella graminicola IPO323 EGP86977.1 - 
PTT_10611 Pyrenophora teres f. teres 0-1 XP_003299581.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
LEMA_P087730.1 KS-AT-DH-MT-ER-ACP 284 SNOG_00308 SNOG_02561 SNOG_02561 
PTRG_12149 KS-AT-DH-MT-ER-KR-ACP 283 SNOG_00308 SNOG_02561 SNOG_02561 
MYCTH_108318 KS-ATDH-MT-KR-ACP 273 SNOG_07866 SNOG_02561 SNOG_05791 
Pc21g03930 KS-AT-DH-MT-ER-KR-ACP 268 SNOG_07866 SNOG_02561 SNOG_02561 
THITE_125678 KS-AT-DH-MT-ER-KR-ACP 262 SNOG_07866 SNOG_02561 SNOG_05791 
SMAC_01188 KS-AT-DH-MT-ER-KR-ACP 259 SNOG_07866 SNOG_02561 SNOG_02561 
MYCTH_115501 KS-AT-DH-ER-KR-ACP 254 SNOG_07866 SNOG_02561 SNOG_05791 
PKS3 KS-AT-DH-MT-ER-KR-ACP 226 SNOG_00308 SNOG_02561 SNOG_05791 
PKS4 (Est?-)KS-AT-DH-ER-KR-ACP 211 SNOG_07866 SNOG_12897 SNOG_05791 
PTT_10611 KS-AT-DH-MT-ER-KR-ACP 230 SNOG_07866 SNOG_02561 SNOG_05791 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_04868 PKS5 XP_001795280.1 KS-AT-DH-MT-ER-KR-ACP reducing clade I 854 
 
putative orthologs 
   
gene number blast hit organism NCBI acc (protein) inferred function 
LEMA_P002660.1 Leptosphaeria maculans CBY01479.1 - 
PTT_16988 Pyrenophora teres f. teres 0-1 XP_003304402.1 - 
MAC_05893 Metarhizium acridum CQMa 102 EFY88029.1 - 
Pc21g03930 Penicillium chrysogenum Wisconsin 54-1255 XP_002567442.1 - 
THITE_125678 Thielavia terrestris NRRL 8126 AEO67408.1 - 
SMAC_01188 Sordaria macrospora k-hell XP_003350293.1 - 
MYCTH_115501 Myceliophthora thermophila ATCC 42464 AEO58293.1 - 
PKS6 Cochliobolus heterostrophus AAR90261.1 - 
PTRG_04144 Pyrenophora tritici-repentis Pt-1C-BFP XP_001934477.1 mycocerosic acid synthase (3) 
PKS3 Mycosphaerella graminicola IPO323 EGP87759.1 - 
 
putative orthologs (continued) 
     
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
LEMA_P002660.1 KS-AT-DH-MT-ER-KR-ACP 820 SNOG_04868 SNOG_04868 SNOG_04868 
PTT_16988 KS-AT-DH-MT-ER-ACP 810 SNOG_04868 SNOG_04868 SNOG_04868 
MAC_05893 KS-AT-DH-MT-ER-KR-ACP 635 SNOG_04868 SNOG_04868 SNOG_04868 
Pc21g03930 KS-AT-DH-MT-ER-KR-ACP 268 SNOG_07866 SNOG_02561 SNOG_02561 
THITE_125678 KS-AT-DH-MT-ER-KR-ACP 262 SNOG_07866 SNOG_02561 SNOG_05791 
SMAC_01188 KS-AT-DH-MT-ER-KR-ACP 259 SNOG_07866 SNOG_02561 SNOG_02561 
MYCTH_115501 KS-AT-DH-ER-KR-ACP 259 SNOG_07866 SNOG_02561 SNOG_05791 
PKS6 KS-AT-DH-MT-ER-KR 316 SNOG_07866 SNOG_05791 #N/A 
PTRG_04144 KS-AT-DH-MT-ER-KR-ACP 322 SNOG_07866 SNOG_05791 SNOG_05791 
PKS3 KS-AT-DH-ER-KR-ACP 317 SNOG_04868 SNOG_05791 SNOG_11066 
  
  
2
1
0
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_05791 PKS1 XP_001796187.1 KS-AT-DH-MT-ER-KR-ACP reducing clade I 256 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
PTT_18319 Pyrenophora teres f. teres 0-1 XP_003305466.1 - 
PTRG_04144 Pyrenophora tritici-repentis Pt-1C-BFP XP_001934477.1 mycocerosic acid synthase (3) 
PKS6 Cochliobolus heterostrophus AAR90261.1 - 
alt5 Alternaria solani BAD83684.1 PKSN - alternapyrone biosynthesis (1) 
GLRG_10317 Glomerella graminicola M1.001 EFQ35173.1 - 
MGG_13596 Magnaporthe oryzae 70-15] XP_001408070.1 - 
0 Phomopsis sp. BCC9451 ACN43294.1 - 
FOXB_11464 Fusarium oxysporum Fo5176 EGU78036.1 - 
HPS1 Mycosphaerella graminicola IPO323 EGP84154.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
PTT_18319 KS-AT-DH-MT-ER-KR-ACP 235 SNOG_07866 SNOG_05791 SNOG_05791 
PTRG_04144 KS-AT-DH-MT-ER-KR-ACP 235 SNOG_07866 SNOG_05791 SNOG_05791 
PKS6 KS-AT-DH-MT-ER-KR 232 SNOG_07866 SNOG_05791 #N/A 
alt5 KS-AT-DH-MT-ER-KR-ACP 231 SNOG_07866 SNOG_05791 SNOG_05791 
GLRG_10317 KS-AT-DH-MT-ER-KR-ACP 222 SNOG_07866 SNOG_08274 SNOG_05791 
MGG_13596 KS 213 SNOG_07866 #N/A #N/A 
0 KS 156 SNOG_05791 #N/A #N/A 
FOXB_11464 KS-AT-DH-MT-DH? 162 SNOG_07866 SNOG_07866 #N/A 
HPS1 KS-AT-DH-MT-KR-ACP-Cond-EntF 149 SNOG_07866 SNOG_00308 SNOG_00308 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 133 SNOG_07866 SNOG_07866 SNOG_05791 
  
  
2
1
1
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_06676 PKS6 XP_001797038.1 KS-AT-DH-ER-KR (ACP in SNOG_06677) reducing clade IV 205 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
AbPKS9/DEP5 Alternaria brassicicola ACZ57548.1 Synthesis of depudecin (1) 
FOXB_12865 Fusarium oxysporum Fo5176 EGU76621.1 - 
MGYG_07327 Arthroderma gypseum CBS 118893 XP_003170083.1 lovastatin nonaketide synthase (3) 
CPC735_040320 Coccidioides posadasii C735 delta SOWgp XP_003070913.1 - 
TSTA_118920 Talaromyces stipitatus ATCC 10500 XP_002482120.1 - 
PTT_07891 Pyrenophora teres f. teres 0-1 XP_003297473.1 - 
PTRG_06803 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937136.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
PKS15 Cochliobolus heterostrophus AAR90269.1 - 
PKS4 Mycosphaerella graminicola IPO323 EGP86977.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued) (note: SNOG_06676 and 06677  
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
AbPKS9/DEP5 KS-AT-DH-ER-KR-ACP 336 SNOG_14927 SNOG_06676 SNOG_06677 
FOXB_12865 KS-AT-DH-ER-KR-ACP 309 SNOG_09490 SNOG_06676 SNOG_06677 
TSTA_118920 KS-AT-DH-ER-KR-ACP 358 SNOG_14927 SNOG_06676 SNOG_06677 
MGYG_07327 KS-AT-DH-ER-KR-ACP 350 SNOG_14927 SNOG_11272 SNOG_06677 
PKS2 KS-AT-DH-ER-KR-ACP 333 SNOG_09490 SNOG_06676 SNOG_06677 
PKS11 KS-AT-DH-MT-ER-KR-ACP 327 SNOG_14927 SNOG_11272 SNOG_05791 
PTT_09821 KS-AT-DH-MT-ER-KR-ACP 385 SNOG_07866 SNOG_04868 SNOG_05791 
PKS3 KS-AT-DH-MT-ER-KR-ACP 477 SNOG_14927 SNOG_09623 SNOG_09623 
PTRG_04244 KS-AT-DH-ER-KR-ACP 350 SNOG_07866 SNOG_12897 SNOG_05791 
LEMA_P117970.1 KS-AT-DH-MT-ER-ACP 371 SNOG_07866 SNOG_07866 SNOG_05791 
  
  
2
1
2
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_06682 PKS7 XP_001797044.1 KS-AT-MT-TE non-reducing clade III 756 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
THITE_2050784 Thielavia terrestris NRRL 8126 AEO67410.1 - 
TSTA_060720 Talaromyces stipitatus ATCC 10500 XP_002339967.1 - 
MpaC Penicillium brevicompactum ADY00130.1 mycophenolic acid biosynthesis (1) 
ATEG_10080 Aspergillus terreus NIH2624 XP_001209382.1 - 
CPC735_009980 Coccidioides posadasii C735 delta SOWgp XP_003068966.1 - 
PKS21 Cochliobolus heterostrophus AAR90275.1 - 
LEMA_P086730.1 Leptosphaeria maculans CBX99434.1 - 
PTT_10610 Pyrenophora teres f. teres 0-1 XP_003299580.1 - 
PKS9 Mycosphaerella graminicola IPO323 EGP90792.1 - 
PTRG_07420 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937752.1 6-methylsalicylic acid synthase (3) 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
THITE_2050784 KS-AT-DH-ACP-ACP-MT 490 SNOG_06682 SNOG_06682 SNOG_06682 
TSTA_060720 KS-AT-DH-ACP-ACP-MT-TE 486 SNOG_06682 SNOG_06682 SNOG_06682 
MpaC KS-AT-DH-ACP-MT-TE 460 SNOG_06682 SNOG_06682 SNOG_06682 
ATEG_10080 KS-AT-DH-ACP-MT-Est-DAP2 459 SNOG_06682 SNOG_06682 SNOG_06682 
CPC735_009980 KS-AT-ACP-TE 451 SNOG_06682 SNOG_06682 SNOG_06682 
PKS21 KS-AT-ACP-MT 320 SNOG_07020 SNOG_06682 SNOG_06682 
LEMA_P086730.1 KS-AT-ACP-MT 317 SNOG_07020 SNOG_06682 SNOG_06682 
PTT_10610 KS-AT-ACP-MT-TE 337 SNOG_07020 SNOG_06682 SNOG_08614 
PKS9 KS-AT-ACP-MT 360 SNOG_07020 SNOG_07020 SNOG_06682 
PTRG_07420 AT-KS-AT-DH-ACP-ACP-ACP-MT 313 SNOG_07020 SNOG_07020 SNOG_07020 
  
  
2
1
3
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_07020 PKS8 XP_001797375.1 KS-AT-ACP-ACP-MT-TE non-reducing clade III 882 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
PTT_13471 Pyrenophora teres f. teres 0-1 XP_003301870.1 - 
PKS23 Cochliobolus heterostrophus AAR90277.1 - 
PTRG_07420 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937752.1 6-methylsalicylic acid synthase (3) 
BC1G_10687 Botrytis cinerea XP_001550802.1 - 
TRIREDRAFT_105804 Trichoderma reesei QM6a EGR49884.1 - 
TSTA_061660 Talaromyces stipitatus ATCC 10500 XP_002340065.1 - 
PMAA_101600 Penicillium marneffei ATCC 18224 XP_002149742.1 - 
PKS2 Ascochyta fabae ACS74445.1 DHN-melanin pigment biosynthesis (1) 
PKS9 Mycosphaerella graminicola IPO323 EGP90792.1 - 
LEMA_P086730.1 Leptosphaeria maculans CBX99434.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
PTT_13471 AT-KS-AT-DH-ACP-ACP-MT-Te 794 SNOG_07020 SNOG_07020 SNOG_07020 
PKS23 KS-AT-DH-ACP-ACP-MT 748 SNOG_07020 SNOG_07020 SNOG_07020 
PTRG_07420 AT-KS-AT-DH-ACP-ACP-ACP-MT 623 SNOG_07020 SNOG_07020 SNOG_07020 
BC1G_10687 KS-AT-ACP-MT-TE 602 SNOG_07020 SNOG_07020 SNOG_07020 
TRIREDRAFT_105804 KS-AT-ACP-TE 549 SNOG_07020 SNOG_07020 SNOG_07020 
TSTA_061660 KS-AT-ACP 529 SNOG_07020 SNOG_07020 SNOG_07020 
PMAA_101600 KS-ACP 528 SNOG_07020 #N/A SNOG_07020 
PKS2 KS 437 SNOG_07020 #N/A #N/A 
PKS9 KS-AT-ACP-MT 401 SNOG_07020 SNOG_07020 SNOG_06682 
LEMA_P086730.1 KS-AT-ACP-MT 378 SNOG_07020 SNOG_06682 SNOG_06682 
  
  
2
1
4
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_07866 PKS2 XP_001798193.1 KS-AT-DH-MT-KR-ACP-TE reducing clade II 850 
 
putative orthologs 
   
gene number blast hit organism NCBI acc (protein) inferred function 
PTT_20032 Pyrenophora teres f. teres 0-1 XP_003306795.1 - 
PKS16 Cochliobolus heterostrophus AAR90270.1 - 
MYCTH_49393 Myceliophthora thermophila ATCC 42464 AEO58317.1 - 
MGG_12451 Magnaporthe oryzae 70-15 XP_001412433.1 - 
TSTA_017120 Talaromyces stipitatus ATCC 10500 XP_002483871.1 - 
PMAA_009380 Penicillium marneffei ATCC 18224 XP_002153037.1 - 
pks1 Gibberella fujikuroi CAC44633.1 - 
PKS10 Mycosphaerella graminicola IPO323 EGP91889.1 - 
PTRG_04244 Pyrenophora tritici-repentis Pt-1C-BFP XP_001934577.1 lovastatin nonaketide synthase (3) 
LEMA_P000820.1 Leptosphaeria maculans CBY01295.1 - 
 
putative orthologs (continued) 
     
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
PTT_20032 KS-AT-DH-MT-KR-ACP 775 SNOG_07866 SNOG_07866 SNOG_07866 
PKS16 KS-AT-DH-MT 738 SNOG_07866 SNOG_07866 #N/A 
MYCTH_49393 KS-AT-DH-MT-KR-AT-KR 603 SNOG_07866 SNOG_07866 SNOG_07866 
MGG_12451 KS-AT 547 SNOG_00308 SNOG_00308 #N/A 
TSTA_017120 KS-AT-DH-MT-KR-ACP-TE 577 SNOG_07866 SNOG_07866 SNOG_07866 
PMAA_009380 KS-AT-DH-MT-KR-TE 575 SNOG_07866 SNOG_07866 #N/A 
pks1 KS-AT 533 SNOG_07866 SNOG_00308 #N/A 
PKS10 KS-AT-DH-MT-ACP 562 SNOG_07866 SNOG_07866 SNOG_07866 
PTRG_04244 KS-AT-DH-MT-ACP-Cond-ACP 509 SNOG_00308 SNOG_00308 #N/A 
LEMA_P000820.1 KS-AT-DH-MT-ACP 469 SNOG_07866 SNOG_00308 #N/A 
  
  
2
1
5
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_08274 PKS9 XP_001798591.1 KS-AT-ACP-ACP-TE non-reducing clade II 910 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
MAC_00177 Metarhizium acridum CQMa 102 EFY93686.1 - 
ATEG_07500 Aspergillus terreus NIH2624 XP_001216121.1 - 
NECHADRAFT_33672 Nectria haematococca mpVI 77-13-4 XP_003045916.1 - 
TSTA_083310 Talaromyces stipitatus ATCC 10500 XP_002478062.1 - 
PMAA_063620 Penicillium marneffei ATCC 18224 XP_002145792.1 - 
LEMA_P098490.1 Leptosphaeria maculans CBX98440.1 - 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (3) 
PTT_09773 Pyrenophora teres f. teres 0-1 XP_003298917.1 - 
PKS18 Cochliobolus heterostrophus AAR90272.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
MAC_00177 AT-KS-AT-ACP-ACP-TE 709 SNOG_08274 SNOG_08274 SNOG_08274 
ATEG_07500 KS-AT-ACP-ACP-TE 702 SNOG_08274 SNOG_08274 SNOG_11981 
NECHADRAFT_33672 KS-AT-ACP-ACP-TE 704 SNOG_08274 SNOG_08274 SNOG_11981 
TSTA_083310 KS-AT-ACP-ACP-TE 694 SNOG_08274 SNOG_08274 SNOG_08274 
PMAA_063620 KS-AT-ACP-ACP-TE 686 SNOG_08274 SNOG_08274 SNOG_11981 
LEMA_P098490.1 AT-KS-AT-ACP-ACP-TE 561 SNOG_11981 SNOG_11981 SNOG_11981 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 553 SNOG_11981 SNOG_11981 SNOG_11981 
PTT_09773 KS-AT-ACP-ACP-TE 551 SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 548 SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  545 SNOG_11981 SNOG_11981 SNOG_11981 
  
  
2
1
6
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_08614 PKS10 XP_001798923.1 KS-AT-ACP-TE non-reducing clade II 911 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
CTB1 Mycosphaerella coffeicola ADO14690.1 cercosporin polyketide synthase (2) 
CTB1 Cercospora nicotianae AAT69682.1 cercosporin biosynthesis (1) 
GLRG_08620 Glomerella graminicola M1.001 EFQ33691.1 - 
pks3 Gibberella fujikuroi CAC88775.1 - 
SS1G_05681 Sclerotinia sclerotiorum 1980 XP_001592760.1 - 
PTT_20106 Pyrenophora teres f. teres 0-1 XP_003306836.1 - 
LEMA_P081920.1 Leptosphaeria maculans CBX98953.1 - 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (3) 
PKS18 Cochliobolus heterostrophus AAR90272.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
CTB1 KS-AT-ACP-ACP-TE 695 SNOG_08614 SNOG_08614 SNOG_08614 
CTB1 KS-AT-ACP-ACP-TE 694 SNOG_08614 SNOG_08614 SNOG_08614 
GLRG_08620 AT-KS-AT-ACP-TE 679 SNOG_08614 SNOG_08614 SNOG_08614 
pks3 KS-AT 596 SNOG_08614 SNOG_09932 #N/A 
SS1G_05681 KS-AT-TE 605 SNOG_09932 SNOG_09932 #N/A 
PTT_20106 KS-AT-ACP-TE 584 SNOG_09932 SNOG_11981 SNOG_08614 
LEMA_P081920.1 KS-AT-ACP-TE 530 SNOG_09932 SNOG_09932 SNOG_08614 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 511 SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 508 SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  505 SNOG_11981 SNOG_11981 SNOG_11981 
  
  
2
1
7
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_09490 PKS11 XP_001799782.1 KS-AT (AT-DH-KR-ER-KR-ACP in SNOG_09491) reducing clade I 640 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
SS1G_09240 Sclerotinia sclerotiorum 1980 XP_001589519.1 - 
BcBOA9 protein Botryotinia fuckeliana B05.10 CBX87032.1 botcinic acid (1) 
PKS10 Peltigera membranacea AEE87273.1 - 
TSTA_099020 Talaromyces stipitatus ATCC 10500 XP_002485885.1 - 
NEUTE1DRAFT_126660 Neurospora tetrasperma FGSC 2508 EGO53332.1 - 
PTT_07891 Pyrenophora teres f. teres 0-1 XP_003297473.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
PTRG_06803 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937136.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
PKS7 Mycosphaerella graminicola IPO323 EGP85920.1 - 
PKS7 Cochliobolus heterostrophus AAR90262.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
SS1G_09240 KS-AT-DH-KR-ER-KR-ACP 403 SNOG_11272 SNOG_11272 SNOG_11272 
BcBOA9 protein KS-AT-DH-KR-ER-KR 395 SNOG_11272 SNOG_11272 #N/A 
PKS10 KS-AT-DH-ER-KR-ACP 352 SNOG_09490 SNOG_11272 SNOG_11272 
TSTA_099020 KS-AT-DH-MT-ER-KR-ACP 346 SNOG_09490 SNOG_11272 SNOG_05791 
NEUTE1DRAFT_126660 KS-AT-DH-KR-ER-KR 343 SNOG_14927 SNOG_11272 SNOG_11076 
PTT_07891 KS-AT-DH-MT-ER-KR-ACP 301 SNOG_14927 SNOG_11272 SNOG_05791 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 272 SNOG_07866 SNOG_07866 SNOG_05791 
PTRG_06803 KS-AT-DH-MT-ER-KR-ACP 270 SNOG_07866 SNOG_04868 SNOG_05791 
PKS7 KS-AT-DH-ER-KR-ACP 260 SNOG_15965 SNOG_15965 SNOG_15965 
PKS7 KS-AT-DH(-MT?)-ER-KR 258 SNOG_07866 SNOG_12897 #N/A 
  
  
2
1
8
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_09623 PKS12 XP_001799912.1 KS-AT-DH-MT-ER-KR-ACP reducing clade IV 801 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
PODANSg7686 Podospora anserina S mat+ XP_001910647.1 - 
NECHADRAFT_123123 Nectria haematococca mpVI 77-13-4 XP_003040707.1 - 
GLRG_06162 Glomerella graminicola M1.001 EFQ31018.1 - 
CIMG_05712 Coccidioides immitis RS XP_001241816.1 - 
AN8910.2 Aspergillus nidulans FGSC A4 XP_682179.1 - 
PTRG_11926 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942300.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
PKS12 Cochliobolus heterostrophus AAR90267.1 - 
PKS5 Mycosphaerella graminicola IPO323 EGP83950.1 - 
PTT_09821 Pyrenophora teres f. teres 0-1 XP_003298948.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
PODANSg7686 KS-AT-DH-MT-ER-KR-ACP 629 SNOG_09623 SNOG_09623 SNOG_09623 
NECHADRAFT_123123 KS-AT-DH-ER-KR-ACP 560 SNOG_09623 SNOG_09623 SNOG_09623 
GLRG_06162 KS-AT-DH-ER-KR 499 SNOG_09623 SNOG_09623 #N/A 
CIMG_05712 KS-AT- 440 SNOG_11076 SNOG_11076 #N/A 
AN8910.2 KS-AT-DH-MT-ER-KR-ACP 460 SNOG_09623 SNOG_09623 SNOG_09623 
PTRG_11926 KS-AT 401 SNOG_11076 SNOG_11076 #N/A 
PKS12 KS-AT-DH-MT-ER-ACP 411 SNOG_14927 SNOG_11076 SNOG_11076 
PKS5 KS-AT-DH-ER-KR-ACP 409 SNOG_11076 SNOG_11076 SNOG_11076 
PTT_09821 KS-AT-DH-MT-ER-KR-ACP 385 SNOG_11076 SNOG_11076 SNOG_11076 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 288 SNOG_07866 SNOG_07866 SNOG_05791 
  
  
2
1
9
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_09932 PKS13 XP_001800218.1 KS-AT-TE non-reducing clade II 890 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
SS1G_05681 Sclerotinia sclerotiorum 1980 XP_001592760.1 - 
ARB_07994 Arthroderma benhamiae CBS 112371 XP_003013882.1 conidial pigment polyketide synthase PksP/Alb1 (3) 
TERG_02850 Trichophyton rubrum CBS 118892 XP_003235798.1 - 
TRV_04611 Trichophyton verrucosum HKI 0517 XP_003021298.1 conidial pigment polyketide synthase PksP/Alb1 (3) 
pks3 Gibberella fujikuroi CAC88775.1 - 
PTT_20106 Pyrenophora teres f. teres 0-1 XP_003306836.1 - 
PKS1 Leptosphaeria maculans AAS92537.1 sirodesmin biosynthesis (1) 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
PKS18 Cochliobolus heterostrophus AAR90272.1 - 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (3) 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
SS1G_05681 KS-AT-TE 612 SNOG_09932 SNOG_09932 #N/A 
ARB_07994 KS-AT-ACP-TE 596 SNOG_09932 SNOG_11981 SNOG_08614 
TERG_02850 KS-AT-ACP-TE 596 SNOG_09932 SNOG_11981 SNOG_08614 
TRV_04611 KS-AT-ACP-TE 594 SNOG_09932 SNOG_11981 SNOG_08614 
pks3 KS-AT 577 SNOG_08614 SNOG_09932 #N/A 
PTT_20106 KS-AT-ACP-TE 593 SNOG_09932 SNOG_11981 SNOG_08614 
PKS1 KS-AT-ACP-TE 509 SNOG_09932 SNOG_09932 SNOG_08614 
PKS1 KS-AT-ACP-ACP  504 SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 503 SNOG_11981 SNOG_11981 SNOG_11981 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 500 SNOG_11981 SNOG_11981 SNOG_11981 
  
  
2
2
0
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_11066 PKS14 XP_001801317.1 KS-AT-DH-ER-KR-ACP reducing clade I 480 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
LEMA_P006610.1 Leptosphaeria maculans CBY01874.1 - 
THITE_123823 Thielavia terrestris NRRL 8126 AEO64476.1 - 
CHGG_08746 Chaetomium globosum CBS 148.51 XP_001226673.1 - 
GLRG_03360 Glomerella graminicola M1.001 EFQ28216.1 - 
SMAC_07941 Sordaria macrospora k-hell XP_003350625.1 - 
NCU06013 Neurospora crassa OR74A XP_958135.2 - 
PKS3 Mycosphaerella graminicola IPO323 EGP87759.1 - 
PTT_10611 Pyrenophora teres f. teres 0-1 XP_003299581.1 - 
PKS7 Cochliobolus heterostrophus AAR90262.1 - 
PTRG_03683 Pyrenophora tritici-repentis Pt-1C-BFP XP_001934016.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
LEMA_P006610.1 KS-AT-DH-ER-KR-ACP-?-? 391 SNOG_11066 SNOG_11066 SNOG_11066 
THITE_123823 KS-AT-DH-ER-KR-ACP 348 SNOG_11066 SNOG_11066 SNOG_11066 
CHGG_08746 KS-AT-DH-ER-KR-ACP 345 SNOG_11066 SNOG_11066 SNOG_11066 
GLRG_03360 KS-AT-DH-ER-KR-ACP 341 SNOG_04868 SNOG_11066 SNOG_11066 
SMAC_07941 KS-AT-DH-ER-KR-ACP 340 SNOG_04868 SNOG_11066 SNOG_11066 
NCU06013 KS-AT-DH-ER-KR-ACP 335 SNOG_11066 SNOG_11066 SNOG_11066 
PKS3 KS-AT-DH-ER-KR-ACP 258 SNOG_04868 SNOG_05791 SNOG_11066 
PTT_10611 KS-AT-DH-MT-ER-KR-ACP 199 SNOG_07866 SNOG_02561 SNOG_05791 
PKS7 KS-AT-DH(-MT?)-ER-KR 196 SNOG_07866 SNOG_12897 #N/A 
PTRG_03683 KS-AT-DH-MT-ER-KR-ACP 189 SNOG_07866 SNOG_12897 #N/A 
  
  
2
2
1
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_11076 PKS15 XP_001801326.1 KS-AT-DH-MT-ER-KR-ACP reducing clade IV 881 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
PKS14 Cochliobolus heterostrophus AAR90268.1 - 
ANI_1_2050094 Aspergillus niger CBS 513.88 XP_001394543.2 - 
HCBG_01655 Ajellomyces capsulatus G186AR EEH10010.1 - 
NECHADRAFT_42353 Nectria haematococca mpVI 77-13-4 XP_003042632.1 - 
CIMG_05712 Coccidioides immitis RS XP_001241816.1 - 
MAA_08699 Metarhizium anisopliae ARSEF 23 EFY95891.1 - 
PTRG_11926 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942300.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
PKS5 Mycosphaerella graminicola IPO323 EGP83950.1 - 
PTT_09821 Pyrenophora teres f. teres 0-1 XP_003298948.1 - 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
PKS14 KS-AT-DH-MT-ER-KR-ACP 717 SNOG_11076 SNOG_11076 SNOG_11076 
ANI_1_2050094 KS-AT-DH-MT-ER-KR-ACP 549 SNOG_11076 SNOG_11076 SNOG_11076 
HCBG_01655 KS-AT-DH-MT-ER-KR-ACP 534 SNOG_11076 SNOG_11076 SNOG_11076 
NECHADRAFT_42353 KS-AT-DH-MT-ER-KR-ACP 526 SNOG_11076 SNOG_11076 SNOG_11076 
CIMG_05712 KS-AT- 494 SNOG_11076 SNOG_11076 #N/A 
MAA_08699 KS-AT-DH-MT-ER-KR-ACP 518 SNOG_11076 SNOG_11076 SNOG_11076 
PTRG_11926 KS-AT 473 SNOG_11076 SNOG_11076 #N/A 
PKS5 KS-AT-DH-ER-KR-ACP 490 SNOG_11076 SNOG_11076 SNOG_11076 
PTT_09821 KS-AT-DH-MT-ER-KR-ACP 448 SNOG_11076 SNOG_11076 SNOG_11076 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 301 SNOG_07866 SNOG_07866 SNOG_05791 
  
  
2
2
2
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_11272 PKS2 XP_001801515.1 KS-AT-DH-ER-KR-ACP reducing clade II 732 
 
putative orthologs       
gene number Blast hit organism  NCBI acc (protein) Inferred function  
BcBOA9 protein Botryotinia fuckeliana B05.10 CBX87032.1 botcinic acid (1) 
SS1G_09240 Sclerotinia sclerotiorum 1980 XP_001589519.1 - 
PODANSg2799 Podospora anserina S mat+ XP_001905772.1 - 
PTRG_11926 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942300.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
VDAG_07270 Verticillium dahliae VdLs.17 EGY16106.1 - 
CHGG_10647 Chaetomium globosum CBS 148.51 XP_001228574.1 - 
PTT_07891 Pyrenophora teres f. teres 0-1 XP_003297473.1 - 
PKS7 Mycosphaerella graminicola IPO323 EGP85920.1 - 
LEMA_P006610.1 Leptosphaeria maculans CBY01874.1 - 
PKS14 Cochliobolus heterostrophus AAR90268.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
BcBOA9 protein KS-AT-DH-KR-ER-KR 482 SNOG_11272 SNOG_11272 #N/A 
SS1G_09240 KS-AT-DH-KR-ER-KR-ACP 465 SNOG_11272 SNOG_11272 SNOG_11272 
PODANSg2799 PKS-AT-DH-MT-ER-KR-ACP 306 SNOG_14927 SNOG_14927 SNOG_06676 
PTRG_11926 KS-AT 278 SNOG_11076 SNOG_11076 #N/A 
VDAG_07270 KS-AT-DH-ER-KR-ACP 286 SNOG_11272 SNOG_11272 SNOG_15965 
CHGG_10647 KS-AT-DH_MT-ER-KR 284 SNOG_14927 SNOG_14927 #N/A 
PTT_07891 KS-AT-DH-MT-ER-KR-ACP 243 SNOG_14927 SNOG_11272 SNOG_05791 
PKS7 KS-AT-DH-ER-KR-ACP 226 SNOG_15965 SNOG_15965 SNOG_15965 
LEMA_P006610.1 KS-AT-DH-ER-KR-ACP-?-? 225 SNOG_11066 SNOG_11066 SNOG_11066 
PKS14 KS-AT-DH-MT-ER-KR-ACP 221 SNOG_11076 SNOG_11076 SNOG_11076 
  
  
2
2
3
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_11981 PKS16 XP_001802212.1 KS-AT-ACP-ACP-TE non-reducing clade II 869 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
ArPKS1 Ascochyta rabiei ACS74449.1 1,3,6,8-tetrahydroxynaphthalene polyketide synthase protei (1) 
PTRG_03323 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933656.1 conidial yellow pigment biosynthesis polyketide synthase (3) 
PTT_09773 Pyrenophora teres f. teres 0-1 XP_003298917.1 - 
PKS18 Cochliobolus heterostrophus AAR90272.1 - 
PKS1 Bipolaris oryzae BAD22832.1 polyketide synthase required for melanin biosynthesis (1) 
N/A Setosphaeria turcica AEE68981.1 related to pathogenicity and melanin production (3) 
ALM1 Alternaria alternata BAK64048.1 conidial pigment polyketide synthase (3) 
LEMA_P098490.1 Leptosphaeria maculans CBX98440.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
EfPKS1 Elsinoe fawcettii ABU63483.1 elsinochrome phytotoxin production (1) 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
ArPKS1 KS-AT 817 SNOG_11981 SNOG_11981 #N/A 
PTRG_03323 AT-KS-AT-ACP-ACP-TE 827 SNOG_11981 SNOG_11981 SNOG_11981 
PTT_09773 KS-AT-ACP-ACP-TE 827 SNOG_11981 SNOG_11981 SNOG_11981 
PKS18 AT-KS-AT-ACP-TE 824 SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 AT-KS-AT-ACP-ACP-TE 825 SNOG_11981 SNOG_11981 SNOG_11981 
N/A KS-AT-AT-ACP-ACP-TE 823 SNOG_11981 SNOG_11981 SNOG_11981 
ALM1 KS-AT-AT-ACP-ACP-TE 820 SNOG_11981 SNOG_11981 SNOG_11981 
LEMA_P098490.1 AT-KS-AT-ACP-ACP-TE 818 SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  771 SNOG_11981 SNOG_11981 SNOG_11981 
EfPKS1 KS-AT-AT-ACP-ACP-TE 770 SNOG_11981 SNOG_11981 SNOG_11981 
  
  
2
2
4
 
Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_12897 PKS17 XP_001803113.1 KS-AT-ER-KR-ACP reducing clade I 441 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
MGYG_03811 Arthroderma gypseum CBS 118893 XP_003173636.1 lovastatin nonaketide synthase (3) 
MCYG_07715 Arthroderma otae CBS 113480 XP_002843932.1 PKSN polyketide synthase for alternapyrone biosynthesis (3) 
PODANSg1131 Podospora anserina S mat+ XP_001904114.1 - 
CCM_01518 Cordyceps militaris CM01 EGX96860.1 - 
AN7838.2 Aspergillus nidulans FGSC A4 XP_681107.1 - 
PKS4 Mycosphaerella graminicola IPO323 EGP86977.1 - 
PTT_10611 Pyrenophora teres f. teres 0-1 XP_003299581.1 - 
PKS3 Cochliobolus heterostrophus AAR90258.1 - 
PTRG_06803 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937136.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
LEMA_P057720.1 Leptosphaeria maculans CBX90738.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
MGYG_03811 KS-AT-DH-ER-KR-ACP 383 SNOG_12897 SNOG_12897 SNOG_12897 
MCYG_07715 KS-AT-DH-ER-KR-ACP 375 SNOG_12897 SNOG_12897 SNOG_12897 
PODANSg1131 KS-AT-DH-ER-KR 344 SNOG_12897 SNOG_12897 #N/A 
CCM_01518 KS-AT-DH-ER-KR-ACP 324 SNOG_07866 SNOG_12897 SNOG_12897 
AN7838.2 KS-AT-DH-KR-ER-KR-ACP 274 SNOG_12897 SNOG_12897 #N/A 
PKS4 (Est?-)KS-AT-DH-ER-KR-ACP 269 SNOG_07866 SNOG_12897 SNOG_05791 
PTT_10611 KS-AT-DH-MT-ER-KR-ACP 247 SNOG_07866 SNOG_02561 SNOG_05791 
PKS3 KS-AT-DH-MT-ER-KR-ACP 245 SNOG_00308 SNOG_02561 SNOG_05791 
PTRG_06803 KS-AT-DH-MT-ER-KR-ACP 234 SNOG_07866 SNOG_04868 SNOG_05791 
LEMA_P057720.1 KS-AT-DH-ER-KR-ACP 233 SNOG_07866 SNOG_12897 SNOG_11272 
  
  
2
2
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_13032 PKS18 XP_001803246.1 KS-AT-DH-MT-KR reducing clade IV 239 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
AFUA_1G01010 Aspergillus fumigatus Af293] XP_749851.1 similar to fumonisin synthase Fum1p (2) 
NECHADRAFT_106233 Nectria haematococca mpVI 77-13-4 XP_003040326.1 - 
MYCTH_103096 Myceliophthora thermophila ATCC 42464 AEO60392.1 - 
GmPKS12 Gibberella moniliformis AAR92219.1 - 
FOXB_16727 Fusarium oxysporum Fo5176 EGU72765.1 - 
PKS15 Cochliobolus heterostrophus AAR90269.1 - 
PKS5 Mycosphaerella graminicola IPO323 EGP83950.1 - 
PTT_09821 Pyrenophora teres f. teres 0-1 XP_003298948.1 - 
LEMA_P057720.1 Leptosphaeria maculans CBX90738.1 - 
PTRG_06299 Pyrenophora tritici-repentis Pt-1C-BFP XP_001936632.1 mycocerosic acid synthase (3) 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
AFUA_1G01010 KS-AT-DH-MT-KR-ACP 453 SNOG_14927 SNOG_13032 SNOG_11076 
NECHADRAFT_106233 KS-AT-DH-MT-ER-KR-ACP 450 SNOG_14927 SNOG_13032 SNOG_11076 
MYCTH_103096 KS-AT-DH-MT-ER-KR-ACP 468 SNOG_14927 SNOG_13032 SNOG_11076 
GmPKS12 KS-AT-DH-MT-ER-KR-ACP 421 SNOG_14927 SNOG_13032 SNOG_11076 
FOXB_16727 KS-AT-DH-MT-ER-KR-ACP 402 SNOG_14927 SNOG_13032 SNOG_11076 
PKS15 KS-AT-DH-MT-ER-KR-ACP 477 SNOG_14927 SNOG_09623 SNOG_09623 
PKS5 KS-AT-DH-ER-KR-ACP 489 SNOG_11076 SNOG_11076 SNOG_11076 
PTT_09821 KS-AT-DH-MT-ER-KR-ACP 447 SNOG_11076 SNOG_11076 SNOG_11076 
LEMA_P057720.1 KS-AT-DH-ER-KR-ACP 328 SNOG_07866 SNOG_12897 SNOG_11272 
PTRG_06299 KS-AT-DH-MT-ER-KR-ACP-Carn_acyltransf 314 #N/A SNOG_12897 SNOG_11066 
  
  
2
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_14927 PKS19 XP_001805097.1 KS-AT-DH-KR-ACP reducing clade IV 850 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
GLRG_00918 Glomerella graminicola M1.001 EFQ25774.1 - 
AN9005.2 Aspergillus nidulans FGSC A4 XP_682274.1 - 
TSTA_055600 Talaromyces stipitatus ATCC 10500 XP_002487169.1 - 
HCEG_09323 Ajellomyces capsulatus H88 EGC42541.1 - 
ANI_1_2674014 Aspergillus niger CBS 513.88 XP_003188554.1 - 
PKS15 Cochliobolus heterostrophus AAR90269.1 - 
PTRG_11830 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942161.1 fatty acid synthase S-acetyltransferase (3) 
PKS5 Mycosphaerella graminicola IPO323 EGP83950.1 - 
PTRG_11926 Pyrenophora tritici-repentis Pt-1C-BFP XP_001942300.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
GLRG_00918 KS-AT-DH-KR-ACP 535 SNOG_14927 SNOG_14927 SNOG_14927 
AN9005.2 KS-AT-DH-MT-ER-KR 507 SNOG_14927 SNOG_09623 SNOG_09623 
TSTA_055600 KS-AT-DH-MT-ER-KR-ACP 506 SNOG_14927 SNOG_14927 SNOG_09623 
HCEG_09323 KS-AT-DH-MT-ER-KR-ACP 506 SNOG_14927 SNOG_11076 SNOG_09623 
ANI_1_2674014 KS-AT 480 SNOG_14927 SNOG_09623 #N/A 
PKS15 KS-AT-DH-MT-ER-KR-ACP 475 SNOG_14927 SNOG_09623 SNOG_09623 
PTRG_11830 KS-AT-ADH-MT-ER-ACP 474 SNOG_14927 SNOG_14927 SNOG_15965 
PKS5 KS-AT-DH-ER-KR-ACP 462 SNOG_11076 SNOG_11076 SNOG_11076 
PTRG_11926 KS-AT 419 SNOG_11076 SNOG_11076 #N/A 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 321 SNOG_07866 SNOG_07866 SNOG_05791 
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_15829 PKS20 XP_001805964.1 KS-AT-ACP non-reducing clade II 902 
 
putative orthologs      
gene number blast hit organism NCBI acc (protein) inferred function 
BC1G_08227 Botrytis cinerea XP_001553397.1 - 
GsfA Penicillium aethiopicum ADI24953.1 contained in viridicatumtoxin and griseofulvin biosynthetic gene cluster (2) 
AN0150.2 Aspergillus nidulans FGSC A4 XP_657754.1 - 
AFUB_071800 Aspergillus fumigatus A1163 EDP50840.1 - 
NFIA_101810 Neosartorya fischeri NRRL 181 XP_001266594.1 - 
PKS19 Cochliobolus heterostrophus AAR90273.1 - 
PTT_06073 Pyrenophora teres f. teres 0-1 XP_003296346.1 - 
PTRG_02708 Pyrenophora tritici-repentis Pt-1C-BFP XP_001933041.1 conidial yellow pigment biosynthesis polyketide synthase (3) 
LEMA_P098490.1 Leptosphaeria maculans CBX98440.1 - 
PKS1 Mycosphaerella graminicola IPO323 EGP83620.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
BC1G_08227 KS-AT-ACP 753 SNOG_15829 SNOG_15829 SNOG_15829 
GsfA KS-AT-ACP 729 SNOG_15829 SNOG_15829 SNOG_15829 
AN0150.2 KS-AT-ACP 640 SNOG_15829 SNOG_11981 SNOG_15829 
AFUB_071800 KS-AT-ACP 629 SNOG_15829 SNOG_11981 SNOG_11981 
NFIA_101810 KS-AT-ACP 630 SNOG_15829 SNOG_15829 SNOG_11981 
PKS19 KS-AT-ACP 595 SNOG_15829 SNOG_11981 SNOG_11981 
PTT_06073 KS-AT-ACP 593 SNOG_15829 SNOG_11981 SNOG_11981 
PTRG_02708 KS-AT-ACP 592 SNOG_15829 SNOG_11981 SNOG_11981 
LEMA_P098490.1 AT-KS-AT-ACP-ACP-TE 561 SNOG_11981 SNOG_11981 SNOG_11981 
PKS1 KS-AT-ACP-ACP  541 SNOG_11981 SNOG_11981 SNOG_11981 
  
  
2
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Snog# name NCBI acc (protein) domain organisation inferred clade blast score KS 
SNOG_15965 PKS21 XP_001806097.1 KS-AT-DH-ER-KR-ACP reducing clade I 628 
 
putative orthologs       
gene number blast hit organism NCBI acc (protein) inferred function 
CCM_08016 Cordyceps militaris CM01 EGX89763.1 - 
BC1G_04310 Botrytis cinerea XP_001557060.1 - 
GLRG_10537 Glomerella graminicola M1.001 EFQ35393.1 - 
THITE_40673 Thielavia terrestris NRRL 8126 AEO62906.1 - 
SS1G_02211 Sclerotinia sclerotiorum 1980 XP_001595995.1 - 
PKS7 Mycosphaerella graminicola IPO323 EGP85920.1 - 
PTT_07049 Pyrenophora teres f. teres 0-1 XP_003296852.1 - 
PTRG_06803 Pyrenophora tritici-repentis Pt-1C-BFP XP_001937136.1 phenolpthiocerol synthesis polyketide synthase ppsA (3) 
LEMA_P082310. Leptosphaeria maculans CBX98992.1 - 
PKS7 Cochliobolus heterostrophus AAR90262.1 - 
 
putative orthologs (continued)           
gene number domain organisation score KS KS hit in S. nodorum AT hit S. nodorum ACP hit S. nodorum 
CCM_08016 KS-AT-DH-KR-ER-KR-ACP 436 SNOG_15965 SNOG_15965 SNOG_15965 
BC1G_04310 KS-AT-DH-KR-ER-KR-ACP 427 SNOG_15965 SNOG_15965 SNOG_15965 
GLRG_10537 KS-AT-DH-KR-ER-KR-ACP 410 SNOG_15965 SNOG_15965 SNOG_15965 
THITE_40673 KS-AT-DH-ER-KR-ACP 396 SNOG_15965 SNOG_15965 SNOG_15965 
SS1G_02211 KS-AT-DH-KR-ER-KR 392 SNOG_15965 SNOG_15965 #N/A 
PKS7 KS-AT-DH-ER-KR-ACP 374 SNOG_15965 SNOG_15965 SNOG_15965 
PTT_07049 KS-AT-DH-(KR?-)ER-KR-ACP 354 SNOG_15965 SNOG_15965 SNOG_15965 
PTRG_06803 KS-AT-DH-MT-ER-KR-ACP 237 SNOG_07866 SNOG_04868 SNOG_05791 
LEMA_P082310. KS-AT-DH-MT-ER-ACP 226 SNOG_07866 SNOG_07866 SNOG_05791 
PKS7 KS-AT-DH(-MT?)-ER-KR 223 SNOG_07866 SNOG_12897 #N/A 
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Appendix II Phylogenetic trees for S. nodorum PKSs and orthologs 
Phylogenetic relationship of S. nodorum PKS KS domains and their respective orthologs. 
Trees are consensus of 10,000 trees obtained by Jukes-Cantor modelling with neighbour 
joining from ClustalW alignments (see 3.2.2). Ustilago maydis is the outgroup. Numbers 
on nodes indicate consensus support in %, scale bar indicates number of substitutions 
per site. S. nodorum PKS are highlighted in red 
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Appendix III Putative SM gene clusters as predicted by SMURF (following pages) 
Gene, Backbone gene and scaffold numbers, gene start and stop coordinates, distance to backbone gene, SMURF domain score (1= SM-related gene) and 
informative BLAST results for S. nodorum genes are given for putative SM gene clusters predicted by SMURF analysis of the S. nodorum genome sequence 
Cluster:1        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_00308 SNOG_00314 1 743023 744855 527 1 MFS drug transporter 
[Aspergillus fumigatus Af293] 
SNOG_00308 SNOG_00313 1 741149 742496 448 0 Dipeptidyl 
aminopeptidase/acylaminoacyl-
peptidase related protein 
[Clostridium acetobutylicum 
ATCC 824] 
SNOG_00308 SNOG_00312 1 739631 740701 547 1 Si:dkey-174m14.2 protein 
[Danio rerio] 
SNOG_00308 SNOG_00311 1 737921 739084 690 0 dehydrogenase [Monascus 
pilosus] 
SNOG_00308 SNOG_00310 1 736155 737231 674 0  
SNOG_00308 SNOG_00309 1 734010 735481 1020 1 isoamyl alcohol oxidase 
[Gibberella zeae] 
SNOG_00308 SNOG_00308 1 720649 732990 0 1 equisetin synthetase [Fusarium 
heterosporum] 
SNOG_00308 SNOG_00307 1 717199 718950 1699 1  
SNOG_00308 SNOG_00306 1 714927 716941 258 1 cytochrome P450 monooxygenase 
[Aspergillus fumigatus Af293] 
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Cluster:2        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_00477 SNOG_00488 1 1132688 1134289 596 1 related to carboxylic acid 
transport protein JEN1 [MIPS] 
[Neurospora crassa OR74A] 
SNOG_00477 SNOG_00487 1 1131736 1132092 1377 0  
SNOG_00477 SNOG_00486 1 1128974 1130359 459 1 isobutene-forming enzyme and 
benzoate 4-hydroxylase 
[Rhodotorula minuta] 
SNOG_00477 SNOG_00485 1 1127760 1128515 318 0 ACR035Wp [Eremothecium 
gossypii] 
SNOG_00477 SNOG_00484 1 1124161 1127442 742 0 Os05g0247900 [Oryza sativa 
(japonica cultivar-group)] 
SNOG_00477 SNOG_00483 1 1122855 1123419 718 0 RNAse III [Aspergillus 
fumigatus Af293] 
SNOG_00477 SNOG_00482 1 1121004 1122137 770 0  
SNOG_00477 SNOG_00481 1 1120081 1120234 109 0  
SNOG_00477 SNOG_00480 1 1117029 1119972 2735 0 AER145Wp [Eremothecium 
gossypii] 
SNOG_00477 SNOG_00479 1 1113448 1114294 2938 0 aspergillopepsin [Aspergillus 
fumigatus Af293] 
SNOG_00477 SNOG_00478 1 1110205 1110510 1084 0  
SNOG_00477 SNOG_00477 1 1103959 1109121 0 1 6-methylsalicylic acid 
synthase [Aspergillus terreus 
NIH2624] 
SNOG_00477 SNOG_00476 1 1102122 1102675 1284 0 GABA permease [Aspergillus 
fumigatus Af293] 
SNOG_00477 SNOG_00475 1 1101022 1102103 19 0 GABA permease [Aspergillus 
fumigatus Af293] 
  
2
4
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Cluster:2 (continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_00477 SNOG_00474 1 1099848 1100184 838 0  
SNOG_00477 SNOG_00473 1 1098153 1098529 1319 0  
SNOG_00477 SNOG_00472 1 1096749 1097664 489 1 60S ribosomal protein L23 
[Ustilago maydis 521] 
SNOG_00477 SNOG_00471 1 1095447 1096638 111 0  
SNOG_00477 SNOG_00470 1 1092375 1093540 1907 0  
SNOG_00477 SNOG_00469 1 1091550 1092287 88 0  
SNOG_00477 SNOG_00468 1 1089593 1091066 484 0  
SNOG_00477 SNOG_00467 1 1087196 1088671 922 0 Lipase B precursor (CALB) 
SNOG_00477 SNOG_00466 1 1083439 1086540 656 1 C6 transcription factor 
[Aspergillus fumigatus Af293] 
 
  
  
2
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Cluster:3       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_01107 SNOG_01112 1 2504060 2508760 310 1 ABC multidrug transporter 
[Aspergillus fumigatus Af293] 
SNOG_01107 SNOG_01110 1 2502100 2503750 771 0 integral to membrane protein 
[Cryptococcus neoformans var. 
neoformans JEC21] 
SNOG_01107 SNOG_01109 1 2500376 2501329 2469 0 Branched-chain amino acid 
aminotransferase II 
[Clostridium sp. OhILAs] 
SNOG_01107 SNOG_01108 1 2493229 2497907 2670 0 fatty acid synthase beta 
subunit dehydratase 
[Aspergillus terreus NIH2624] 
SNOG_01107 SNOG_01107 1 2485803 2490559 0 0 fatty acid synthase 
SNOG_01107 SNOG_01106 1 2483300 2485183 620 1 cytochrome P450 monooxygenase 
[Gibberella zeae] 
SNOG_01107 SNOG_01105 1 2464026 2482076 1224 1 nonribosomal peptide 
synthetase 4 [Cochliobolus 
heterostrophus] 
SNOG_01107 SNOG_01104 1 2463010 2463539 487 0  
SNOG_01107 SNOG_01103 1 2462563 2463225 215 0  
SNOG_01107 SNOG_01102 1 2461593 2461904 659 0  
SNOG_01107 SNOG_01101 1 2459454 2460657 936 0 GTP-binding protein ypt5 
[Aspergillus terreus NIH2624] 
SNOG_01107 SNOG_01100 1 2456977 2459193 261 0 Lipid phosphoinositide 
phosphatase of the ER and 
Golgi 
SNOG_01107 SNOG_01099 1 2454795 2456348 629 1 monocarboxylate transporter 
Mct 
  
2
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Cluster:4        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_01846 SNOG_01846 2 1626156 1629265 0 0  nonribosomal peptide synthase 
NRPS [Aspergillus fumigatus 
Af293] 
SNOG_01846 SNOG_01845 2 1624044 1625109 1047 0 2-hydroxyacid dehydrogenase 
[Cryptococcus neoformans var. 
neoformans JEC21] 
SNOG_01846 SNOG_01844 2 1621383 1623211 833 1 PROBABLE OXIDOREDUCTASE 
[Mycobacterium tuberculosis 
H37Rv] 
SNOG_01846 SNOG_01843 2 1619179 1620429 954 0 oxidoreductase, Gfo/Idh/MocA 
family protein [Photobacterium 
sp. SKA34] 
SNOG_01846 SNOG_01842 2 1618302 1618505 674 0  
SNOG_01846 SNOG_01841 2 1615670 1617262 1040 0  
SNOG_01846 SNOG_01840 2 1614577 1615597 73 0 Glyoxalase/bleomycin 
resistance protein/dioxygenase 
[Sphingopyxis alaskensis 
RB2256] 
SNOG_01846 SNOG_01839 2 1614004 1614902 325 1 short-chain 
dehydrogenase/reductase SDR 
[Desulfitobacterium hafniense 
DCB-2] 
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Cluster:5        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_02561 SNOG_02566 4 33021 34803 827 1 pisatin demethylase [Fusarium 
oxysporum f. sp. pisi] 
SNOG_02561 SNOG_02565 4 30891 32194 772 1 cytochrome P450 monoxygenase 
[Botryotinia fuckeliana] 
SNOG_02561 SNOG_02564 4 28693 30119 1033 0 ABA 3 protein [Botryotinia 
fuckeliana] 
SNOG_02561 SNOG_02563 4 25914 27660 94 1 Fum15p [Gibberella 
moniliformis] 
SNOG_02561 SNOG_02562 4 24279 25820 1454 1  
SNOG_02561 SNOG_02561 4 15728 22825 0 1 type I polyketide synthase 
[Phoma sp. C2932] 
 
Cluster:6        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_03771 SNOG_03776 5 906624 908436 1601 1 multidrug resistant protein 
[Aspergillus fumigatus Af293] 
SNOG_03771 SNOG_03774 5 902744 905023 806 1 aflatoxin efflux pump 
[Aspergillus flavus] 
SNOG_03771 SNOG_03773 5 899983 901938 328 0  
SNOG_03771 SNOG_03772 5 896985 899655 646 0 Het-eN [Nectria haematococca] 
SNOG_03771 SNOG_03771 5 893054 896339 0 0  nonribosomal peptide synthase 
NRPS [Aspergillus fumigatus 
Af293] 
SNOG_03771 SNOG_03770 5 890873 891025 2029 0  
SNOG_03771 SNOG_03769 5 889400 890511 362 0  
  
2
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Cluster:6 (Continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_03771 SNOG_03768 5 887112 888698 702 0 GPD_MAGGR Glycerol-3-phosphate 
dehydrogenase [NAD+] 
SNOG_03771 SNOG_03767 5 881118 886245 867 1 ABC drug exporter AtrF 
[Aspergillus fumigatus Af293] 
SNOG_03771 SNOG_03765 5 879801 880571 547 0  
SNOG_03771 SNOG_03764 5 878085 878928 873 0 proteasome component Prs3 
[Aspergillus fumigatus Af293] 
SNOG_03771 SNOG_03763 5 876821 877792 293 0 UDP-glucose 4-epimerase 
[Agrobacterium tumefaciens 
str. C58] 
SNOG_03771 SNOG_03762 5 875414 876450 371 1 20S proteasome beta-type 
subunit 
SNOG_03771 SNOG_03761 5 874463 875342 72 0  
SNOG_03771 SNOG_03760 5 874184 874341 122 0  
SNOG_03771 SNOG_03759 5 873174 874061 123 1 2-hydroxychromene-2-
carboxylate isomerase 
[Aspergillus fumigatus Af293] 
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Cluster:7        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_04863 SNOG_04868 7 192267 200297 1143 1 polyketide synthase 
[Cochliobolus heterostrophus] 
SNOG_04863 SNOG_04866 7 189358 191124 823 1 related to cytochrome P450 3A7 
[Neurospora crassa] 
SNOG_04863 SNOG_04865 7 187459 188535 1456 1 alcohol dehydrogenase 
[Aspergillus fumigatus Af293] 
SNOG_04863 SNOG_04864 7 185068 186003 335 0  
SNOG_04863 SNOG_04863 7 181775 184733 0 0 HC-toxin synthetase - fungus 
(Cochliobolus carbonum) 
SNOG_04863 SNOG_04862 7 180576 180804 971 0  
SNOG_04863 SNOG_04861 7 179087 180266 310 1 30 KD HEAT SHOCK PROTEIN 
[Neurospora crassa OR74A] 
        
 
Cluster:8        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_05563 SNOG_05567 8 256719 257852 2819 1 short-chain dehydrogenase 
[Aedes aegypti] 
SNOG_05563 SNOG_05566 8 253067 253900 1635 0  
SNOG_05563 SNOG_05565 8 250732 251432 53 0 OmtB [Aspergillus flavus] 
SNOG_05563 SNOG_05564 8 248919 250679 2519 1 cytochrome P450 monooxygenase 
[Aspergillus fumigatus Af293] 
SNOG_05563 SNOG_05563 8 244865 246400 0 0 nonribosomal peptide 
synthetase 1 [Cochliobolus 
heterostrophus] 
  
2
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Cluster:9        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_05791 SNOG_05805 8 736245 736822 354 1 GCN5-related N-
acetyltransferase [Marinomonas 
sp. MED121] 
SNOG_05791 SNOG_05804 8 735272 735891 5 0  
SNOG_05791 SNOG_05803 8 733911 735267 699 0  
SNOG_05791 SNOG_05802 8 732472 733212 1547 1 4MeS [Metarhizium anisopliae] 
SNOG_05791 SNOG_05801 8 730093 730925 267 0  
SNOG_05791 SNOG_05800 8 729038 729826 1913 0 UPF0308 protein C9orf21 
homolog (fmHP) 
SNOG_05791 SNOG_05799 8 726076 727125 577 0 related to L-fucose permease 
[Neurospora crassa] 
SNOG_05791 SNOG_05798 8 724659 725499 2029 1 glutathione transferase 2 
[Aspergillus fumigatus] 
SNOG_05791 SNOG_05797 8 721899 722630 417 0 SJCHGC02857 protein 
[Schistosoma japonicum] 
SNOG_05791 SNOG_05796 8 720799 721482 1116 0  
SNOG_05791 SNOG_05795 8 716363 719683 1425 1 Probable sterigmatocystin 
biosynthesis P450 
monooxygenase STCF (Cytochrome 
P450 60A2) 
SNOG_05791 SNOG_05793 8 713299 714938 552 1 FAD/FMN-dependent 
oxygenase/oxidase [Alternaria 
solani] 
SNOG_05791 SNOG_05792 8 712278 712747 1477 0  
SNOG_05791 SNOG_05791 8 703863 710801 0 1 polyketide synthase 
[Penicillium citrinum] 
        
 
  
2
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Cluster:10        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_06680 SNOG_06685 9 1321966 1323404 245 1 cytochrome P450 [Fusarium 
meridionale] 
SNOG_06680 SNOG_06684 9 1320382 1321721 299 1 O-methyltransferase 
[Aspergillus fumigatus Af293] 
SNOG_06680 SNOG_06683 9 1319156 1320083 340 1 dehydrogenase [Streptomyces 
avermitilis MA-4680] 
SNOG_06680 SNOG_06682 9 1311413 1318816 92 0 polyketide synthase 
[Aspergillus fumigatus Af293] 
SNOG_06680 SNOG_06681 9 1310257 1311321 484 1 Beta-lactamase-like [Ralstonia 
eutropha JMP134] 
SNOG_06680 SNOG_06680 9 1308712 1309773 0 0 tryptophan 
dimethylallyltransferase 
[Aspergillus fumigatus] 
SNOG_06680 SNOG_06679 9 1306567 1307863 849 1 cytochrome P450 monooxygenase 
pc-bph [Phanerochaete 
chrysosporium] 
SNOG_06680 SNOG_06678 9 1303368 1305371 1196 0  
SNOG_06680 SNOG_06677 9 1302383 1303024 344 0 polyketide synthase 
[Gibberella moniliformis] 
SNOG_06680 SNOG_06676 9 1296832 1302352 31 1 polyketide synthase 
[Aspergillus fumigatus Af293] 
SNOG_06680 SNOG_06673 9 1295831 1296761 71 0  
SNOG_06680 SNOG_06672 9 1292907 1294271 1560 0 MFS toxin efflux pump 
[Aspergillus fumigatus Af293] 
SNOG_06680 SNOG_06670 9 1290494 1291501 1406 0 COG0288: Carbonic anhydrase 
[Nostoc punctiforme PCC 73102] 
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Cluster:10 (continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_06680 SNOG_06669 9 1288614 1290372 122 0 MPG1_ASPOR Mannose-1-phosphate 
guanyltransferase  
SNOG_06680 SNOG_06668 9 1286931 1287932 682 0  
SNOG_06680 SNOG_06667 9 1284478 1285485 1446 0 polyubiquitin 
[Schizosaccharomyces pombe] 
SNOG_06680 SNOG_06666 9 1283069 1284261 217 0 aryl alcohol dehydrogenase 
[Candida albicans SC5314] 
SNOG_06680 SNOG_06665 9 1278717 1282093 976 1   
 
  
  
2
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Cluster:11        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07021 SNOG_07033 10 796763 798454 857 1 transmembrane transporter 
Liz1p [Cryptococcus neoformans 
var. neoformans JEC21] 
SNOG_07021 SNOG_07032 10 794692 795906 119 1 oxidoreductase 
SNOG_07021 SNOG_07031 10 794309 794573 931 0  
SNOG_07021 SNOG_07030 10 790177 793378 75 0 beta transducin-like protein 
HET-E2C*40 [Podospora 
anserina] 
SNOG_07021 SNOG_07029 10 789800 790102 315 0  
SNOG_07021 SNOG_07028 10 787273 789485 127 0 AFR744Wp [Eremothecium 
gossypii] 
SNOG_07021 SNOG_07027 10 786930 787146 583 0  
SNOG_07021 SNOG_07026 10 785281 786347 2159 1 oxidoreductase [Deinococcus 
radiodurans R1] 
SNOG_07021 SNOG_07025 10 782434 783122 135 0  
SNOG_07021 SNOG_07024 10 782031 782299 1112 0  
SNOG_07021 SNOG_07023 10 779321 780919 1605 0 protoporphyrinogen oxidase 
[Legionella pneumophila subsp. 
pneumophila str. Philadelphia 
1] 
SNOG_07021 SNOG_07022 10 776458 777716 2965 0 integral membrane protein 
[Aspergillus fumigatus Af293] 
SNOG_07021 SNOG_07021 10 769954 773493 0 0 peptide synthetase 
[Metarhizium anisopliae] 
SNOG_07021 SNOG_07020 10 761025 769096 858 1 citrinin polyketide synthase 
[Monascus purpureus] 
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Cluster:11 (continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07021 SNOG_07019 10 759590 760494 531 0 sterigmatocystin biosynthesis 
P450 monooxygenase StcL 
[Aspergillus nidulans FGSC A4] 
SNOG_07021 SNOG_07018 10 758843 759528 62 0 cytochrome P450 [Aspergillus 
fumigatus Af293] 
SNOG_07021 SNOG_07017 10 754682 756444 2399 1 MSF monosaccharide transporter 
[Aspergillus fumigatus Af293] 
SNOG_07021 SNOG_07016 10 752155 753186 1496 0  
SNOG_07021 SNOG_07015 10 750573 751837 318 0 arginase [Cryptococcus 
neoformans var. neoformans 
JEC21] 
SNOG_07021 SNOG_07014 10 745291 750088 485 0 EMB2753 [Arabidopsis thaliana] 
SNOG_07021 SNOG_07012 10 745143 745323 32 0  
SNOG_07021 SNOG_07011 10 738722 744867 276 1 ZK1067.2 [Caenorhabditis 
elegans] 
SNOG_07021 SNOG_07009 10 736171 737937 785 1 dichlorophenol hydroxylase 
[Sphingobium herbicidovorans] 
SNOG_07021 SNOG_07008 10 733938 735869 302 1 trehalose transport-related 
protein [Cryptococcus 
neoformans var. neoformans 
JEC21] 
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Cluster:12        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07126 SNOG_07131 10 1049655 1051996 921 1 C6 transcription factor 
[Aspergillus fumigatus Af293] 
SNOG_07126 SNOG_07130 10 1048372 1048734 1579 0  
SNOG_07126 SNOG_20077 10 1046097 1046793 812 0  
SNOG_07126 SNOG_07128 10 1043970 1045285 1278 0 probable acyl-CoA 
dehydrogenase [Glomus 
intraradices] 
SNOG_07126 SNOG_07127 10 1042309 1042692 536 0  
SNOG_07126 SNOG_07126 10 1037920 1041773 0 1 MxaA [Stigmatella aurantiaca] 
SNOG_07126 SNOG_07125 10 1036250 1037403 517 0  
SNOG_07126 SNOG_07124 10 1032146 1035047 1203 0 SCD1 (STOMATAL CYTOKINESIS-
DEFECTIVE 1) [Arabidopsis 
thaliana] 
SNOG_07126 SNOG_07123 10 1031396 1031957 189 0  
SNOG_07126 SNOG_07122 10 1028765 1030050 1346 0  
SNOG_07126 SNOG_07121 10 1026592 1027270 1495 0  
SNOG_07126 SNOG_07120 10 1024022 1025126 1466 1 4-hydroxybenzoate 
nonaprenyltransferase 
[Dictyostelium discoideum AX4] 
SNOG_07126 SNOG_07119 10 1021509 1023595 427 0  
SNOG_07126 SNOG_07118 10 1018810 1019625 1884 0 Os10g0548000 [Oryza sativa 
(japonica cultivar-group)] 
SNOG_07126 SNOG_07117 10 1016063 1017859 951 0 adenosylhomocysteinase 
[Aspergillus terreus NIH2624] 
  
  
2
5
5
 
 
Cluster:12(continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07126 SNOG_20076 10 1013448 1014640 1423 0 growth regulation protein 
SNOG_07126 SNOG_07116 10 1010141 1012502 946 1 translation initiation 
regulator Gcn20 [Aspergillus 
fumigatus Af293] 
 
Cluster:13        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07866 SNOG_07872 11 1268093 1270413 706 1 salicylate hydroxylase 
[Aspergillus fumigatus Af293] 
SNOG_07866 SNOG_07871 11 1265892 1267387 301 0 histidinol dehydrogenase 
[Ralstonia eutropha H16] 
SNOG_07866 SNOG_07870 11 1265377 1265591 162 0  
SNOG_07866 SNOG_07869 11 1264929 1265215 260 0  
SNOG_07866 SNOG_07868 11 1263736 1264669 836 1 short-chain 
dehydrogenase/reductase SDR 
[Desulfitobacterium hafniense 
DCB-2] 
SNOG_07866 SNOG_07867 11 1260729 1262900 1107 0 CMR1 [Colletotrichum 
lagenarium] 
SNOG_07866 SNOG_07866 11 1250790 1259622 0 1 polyketide synthase [Monascus 
pilosus] 
SNOG_07866 SNOG_07865 11 1248339 1249991 799 1 cytochrome P450 monooxygenase 
[Gibberella zeae] 
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Cluster:13(continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_07866 SNOG_07864 11 1246426 1247653 686 1 enoyl reductase [Aspergillus 
fumigatus Af293] 
SNOG_07866 SNOG_07863 11 1244517 1245944 482 1 cytochrome P450 [Aspergillus 
fumigatus Af293] 
SNOG_07866 SNOG_07862 11 1243290 1244297 220 1  
SNOG_07866 SNOG_07861 11 1241302 1242370 920 1 isoamyl alcohol oxidase 
[Aspergillus oryzae] 
SNOG_07866 SNOG_07860 11 1238470 1239660 1642 0  
SNOG_07866 SNOG_07859 11 1236921 1238066 404 0 related to integral membrane 
protein PTH11 [Neurospora 
crassa] 
SNOG_07866 SNOG_07858 11 1234582 1235709 1212 0  
SNOG_07866 SNOG_07857 11 1233917 1234372 210 0  
SNOG_07866 SNOG_07856 11 1233083 1233826 91 0  
SNOG_07866 SNOG_07855 11 1229486 1232783 300 0 beta-galactosidase 
[Penicillium sp.] 
SNOG_07866 SNOG_07854 11 1227334 1228448 1038 1 CypX [Aspergillus flavus] 
SNOG_07866 SNOG_07853 11 1224505 1226315 1019 0  
SNOG_07866 SNOG_07852 11 1221941 1224228 277 1 70 kDa heat shock protein 
[Entamoeba histolytica HM-
1:IMSS] 
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Cluster:14        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_08274 SNOG_08286 12 829943 830992 458 1  
SNOG_08274 SNOG_08285 12 828035 829485 88 1 OmtA [Aspergillus nomius] 
SNOG_08274 SNOG_08284 12 825777 827947 1690 0 C6 transcription factor 
[Aspergillus fumigatus Af293] 
SNOG_08274 SNOG_08283 12 823768 824087 10 0  
SNOG_08274 SNOG_08282 12 822492 823758 1251 1 probable oxidoreductase 
protein 
SNOG_08274 SNOG_08281 12 819289 821241 1059 0 pyranose dehydrogenase 
[Leucoagaricus meleagris] 
SNOG_08274 SNOG_08280 12 817355 818230 93 1 short chain dehydrogenase 
[Xanthomonas axonopodis pv. 
citri str. 306] 
SNOG_08274 SNOG_08279 12 816786 817262 418 0 chlorohydrolase/deaminase 
family protein [Vibrio 
fischeri ES114] 
SNOG_08274 SNOG_08278 12 815709 816368 812 0 Amidohydrolase [Kineococcus 
radiotolerans SRS30216] 
SNOG_08274 SNOG_08277 12 814321 814897 508 1 17beta-hydroxysteroid 
dehydrogenase [Cochliobolus 
lunatus] 
SNOG_08274 SNOG_08276 12 812111 813813 15 1 cercosporin toxin biosynthesis 
protein [Cercospora 
nicotianae] 
SNOG_08274 SNOG_08275 12 811634 812096 1754 0  
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Cluster:14        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_08274 SNOG_08274 12 802291 809880 0 1 polyketide synthetase PksP 
[Aspergillus fumigatus Af293] 
SNOG_08274 SNOG_08271 12 801987 802182 109 0  
SNOG_08274 SNOG_08270 12 800185 801111 876 1 VerB [Aspergillus flavus] 
SNOG_08274 SNOG_08269 12 799329 799984 201 0 Cupin region [Paracoccus 
denitrificans PD1222] 
>gi|119385875|ref|YP_916930.1|  
SNOG_08274 SNOG_08268 12 796956 798666 663 1 cytochrome P450 [Aspergillus 
fumigatus Af293] 
SNOG_08274 SNOG_08267 12 795639 796571 385 0 NmrA-like protein 
[Dictyostelium discoideum AX4] 
SNOG_08274 SNOG_08266 12 793670 795061 578 1 cercosporin toxin biosynthesis 
protein [Cercospora 
nicotianae] 
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Cluster:15        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_08527 SNOG_08536 13 152918 154957 368 1 isoamyl alcohol oxidase 
[Aspergillus oryzae] 
SNOG_08527 SNOG_08535 13 152060 152550 485 0  
SNOG_08527 SNOG_08534 13 150502 151575 497 0  
SNOG_08527 SNOG_08533 13 149484 150005 113 0  
SNOG_08527 SNOG_08532 13 148130 149371 2188 0 W05H9.1 [Caenorhabditis 
elegans] 
SNOG_08527 SNOG_08531 13 143167 145942 394 0 TOL [Neurospora crassa] 
SNOG_08527 SNOG_08529 13 141928 142773 845 0  
SNOG_08527 SNOG_08528 13 140049 141083 2448 0 phenylalanine ammonia-lyase 
[Aspergillus terreus NIH2624] 
SNOG_08527 SNOG_08527 13 136530 137601 0 0 dimethylallyl tryptophan 
synthase-related [Aspergillus 
fumigatus Af293] 
Cluster:16        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_08614 SNOG_08614 13 301168 307317 0 0 polyketide synthetase PksP 
[Aspergillus fumigatus Af293] 
SNOG_08614 SNOG_08613 13 299952 300302 866 0  
SNOG_08614 SNOG_08612 13 296614 299526 426 1 probable FAD-dependent 
monooxygenase [Chromobacterium 
violaceum ATCC 12472] 
SNOG_08614 SNOG_08611 13 292467 294732 1882 1 DHA14-like major facilitator 
[Botryotinia fuckeliana] 
SNOG_08614 SNOG_08610 13 290866 292239 228 1 o-methyltransferase 
[Aspergillus fumigatus Af293] 
SNOG_08614 SNOG_08609 13 288580 289910 956 1 AFLR [Aspergillus flavus] 
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Cluster:17        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09081 SNOG_09091 14 245088 251161 889 1 fatty acid synthetase beta 
subunit [Pichia angusta] 
SNOG_09081 SNOG_09090 14 244046 244199 284 0  
SNOG_09081 SNOG_09089 14 238877 243762 1699 0 fatty acid synthase alpha-
subunit [Schizosaccharomyces 
pombe] 
SNOG_09081 SNOG_09088 14 235785 237178 1237 1 isobutene-forming enzyme and 
benzoate 4-hydroxylase 
[Rhodotorula minuta] 
SNOG_09081 SNOG_09087 14 229727 234548 1137 1 ABC transporter [Alternaria 
brassicae] 
SNOG_09081 SNOG_09086 14 227723 228590 172 0  
SNOG_09081 SNOG_09085 14 226078 227551 182 1 Protein with similarity to 
mammalian monocarboxylate 
permeases 
SNOG_09081 SNOG_09084 14 224879 225896 1255 0 arsenic resistance protein 
ArsH [Aspergillus fumigatus 
Af293] 
SNOG_09081 SNOG_09083 14 222247 223624 210 0 parasitic phase-specific 
protein PSP-1 [Coccidioides 
posadasii] 
SNOG_09081 SNOG_09082 14 221771 222037 1001 0  
SNOG_09081 SNOG_09081 14 205186 220770 0 0 peptide synthetase 
[Metarhizium anisopliae] 
SNOG_09081 SNOG_09080 14 203852 204885 301 0 transmembrane transporter 
Liz1p [Cryptococcus neoformans 
var. neoformans JEC21] 
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Cluster:17(continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09081 SNOG_09079 14 203680 203868 16 0  
SNOG_09081 SNOG_09078 14 203076 203499 181 0  
SNOG_09081 SNOG_09077 14 199620 201291 1785 0 PKD [Herpetosiphon aurantiacus 
ATCC 23779] 
SNOG_09081 SNOG_09075 14 198439 199124 496 0  
SNOG_09081 SNOG_09074 14 196806 198108 331 0 cyclin [Candida albicans 
SC5314] 
SNOG_09081 SNOG_09073 14 194214 196665 141 0  
SNOG_09081 SNOG_09072 14 193954 194188 26 0  
SNOG_09081 SNOG_09071 14 191724 193412 542 1 26S protease regulatory 
subunit 4 [Aspergillus terreus 
NIH2624] 
Cluster:18               
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09488 SNOG_09495 15 116391 117911 1277 1 oxidoreductase 
SNOG_09488 SNOG_09494 15 114179 115114 1422 1 retinol dehydrogenase 12 
SNOG_09488 SNOG_09493 15 111720 112757 649 0  
SNOG_09488 SNOG_09491 15 105970 111071 156 1 polyketide synthase type I 
[Aspergillus fumigatus Af293] 
SNOG_09488 SNOG_09490 15 103817 105814 837 0 polyketide synthase 
[Gibberella moniliformis] 
SNOG_09488 SNOG_09489 15 102640 102980 1766 0  
SNOG_09488 SNOG_09488 15 87028 100874 0 0 peptide synthetase 
[Metarhizium anisopliae] 
  
2
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Cluster:19        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09623 SNOG_09623 15 406674 415070 0 1 Fum1p 
SNOG_09623 SNOG_09622 15 404788 406089 585 0 probable chalcone synthase 
protein [Rhizobium etli] 
SNOG_09623 SNOG_09621 15 402225 403931 857 1 cytochrome P450 52A12 
[Aspergillus terreus NIH2624] 
SNOG_09623 SNOG_09620 15 400770 401879 346 0 NADPH dehydrogenase 1 (Old 
yellow enzyme 1) 
SNOG_09623 SNOG_09619 15 399250 399842 928 0 probable membrane transport 
protein [Mesorhizobium loti 
MAFF303099] 
SNOG_09623 SNOG_09618 15 395987 396654 2596 0  
SNOG_09623 SNOG_09617 15 393969 395473 514 1  
SNOG_09623 SNOG_09616 15 392208 393209 760 1 short chain dehydrogenase 
[Mycobacterium tuberculosis 
CDC1551] 
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Cluster:20        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09932 SNOG_09936 16 52738 53838 109 1 Alcohol dehydrogenase GroES 
domain protein [Burkholderia 
cepacia AMMD] 
SNOG_09932 SNOG_09935 16 50683 52629 1830 0 Chloroperoxidase From The 
Fungus Curvularia Inaequalis: 
Mutant D292a 
SNOG_09932 SNOG_09934 16 47335 48853 1269 1 FAD linked oxidase, N-terminal 
[Solibacter usitatus 
Ellin6076] 
SNOG_09932 SNOG_09933 16 45104 46066 668 0 polyketide synthase 
[Aspergillus fumigatus Af293] 
SNOG_09932 SNOG_09932 16 41963 44436 0 0 polyketide synthetase PksP 
[Aspergillus fumigatus Af293] 
SNOG_09932 SNOG_09931 16 40786 40985 978 0  
SNOG_09932 SNOG_09930 16 39622 40567 219 1 oxidoreductase 
SNOG_09932 SNOG_09929 16 37914 39346 276 0 cation-transporting ATPase 4 
[Aspergillus terreus NIH2624] 
SNOG_09932 SNOG_09928 16 36131 37571 343 1 A Chain A 
SNOG_09932 SNOG_09927 16 35213 35650 481 0  
SNOG_09932 SNOG_09926 16 33996 35210 3 0 probable FAD-dependent 
monooxygenase [Chromobacterium 
violaceum ATCC 12472] 
SNOG_09932 SNOG_09925 16 31549 33644 352 0 VBS [Aspergillus flavus] 
SNOG_09932 SNOG_09924 16 30236 31510 39 1 AFLJ [Aspergillus parasiticus] 
SNOG_09932 SNOG_09923 16 27954 29421 815 1 MFS transporter [Aspergillus 
fumigatus Af293] 
SNOG_09932 SNOG_09922 16 26003 27169 785 0 oxidoreductase 
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Cluster:20(continued)       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_09932 SNOG_09921 16 23926 24924 1079 1 short chain dehydrogenase 
[Salmonella enterica subsp. 
enterica serovar Paratyphi A 
str. ATCC 9150] 
SNOG_09932 SNOG_09920 16 22413 23553 373 0 FAD-dependent oxygenase 
[Aspergillus fumigatus Af293] 
SNOG_09932 SNOG_09919 16 18985 20463 1950 0  
SNOG_09932 SNOG_09918 16 17320 18718 267 1 Salicylate 1-monooxygenase 
[Burkholderia xenovorans 
LB400] 
SNOG_09932 SNOG_09917 16 15997 16875 445 0  
SNOG_09932 SNOG_09916 16 12476 14178 1819 1 cytochrome P450 
[Heterobasidion annosum] 
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Cluster:21        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_11076 SNOG_11076 18 495859 503799 0 1 polyketide synthase 
[Cochliobolus heterostrophus] 
SNOG_11076 SNOG_11074 18 493105 494824 1035 1 5-aminolevulinic acid synthase 
[Rhodopseudomonas palustris 
BisA53] 
SNOG_11076 SNOG_11073 18 490416 491847 1258 1 short chain dehydrogenase 
[Mycobacterium tuberculosis 
H37Rv] 
SNOG_11076 SNOG_11072 18 487471 489223 1193 1 DHA14-like major facilitator 
[Botryotinia fuckeliana] 
SNOG_11076 SNOG_11071 18 485678 486253 1218 0  
SNOG_11076 SNOG_11070 18 482868 484007 1671 0 exopolyphosphatase 
[Cryptococcus neoformans var. 
neoformans JEC21] 
SNOG_11076 SNOG_11069 18 481565 482333 535 0  
SNOG_11076 SNOG_11068 18 475418 480904 661 0  
SNOG_11076 SNOG_11067 18 473825 474553 865 0  
SNOG_11076 SNOG_11066 18 466272 473618 207 1 type I polyketide synthase 
[Phoma sp. C2932] 
SNOG_11076 SNOG_11064 18 464589 464909 1363 0  
SNOG_11076 SNOG_11063 18 463657 464882 27 0 Os04g0450100 [Oryza sativa 
(japonica cultivar-group)] 
SNOG_11076 SNOG_11062 18 462522 462865 792 0  
SNOG_11076 SNOG_11061 18 459461 461604 918 1 multidrug resistance protein 1 
[Aspergillus terreus NIH2624] 
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Cluster:22        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_11272 SNOG_11276 19 20023 21163 1225 1 oxidoreductase family 
[Aspergillus fumigatus Af293] 
SNOG_11272 SNOG_11275 19 18444 18798 225 0 short chain 
dehydrogenase/reductase family 
[Aspergillus fumigatus Af293] 
SNOG_11272 SNOG_11274 19 17572 18219 375 0 CG5412-PA [Drosophila 
melanogaster] 
SNOG_11272 SNOG_11273 19 16698 17197 336 0  
SNOG_11272 SNOG_11272 19 9009 16362 0 1 polyketide synthase 
[Gibberella moniliformis] 
Cluster:23        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_11981 SNOG_11990 21 107990 108900 1785 1 1 
SNOG_11981 SNOG_11989 21 105954 106205 1093 0  
SNOG_11981 SNOG_11988 21 104727 104861 1037 0  
SNOG_11981 SNOG_11987 21 100714 103690 693 1 related to transcriptional 
activator CMR1 [Neurospora 
crassa] 
SNOG_11981 SNOG_11986 21 99466 100021 1877 0  
SNOG_11981 SNOG_11985 21 97356 97589 3163 0  
SNOG_11981 SNOG_11984 21 93797 94193 1591 0  
SNOG_11981 SNOG_11983 21 91718 92206 875 0  
SNOG_11981 SNOG_11982 21 90393 90843 1214 0  
SNOG_11981 SNOG_11981 21 82184 89179 0 0 melanin synthase [Xylaria sp. 
BCC 1067] 
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Cluster:24        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_13032 SNOG_13045 25 62362 64202 668 1 GA14-synthase [Fusarium 
proliferatum] 
SNOG_13032 SNOG_13044 25 59849 61694 529 0  
SNOG_13032 SNOG_13043 25 57787 59320 2126 1 FAD dependent oxidoreductase 
[Aspergillus fumigatus Af293] 
SNOG_13032 SNOG_13042 25 54666 55661 327 1 csgA protein [Myxococcus 
xanthus DK 1622] 
SNOG_13032 SNOG_13041 25 52890 54339 771 1 OmtA [Aspergillus flavus] 
SNOG_13032 SNOG_13040 25 50272 52119 410 1 cytochrome P450 
SNOG_13032 SNOG_13039 25 48464 49862 2 1 methyltransferase B 
[Aspergillus parasiticus] 
SNOG_13032 SNOG_13038 25 48231 48462 567 0  
SNOG_13032 SNOG_13037 25 46621 47664 1502 0 coiled-coil domain containing 
130 [Homo sapiens] 
SNOG_13032 SNOG_13036 25 43829 45119 760 0 MFS monocarboxylate 
transporter [Aspergillus 
fumigatus Af293] 
SNOG_13032 SNOG_13035 25 42016 43069 1667 0 FAD linked oxidase-like 
[Polaromonas sp. JS666] 
SNOG_13032 SNOG_13034 25 39388 40349 750 1 short chain oxidoreductase 
[Streptomyces coelicolor 
A3(2)] 
SNOG_13032 SNOG_13033 25 37256 38638 2789 1 oxidoreductase family 
[Aspergillus fumigatus Af293] 
SNOG_13032 SNOG_13032 25 28823 34467 0 1 polyketide synthase 
[Aspergillus fumigatus Af293] 
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Cluster:25        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_14098 SNOG_14110 30 48682 50160 472 1 FAD dependent oxidoreductase 
[Aspergillus fumigatus Af293] 
SNOG_14098 SNOG_14109 30 47710 48210 171 0 branched-chain amino acid 
aminotransferase [Bacteroides 
fragilis YCH46] 
SNOG_14098 SNOG_14108 30 46925 47539 1045 0 Branched-chain amino acid 
aminotransferase II 
[Clostridium sp. OhILAs] 
SNOG_14098 SNOG_14107 30 44907 45880 1411 0  
SNOG_14098 SNOG_14106 30 42153 43496 1106 1 Isotrichodermin C-15 
hydroxylase (Cytochrome P450 
65A1) 
SNOG_14098 SNOG_14105 30 40103 41047 680 0  
SNOG_14098 SNOG_14104 30 38557 39423 272 0 ankyrin repeat protein E4_8 
[synthetic construct] 
SNOG_14098 SNOG_14103 30 37127 38285 431 0  
SNOG_14098 SNOG_14102 30 36363 36696 134 0  
SNOG_14098 SNOG_14101 30 35569 36229 109 0  
SNOG_14098 SNOG_14100 30 31876 36120 781 1 multidrug resistance protein 
MDR [Coccidioides posadasii] 
SNOG_14098 SNOG_14099 30 29936 31095 1420 0  
SNOG_14098 SNOG_14098 30 11280 28516 0 0 peptide synthetase 
[Metarhizium anisopliae] 
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Cluster:26       
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_14368 SNOG_14375 31 208383 214218 987 1 D-lactate dehydrogenase 
SNOG_14368 SNOG_14373 31 206851 207396 1769 0  
SNOG_14368 SNOG_14372 31 203311 205082 215 1 multidrug resistance protein 3 
[Aspergillus fumigatus] 
SNOG_14368 SNOG_14371 31 202626 203096 1335 0  
SNOG_14368 SNOG_14370 31 199836 201291 779 0 monooxygenase [Fusarium 
sporotrichioides] 
SNOG_14368 SNOG_14369 31 198324 199057 364 0  
SNOG_14368 SNOG_14368 31 192020 197960 0 0 nonribosomal peptide 
synthetase 6 [Botryotinia 
fuckeliana] 
SNOG_14368 SNOG_14366 31 189943 190675 1345 1  
SNOG_14368 SNOG_14365 31 185615 189956 13 1 ATP-binding cassette 
transporter ABC3 [Venturia 
inaequalis] 
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Cluster:27        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_14834 SNOG_14841 34 86818 92873 1233 1 tetracycline resistance efflux 
protein [Pasteurella 
aerogenes] 
SNOG_14834 SNOG_14839 34 84803 85585 704 0  
SNOG_14834 SNOG_14838 34 83764 84099 339 0  
SNOG_14834 SNOG_14837 34 82012 83425 340 0  
SNOG_14834 SNOG_14836 34 76243 81672 1628 1 Fum19p [Gibberella 
moniliformis] 
SNOG_14834 SNOG_14835 34 73844 74615 1430 0  
Cluster:28        
Backbone_gene Gene_id Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_14927 SNOG_14927 34 295360 301569 0 1 polyketide synthase 
[Cochliobolus heterostrophus] 
SNOG_14927 SNOG_14926 34 293429 293964 1396 0  
SNOG_14927 SNOG_14925 34 291985 293033 396 0  
SNOG_14927 SNOG_14924 34 290616 291494 491 0 metalloreductase [Aspergillus 
fumigatus Af293] 
SNOG_14927 SNOG_14923 34 281542 288713 1903 0 nonribosomal peptide synthase 
NRPS [Aspergillus fumigatus 
Af293] 
SNOG_14927 SNOG_14922 34 277598 278301 3241 0 mycocerosate synthase 
[Rhodopirellula baltica SH 1] 
SNOG_14927 SNOG_14921 34 275675 276263 1335 0  
SNOG_14927 SNOG_14920 34 273161 274907 768 0 tannase [Aspergillus oryzae] 
SNOG_14927 SNOG_14919 34 271079 272918 243 1 MFS multidrug transporter 
[Aspergillus fumigatus Af293] 
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Cluster:29        
Backbone_gene Gene_nr Scaff_nr 5'end 3'end G_dist Dom_scr Annotated_gene_function 
SNOG_15829 SNOG_15829 41 10629 15339 0 0 polyketide synthase 
[Cochliobolus heterostrophus] 
SNOG_15829 SNOG_15827 41 8031 9452 1177 1 OmtB [Aspergillus flavus] 
SNOG_15829 SNOG_15826 41 6313 7506 525 0 beta-lactamase [Aspergillus 
fumigatus Af293] 
SNOG_15829 SNOG_15824 41 3830 6037 276 1 ABC multidrug transporter 
[Aspergillus fumigatus Af293] 
 272 
 
Appendix IV Microarray data for in planta expressed PKS genes 
Averaged arbitrary fluorescence readings are given for each timepoint and gene. 
Early>late classifies genes according to their expression during 3 and 5 dpi (early) 
compared to 7 and 10 dpi (late). Genes up-regulated early in planta are highlighted in 
bold font, genes selected for the knockout experiments are highlighted with underscore. 
gene 3 dpi avg 5 dpi avg 7 dpi avg 10 dpi avg early/late 
SMS1 1.82E+04 1.51E+04 6.43E+03 5.49E+03 2.79E+00 
MEL1 1.75E+03 4.39E+03 7.48E+03 6.78E+03 4.31E-01 
PKS1 3.11E+03 2.41E+02 1.05E+02 9.02E+01 1.72E+01 
PKS2 1.55E+03 1.10E+02 5.18E+01 5.27E+01 1.59E+01 
PKS3 8.96E+03 2.32E+03 2.57E+02 1.79E+02 2.59E+01 
PKS4 1.27E+03 2.99E+02 1.95E+02 1.66E+02 4.35E+00 
PKS9 6.52E+02 1.47E+03 6.06E+03 7.72E+03 1.54E-01 
PKS10 4.55E+02 6.70E+02 2.81E+03 1.07E+03 2.90E-01 
PKS15 2.43E+02 2.41E+03 6.09E+03 8.03E+02 3.85E-01 
PKS17 8.05E+02 1.13E+03 4.24E+02 3.20E+02 2.60E+00 
PKS19 2.15E+02 2.86E+02 7.00E+02 6.15E+02 3.81E-01 
PKS21 4.74E+02 2.00E+03 2.58E+03 2.34E+03 5.03E-01 
 
Appendix V Gene expression data as determined by qRT-PCR 
Relative expression compared to actin as reference gene is given for each gene and time 
point. 
gene 3 dpi 5 dpi 7 dpi 10 dpi 
SMS1 1.81E-01 2.81E-01 2.19E-01 1.88E-01 
PKS1 4.34E-02 4.49E-03 5.86E-04 6.30E-04 
PKS3 1.11E-01 4.31E-03 1.09E-03 2.95E-04 
 
Appendix VI Comparison of microarray and qRT-PCR data 
Expression relative to 3dpi is given for each gene, method and time point are given. 
Overall trends between time points are the same for PKS1 and PKS3 microarray (―array‖) 
and qRT-PCR data, whereas they differ for SMS1 between time points 3 and 5 dpi, 
highlighted in bold font 
gene 
3dpi 5dpi 7dpi 10dpi 
qRT-PCR array qRT-PCR array qRT-PCR array qRT-PCR array 
SMS1 1.000 1.000 1.552 0.830 1.210 0.354 1.039 0.303 
PKS1 1.000 1.000 0.103 0.077 0.014 0.034 0.015 0.029 
PKS3 1.000 1.000 0.039 0.258 0.010 0.029 0.003 0.020 
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Appendix VII Growth assay results for individual knockout mutants 
Relative growth is given for each strain and carbon source/medium (C1-C10). Growth was calculated by subtracting day 0 readings from day 7 
readings. Plate layout is as described in Table 4-1. Each plate contains two replicates; two replicate plates were prepared per knockout. Strains 
are as indicated. 
SMS1 plate1 
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
sms1-26 0.2342 0.2647 0.0497 0.1383 0.3221 0.1948 0.5358 0.1258 0.0184 -0.001 
sms1-28 0.2082 0.2342 0.0493 0.2502 0.2324 0.1644 0.8367 0.1078 0.0249 0.0028 
Ecto1 0.3311 0.3032 0.043 0.2012 0.2316 0.1476 1.6032 0.169 0.0225 0.0017 
SN15 0.2733 0.2503 0.0475 0.3 0.2114 0.159 0.7029 0.0965 0.0274 0.0146 
sms1-26 0.204 0.2129 0.0675 0.1566 0.216 0.1726 0.8201 0.1117 0.024 0.0019 
sms1-28 0.2167 0.2481 0.0584 0.2248 0.2103 0.1547 1.2109 0.1073 0.0335 0.0043 
Ecto1 0.2183 0.2807 0.0621 0.2347 0.2267 0.1573 0.5105 0.103 0.027 0.0086 
SN15 0.2953 0.5003 0.0652 0.3038 0.2579 0.2193 0.5332 0.0999 0.0418 0.0051 
           
SMS1 plate2 
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
sms1-26 0.2457 0.2571 0.0518 0.1986 0.26 0.1791 0.7399 0.1969 0.0222 0.0046 
sms1-28 0.2348 0.2155 0.0585 0.1908 0.2014 0.1801 0.5213 0.1992 0.0258 0.0052 
Ecto1 0.2126 0.2302 0.0508 0.2093 0.2015 0.1539 1.2726 0.1646 0.0394 0.0033 
SN15 0.1997 0.251 0.0565 0.2169 0.2194 0.153 1.1407 0.1108 0.0292 0.0133 
sms1-26 0.2563 0.2398 0.0634 0.1492 0.2192 0.1559 0.5242 0.1184 0.0245 0.0009 
sms1-28 0.2467 0.2447 0.0556 0.2048 0.1965 0.1468 1.1782 0.1062 0.0294 0.0042 
Ecto1 0.2191 0.2717 0.0655 0.1973 0.21 0.156 0.6403 0.1186 0.0231 0.0031 
SN15 0.2293 0.4945 0.0588 0.2134 0.2428 0.1926 0.5497 0.1107 0.0352 0.0162 
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Appendix VII Growth assay results for individual knockout mutants (continued) 
PKS1 plate1                   
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
pks1-16 0.3968 0.4187 0.0457 0.2199 0.327 0.1922 1.5349 0.11 0.0286 0.0047 
pks1-48 0.5494 0.5976 0.1028 0.2051 0.3658 0.3585 1.6519 0.1505 0.0414 1E-04 
Ecto1 1.0502 0.5167 0.0519 0.2134 0.2755 0.5854 0.929 0.1356 0.033 0.0019 
SN15 0.811 0.4058 0.061 0.2068 0.311 0.6339 1.8009 0.3676 0.0474 0.0031 
pks1-16 0.6795 0.887 0.0706 0.2219 0.316 0.4046 1.6185 0.236 0.0351 0.0033 
pks1-48 0.7039 0.6481 0.0759 0.2307 0.5791 0.2783 1.7112 0.1716 0.0366 0.0032 
Ecto1 0.4765 0.3359 0.061 0.2376 0.1995 0.2195 0.988 0.1769 0.0334 0.0031 
SN15 0.5453 0.293 0.0877 0.2375 0.4688 0.2972 1.7558 0.1531 0.0657 0.0117 
           
PKS1 plate2                   
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
pks1-16 0.6501 0.539 0.0585 0.2106 0.2468 0.4682 1.4405 0.1157 0.0433 0.0045 
pks1-48 0.2439 0.5469 0.0637 0.2173 0.3607 0.2129 1.5532 0.1337 0.0401 0.0065 
Ecto1 0.6796 0.25 0.0563 0.23 0.587 0.1809 0.8373 0.1658 0.0334 0.0051 
SN15 0.2274 0.5562 0.0564 0.2183 0.6173 0.1858 0.739 0.2228 0.0624 0.0055 
pks1-16 0.4749 0.2865 0.0603 0.2176 0.419 0.2438 0.877 0.1255 0.0543 0.0058 
pks1-48 0.2125 0.6006 0.0812 0.2275 0.2726 0.1963 0.7874 0.1393 0.057 0.0033 
Ecto1 0.223 0.3193 0.0739 0.2776 0.2235 0.2413 0.9638 0.2165 0.0396 0.0037 
SN15 0.2406 0.4104 0.0749 0.2321 0.3322 0.3853 0.976 0.1886 0.1047 0.0161 
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Appendix VII Growth assay results for individual knockout mutants (continued) 
PKS3 plate1                   
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
pks3-1 0.3055 0.2769 0.0471 0.2318 0.2896 0.3799 1.2923 0.1012 0.0294 -0.0023 
pks3-16 0.4694 0.5855 0.1611 0.2112 0.2512 0.1489 1.4378 0.126 0.0273 0.0016 
Ecto1 0.1663 0.6173 0.1013 0.1924 0.1676 0.2506 1.5868 0.212 0.017 0.0029 
SN15 0.3825 0.9593 0.0974 0.1671 0.2361 0.7308 0.7633 0.1709 0.0248 0.004 
pks3-1 0.5281 1.1357 0.267 0.1947 0.8035 0.6617 1.7089 0.1474 0.0164 -0.0024 
pks3-16 0.3466 0.8615 0.0722 0.2297 0.4705 0.3046 1.5746 0.2001 0.0112 0.0042 
Ecto1 0.2965 0.4706 0.0671 0.1798 0.3 0.3935 1.4524 0.1227 0.0205 -0.0002 
SN15 0.4722 0.3575 0.072 0.2013 0.381 0.1897 1.6316 0.24 0.0303 0.0025 
           
PKS3 plate2                   
strain C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
pks3-1 0.7077 0.9452 0.2285 0.2062 0.7097 0.627 1.8681 0.1276 0.0608 0.006 
pks3-16 0.5964 0.9032 0.1076 0.1786 0.2704 0.4029 1.278 0.2373 0.0311 0.0018 
Ecto1 0.4129 0.5738 0.1176 0.2025 0.2761 0.6153 1.6091 0.1477 0.0328 0.0007 
SN15 1.073 0.8463 0.1254 0.1899 0.2486 0.6618 1.3635 0.1964 0.0306 0.001 
pks3-1 0.8547 0.6848 0.2331 0.1959 0.4585 0.406 1.4913 0.1126 0.0353 1E-04 
pks3-16 0.27 0.569 0.0806 0.2119 0.2359 0.6431 1.3412 0.2239 0.0283 0.0019 
Ecto1 0.6441 0.5072 0.0833 0.2188 0.2881 0.5195 1.5464 0.1519 0.0209 0.0014 
SN15 0.6673 0.3854 0.0936 0.1998 0.2251 0.297 1.4765 0.1323 0.0316 0.0044 
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Appendix VIII Tukey-Kramer analysis of growth assays  
Mean, standard error and significance (―Tukey‖) are given for each strain per carbon 
source/medium. Strains not connected with the same letter have significantly different 
means (p<0.05). Carbon sources/media with significant differences are highlighted in 
bold font 
 
SMS1 
C1 
Strain Mean Std Error Tukey 
 
C6 
Strain Mean Std Error Tukey 
sms1-26 0.23505 0.01928 A 
  
sms1-26 0.1756 0.00949 A   
sms1-28 0.2266 0.01928 A 
  
sms1-28 0.1615 0.00949 A   
Ecto1 0.245275 0.01928 A 
  
Ecto1 0.1537 0.00949 A   
SN15 0.2494 0.01928 A 
  
SN15 0.180975 0.00949 A   
C2 
Strain Mean Std Error Tukey 
 
C7 
Strain Mean Std Error Tukey 
sms1-26 0.243625 0.03706 A 
  
sms1-26 0.655 0.17257 A   
sms1-28 0.235625 0.03706 A 
  
sms1-28 0.93678 0.17257 A   
Ecto1 0.27145 0.03706 A 
  
Ecto1 1.00665 0.17257 A   
SN15 0.374025 0.03706 A 
  
SN15 0.73163 0.17257 A   
C3 
Strain Mean Std Error Tukey 
 
C8 
Strain Mean Std Error Tukey 
sms1-26 0.0581 0.00399 A 
  
sms1-26 0.1382 0.01737 A   
sms1-28 0.05545 0.00399 A 
  
sms1-28 0.130125 0.01737 A   
Ecto1 0.05535 0.00399 A 
  
Ecto1 0.1388 0.01737 A   
SN15 0.057 0.00399 A 
  
SN15 0.104475 0.01737 A   
C4 
Strain Mean Std Error Tukey 
 
C9 
Strain Mean Std Error Tukey 
sms1-26 0.160675 0.01612   B 
 
sms1-26 0.022275 0.00282 A   
sms1-28 0.21765 0.01612 A B 
 
sms1-28 0.0284 0.00282 A   
Ecto1 0.210625 0.01612 A B 
 
Ecto1 0.028 0.00282 A   
SN15 0.258525 0.01612 A   
 
SN15 0.0334 0.00282 A   
C5 
Strain Mean Std Error Tukey 
 
C10 
Strain Mean Std Error Tukey 
sms1-26 0.254325 0.01447 A   
 
sms1-26 0.0016 0.00158   B 
sms1-28 0.21015 0.01447 A   
 
sms1-28 0.004125 0.00158   B 
Ecto1 0.21745 0.01447 A   
 
Ecto1 0.004175 0.00158   B 
SN15 0.232875 0.01447 A   
 
SN15 0.0123 0.00158 A   
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Appendix VIII Tukey-Kramer analysis of growth assay (continued) 
PKS1 
C1 
Strain Mean Std Error Tukey 
 
C6 
Strain Mean Std Error Tukey 
pks1-16 0.550325 0.13117 A   
 
pks1-16 0.3272 0.07661 A   
pks1-48 0.427425 0.13117 A   
 
pks1-48 0.2615 0.07661 A   
Ecto1 0.607325 0.13117 A   
 
Ecto1 0.306775 0.07661 A   
SN15 0.456075 0.13117 A   
 
SN15 0.37555 0.07661 A   
C2 
Strain Mean Std Error Tukey 
 
C7 
Strain Mean Std Error Tukey 
pks1-16 0.5328 0.07611 A   
 
pks1-16 1.36773 0.19276 A   
pks1-48 0.5983 0.07611 A   
 
pks1-48 1.42593 0.19276 A   
Ecto1 0.355475 0.07611 A   
 
Ecto1 0.92953 0.19276 A   
SN15 0.41635 0.07611 A   
 
SN15 1.31793 0.19276 A   
C3 
Strain Mean Std Error Tukey 
 
C8 
Strain Mean Std Error Tukey 
pks1-16 0.058775 0.00644 A   
 
pks1-16 0.1468 0.02941 A   
pks1-48 0.0809 0.00644 A   
 
pks1-48 0.148775 0.02941 A   
Ecto1 0.060775 0.00644 A   
 
Ecto1 0.1737 0.02941 A   
SN15 0.07 0.00644 A   
 
SN15 0.233025 0.02941 A   
C4 
Strain Mean Std Error Tukey 
 
C9 
Strain Mean Std Error Tukey 
pks1-16 0.2175 0.00826 A   
 
pks1-16 0.040325 0.00712 A B 
pks1-48 0.22015 0.00826 A   
 
pks1-48 0.043775 0.00712 A B 
Ecto1 0.23965 0.00826 A   
 
Ecto1 0.03485 0.00712   B 
SN15 0.223675 0.00826 A   
 
SN15 0.07005 0.00712 A   
C5 
Strain Mean Std Error Tukey 
 
C10 
Strain Mean Std Error Tukey 
pks1-16 0.3272 0.06821 A   
 
pks1-16 0.004575 0.00167 A   
pks1-48 0.39455 0.06821 A   
 
pks1-48 0.003275 0.00167 A   
Ecto1 0.321375 0.06821 A   
 
Ecto1 0.00345 0.00167 A   
SN15 0.432325 0.06821 A   
 
SN15 0.0091 0.00167 A   
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Appendix VIII Tukey-Kramer analysis of growth assay (continued) 
PKS3 
C1 
Strain Mean Std Error Tukey 
 
C6 
Strain Mean Std Error Tukey 
pks3-1 0.599 0.11508 A   
 
pks3-1 0.51865 0.10012 A   
pks3-16 0.4206 0.11508 A   
 
pks3-16 0.374875 0.10012 A   
Ecto1 0.37995 0.11508 A   
 
Ecto1 0.444725 0.10012 A   
SN15 0.64875 0.11508 A   
 
SN15 0.469825 0.10012 A   
C2 
Strain Mean Std Error Tukey 
 
C7 
Strain Mean Std Error Tukey 
pks3-1 0.76065 0.12996 A   
 
pks3-1 1.59015 0.11964 A   
pks3-16 0.7298 0.12996 A   
 
pks3-16 1.4079 0.11964 A   
Ecto1 0.542225 0.12996 A   
 
Ecto1 1.54868 0.11964 A   
SN15 0.637125 0.12996 A   
 
SN15 1.30873 0.11964 A   
C3 
Strain Mean Std Error Tukey 
 
C8 
Strain Mean Std Error Tukey 
pks3-1 0.193925 0.02789 A   
 
pks3-1 0.1222 0.01991 A   
pks3-16 0.105375 0.02789 A   
 
pks3-16 0.196825 0.01991 A   
Ecto1 0.092325 0.02789 A   
 
Ecto1 0.158575 0.01991 A   
SN15 0.0971 0.02789 A   
 
SN15 0.1849 0.01991 A   
C4 
Strain Mean Std Error Tukey 
 
C9 
Strain Mean Std Error Tukey 
pks3-1 0.20715 0.00891 A   
 
pks3-1 0.035475 0.00551 A   
pks3-16 0.20785 0.00891 A   
 
pks3-16 0.024475 0.00551 A   
Ecto1 0.198375 0.00891 A   
 
Ecto1 0.0228 0.00551 A   
SN15 0.189525 0.00891 A   
 
SN15 0.029325 0.00551 A   
C5 
Strain Mean Std Error Tukey 
 
C10 
Strain Mean Std Error Tukey 
pks3-1 0.565325 0.06897 A   
 
pks3-1 0.00035 0.00115 A   
pks3-16 0.307 0.06897 A B 
 
pks3-16 0.002375 0.00115 A   
Ecto1 0.25795 0.06897   B 
 
Ecto1 0.0012 0.00115 A   
SN15 0.2727 0.06897   B 
 
SN15 0.002975 0.00115 A   
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Appendix IX Disease scores  
Disease scores are given per pot and strain used with averages, standard deviation and 
standard error per strain. S1-1/2: sms1-26/28; P1-1/2: pks1-16/48; P3-1/2: pks3-1/16; 
Ecto: ectopic (pks3-27) 
Pot Strain  Score   Pot Strain  Score   Pot Strain  Score 
23 S1-1 8 
 
7 P1-1 8 
 
14 P3-1 9 
49 S1-1 8 
 
13 P1-1 8 
 
22 P3-1 9 
50 S1-1 8 
 
34 P1-1 8 
 
28 P3-1 9 
63 S1-1 7 
 
53 P1-1 8 
 
40 P3-1 9 
73 S1-1 8 
 
65 P1-1 8 
 
45 P3-1 8 
76 S1-1 8 
 
74 P1-1 8 
 
46 P3-1 9 
81 S1-1 7 
 
78 P1-1 8 
 
61 P3-1 8 
82 S1-1 7   80 P1-1 8   66 P3-1 9 
           
Pot Strain  Score   Pot Strain  Score   Pot Strain  Score 
4 S1-2 7 
 
3 P1-2 8 
 
2 P3-2 8 
32 S1-2 8 
 
10 P1-2 8 
 
11 P3-2 8 
35 S1-2 8 
 
16 P1-2 9 
 
17 P3-2 8 
55 S1-2 7 
 
31 P1-2 9 
 
27 P3-2 8 
62 S1-2 8 
 
33 P1-2 9 
 
30 P3-2 8 
68 S1-2 7 
 
43 P1-2 7 
 
42 P3-2 8 
70 S1-2 8 
 
59 P1-2 8 
 
48 P3-2 9 
84 S1-2 8   69 P1-2 9   71 P3-2 8 
           Pot Strain  Score   Pot Strain  Score   Pot Strain  Score 
6 Ecto 9 
 
1 SN15 8 
 
5 Tween 1 
9 Ecto 8 
 
12 SN15 7 
 
8 Tween 1 
19 Ecto 9 
 
15 SN15 7 
 
18 Tween 1 
25 Ecto 8 
 
38 SN15 8 
 
24 Tween 1 
39 Ecto 9 
 
47 SN15 8 
 
26 Tween 1 
67 Ecto 9 
 
64 SN15 7 
 
29 Tween 1 
77 Ecto 7 
 
75 SN15 7 
 
36 Tween 1 
79 Ecto 9   83 SN15 8   37 Tween 1 
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Appendix X Detached leaf assays – necrotic lesion sizes 
Sizes [mm] for individual replicate leaves, average and standard error are given for 
necrotic lesions for the respective strains. Strains not connected have significantly 
different means (p<0.05)  
7dpi 
strain lesion size in mm average  std err. Tukey  
SN15 7 6 5 7 6.25 0.48 A  
Ecto1 7 7 6 6 6.5 0.29 A  
Tween 0 0 1 0 0.25 0.25  B 
sms1-26 6 7 5 6 6 0.41 A  
sms1-28 8 6 6 7 6.75 0.48 A  
         
strain lesion size in mm average std err. Tukey  
SN15 6 4 5 6 5.25 0.48 A  
Ecto1 5 4 6 6 5.25 0.48 A  
Tween 0 0 0 0 0 0  B 
pks1-16 4 5 6 5 5 0.41 A  
pks1-48 6 5 5 5 5.25 0.25 A  
         
strain lesion size in mm average std err. Tukey  
SN15 7 7 7 6 6.75 0.25 A  
Ecto1 7 6 6 6 6.25 0.25 A  
Tween 0 0 1 0 0.25 0.25  B 
pks3-1 8 6 6 7 6.75 0.41 A  
pks3-16 6 7 5 6 6 0.48 A  
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Appendix X Detached leaf assays – necrotic lesion sizes (continued) 
14dpi 
strain lesion size in mm average std err. Tukey  
SN15 20 20 18 17 18.75 0.75 A  
Ecto1 16 20 20 19 18.75 0.95 A  
Tween 0 0 1 0 0.25 0.25  B 
sms1-26 18 20 20 20 19.5 0.5 A  
sms1-28 18 20 19 18 18.75 0.48 A  
         
strain lesion size in mm average std err. Tukey  
SN15 18 18 19 18 18.25 0.25 A  
Ecto1 19 18 18 20 18.75 0.48 A  
Tween 0 0 0 0 0 0  B 
pks1-16 21 17 17 18 18.25 0.95 A  
pks1-48 18 17 19 19 18.25 0.48 A  
         
strain lesion size in mm average std err. Tukey  
SN15 20 20 20 20 20 0 A  
Ecto1 21 20 20 20 20.25 0.25 A  
Tween 0 0 2 0 0.5 0.5  B 
pks3-1 21 21 20 20 20.5 0.48 A  
pks3-16 18 20 19 20 19.25 0.29 A  
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Appendix XI Spore counts in vitro and in planta for individual strains 
Three technical replicate spore counts, average and standard error are given for each 
individual strain. Spore counts were done in triplicate from pooled samples. Strains not 
connected have significantly different means (p<0.05) 
strain spores in vitro avg std err Tukey 
SN15 1.69E+08 1.50E+08 1.20E+08 1.46E+08 1.41E+07 A  
Ecto1 1.40E+08 1.49E+08 1.29E+08 1.39E+08 5.70E+06 A  
sms1-26 1.50E+08 1.42E+08 1.29E+08 1.40E+08 6.13E+06 A  
sms1-28 1.40E+08 1.52E+08 1.39E+08 1.43E+08 4.17E+06 A  
pks1-16 1.60E+08 1.39E+08 1.21E+08 1.40E+08 1.13E+07 A  
pks1-48 1.23E+08 1.31E+08 1.60E+08 1.38E+08 1.12E+07 A  
pks3-1 1.43E+08 1.46E+08 1.41E+08 1.43E+08 1.50E+06 A  
pks3-16 1.49E+08 1.42E+08 1.40E+08 1.43E+08 2.92E+06 A  
      
 
strain spores in planta avg std err Tukey 
SN15 7.00E+05 6.55E+05 5.75E+05 6.43E+05 3.66E+04 A  
Ecto1 5.50E+05 5.50E+05 4.90E+05 5.30E+05 2.00E+04 A B 
sms1-26 5.75E+05 5.50E+05 5.20E+05 5.48E+05 1.59E+04 A B 
sms1-28 5.00E+05 6.00E+05 5.00E+05 5.33E+05 3.33E+04 A B 
pks1-16 5.25E+05 5.00E+05 4.90E+05 5.05E+05 1.04E+04  B 
pks1-48 5.45E+05 5.70E+05 5.60E+05 5.58E+05 7.26E+03  B 
pks3-1 6.00E+05 5.00E+05 6.50E+05 5.83E+05 4.41E+04 A B 
pks3-16 5.25E+05 4.90E+05 4.70E+05 4.95E+05 1.61E+04 A B 
 
